Medizinische Universität Graz - Research portal

Logo MUG Resarch Portal

Mader Julia |

Presentations at scientific and public conferences

Brosen, JMB; Divilly, P; Martine-Edith, G; Zaremba, N; Ali, N; Evans, M; McCrimmon, R; Heller, S; de Galan, B; Mader, J; Renard, E; Vaag, AA; Choudhary, P; Bjergaard, UP Hypoglycaemia measured by continuous glucose monitoring in people with insulin-treated type 2 diabetes and chronic kidney disease: post hoc analysis from the HypoMETRICS study
DIABETOLOGIA. Abstracts. 2024; 67: S390-S391.-60th Annual Meeting of the EASD; SEP 9-13, 2024; Madrid, SPAIN. [Oral Communication]
Web of Science

 

De Ridder, F; Dovc, K; Potocnik, N; Oberosler, M; Kheir, S; Windhaber, J; Mader, JK; Battelino, T; De Block, C Cardiopulmonary and aerobic exercise tests assessing multiple biomarkers and hormones in type 1 diabetes under different circumstances: the act-one study
DIABETOLOGIA. Abstracts. 2024; 67: S513-S513.-60th Annual Meeting of the EASD; SEP 9-13, 2024; Madrid, SPAIN. [Oral Communication]
Web of Science

 

Divilly, P; Martine-Edith, G; Mahmoudi, Z; Zaremba, N; Soholm, U; Broadley, M; de Galan, B; Pedersen-Bjergaard, U; McCrimmon, RJ; Renard, E; Heller, S; Evans, M; Mader, JK; Seibold, A; Speight, J; Amiel, SA; Choudhary, P Symptomatic hypoglycaemia in insulin treated Type 2 Diabetes assessed by real time person reported hypoglycaemia and continuous glucose monitoring based on awareness status: the Hypo-METRICS study
IRISH J MED SCI. Abstracts. 2024; 193: S127-S127.-46th Annual Meeting of the Irish Endocrine Society; NOV 11-12, 2022; Dublin, IRELAND. [Oral Communication]
Web of Science

 

Fan, K; Paterson, M; Manoli, A; Shojaee-Moradie, F; Edwards, V; Lee, V; Hutchison, E; Koehler, G; Mathieu, C; Mader, J; King, B; Russell-Jones, D Simulated commercial flights and the effects of atmospheric pressure changes on insulin pump delivery
DIABETOLOGIA. Abstracts. 2024; 67: S400-S400.-60th Annual Meeting of the EASD; SEP 9-13, 2024; Madrid, SPAIN. [Oral Communication]
Web of Science

 

Hochfellner, DA; Pöttler, T; Schörghuber, M; Lukic, E; Yates, A; Keeling, I; Zimpfer, D; Elsayed, H; Aberer, F; Berti. F; Lucarelli, F; Valgimigli, F; Mader, J; Accuracy and Safety of an Intravascular Continuous Glucose Monitoring System (ivCGM) in Patients on Cardiac Surgical Intensive Care Unit – A Pilot Study
Wien Klin Wochenschr (2024) . 2024; (136):689-724.-52. Jahrestagung der Österreichischen Diabetes Gesellschaft; NOV 14–16, 2024; Salzburg, AUSTRIA. [Poster]
FullText

 

Kulzer, B; Ehrmann, D; Heinemann, L; Faber-Heinemann, G; Roos, T; Resl, M; Mader, J; Diem, P; Truempy, C; Brandt, D; Hermanns, N Can AID systems reduce diabetes-related stress?
DIABETOLOGIA. Abstracts. 2024; 67: S419-S419.-60th Annual Meeting of the EASD; SEP 9-13, 2024; Madrid, SPAIN. [Poster]
Web of Science

 

Mader, JK; Baumann, PM; Cigler, M; Poettler, T; Oberosler, M; Gruber, J; Kheir, S; Harer, C; Meçani, R; Sourij, H 996-P: Correlation of GMI with HbA1c in People Living with Diabetes over Time.
Diabetes 2024;73(Supplement_1):996-P. 2024; -American Diabetes Association 84TH SCIENTIFIC SESSIONS; JUN 21-24, 2024; Orlando, FL. [Poster]
FullText

 

Mader, JK; Hartvig, NV; Kaas, A; Knudsen, NN; Winhofer, Y Improvement in time in range after smart insulin pen initiation in Austria
DIABETOLOGIA. Abstracts. 2024; 67: S131-S131.-60th Annual Meeting of the EASD; SEP 9-13, 2024; Madrid, SPAIN. [Oral Communication]
Web of Science

 

Mecani, R; Aleksi, K; Gold, H; Scheipl, G; Mader, J; Scheipl, S The Impact of Gender, Race, and Socioeconomic Factors on Mortality and Amputation Risk in Diabetes: A review of longitudinal studies.
Abstract Band des 3. Österreichischen Kongresses für Orthopädie und Traumatologie. 2024; 68-68.-3. Österreichischer Kongress für Orthopädie und Traumatologie; JUN 26-28, 2024; Linz, AUSTRIA. [Poster]

 

Mecani, R; Aleksi, K; Gold, H; Scheipl, G; Mader, J; Scheipl, S . The Impact of Gender, Race, and Socioeconomic Factors on Mortality and Amputation Risk in Diabetes: A review of longitudinal studies
52. ÖDG-Jahrestagung 2024;; Salzburg, Austria. 2024. . 2024; -52. ÖDG-Jahrestagung 2024;; Salzburg, Austria. 2024. ; NOV 14-16, 2024; Salzburg, Austria. [Poster]
FullText

 

Scheipl, S; Mader, J; Ornig, M Gender Aspects of Foot Disorders. Interims Report of Project Group “Medical University of Graz”.
MedSens Projekt-Meeting 08; MAR 12, 2024; Joanneum Research Policies, Graz, Austria. 2024. [Oral Communication]

 

Scheipl, S; Mader, J; Ornig, M Gender Aspects of Foot Disorders. Final Report of Project Group “Medical University of Graz”.
MedSens Projekt-Meeting 09 ; DEC 16, 2024; Joanneum Research Forschungsgesellschaft mbH, Institut DIGITAL, Graz, Austria. 2024. [Oral Communication]

 

Adolfsson, P; Hartvig, NV; Kaas, A; Knudsen, NN; Mader, JK Improvement in time in range after smart pen initiation in routine clinical practice
DIABETOLOGIA. 2023; 66(SUPPL 1):S81-S82.-59th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD); OCT 02-06, 2023; Hamburg, GERMANY. [Oral Communication]
Web of Science

 

Adolfsson, P; Hartvig, NV; Kaas, A; Knudsen, NN; Mader, JK Improvement in time in range after smart pen initiation in routine clinical practice
WIEN KLIN WOCHENSCHR. 2023; 135: S768-S768. [Poster]
Web of Science

 

Alwan, H; Ware, J; Wilinska, M; Boughton, C; Allen, J; Lakshman, R; Nwokolo, M; Hartnell, S; Bally, L; De Beaufort, C; Besser, R; Campbell, F; Evans, M; Frohlich-Reiterer, E; Ghatak, A; Hofer, S; Kapellen, T; Leelarathna, L; Mader, J; Narendran, P; Rami-Mehrar, B; Thabit, H; Thankamony, A; Denvir, L; Davis, N; Hovorka, R TIME SPENT IN HYPOGLYCAEMIA ACCORDING TO AGE AND TIME OF DAY: OBSERVATIONS DURING CLOSED-LOOP INSULIN DELIVERY
DIABETES TECHNOL THE. 2023; 25: A134-A134. [Poster]
Web of Science

 

Auzannneau, M; Schwettmann, L; Mader, J; Jung, R; Altmeier, M; Kopp, F; Zeyfang, A; Holl, RW SOCIOECONOMIC DISPARITIES IN ACCESS TO CGM FOR ADULTS WITH DIABETES. RESULTS FROM THE GERMAN DPV REGISTRY
DIABETES TECHNOL THE. 2023; 25: A57-A57. [Poster]
Web of Science

 

Baumann, P; Cigler, M; Kuznetsov, D; Rosilio, M; Hochfellner, D; Ibberson, M; Amiel, S; Heller, S; Gall, MA; De Galan, B; Pieber, T; Choudhary, P; Mader, J ASSOCIATION OF SENSOR-DETECTED HYPOGLYCAEMIC EPISODES (SDHE) WITH HYPOGLYCAEMIA FROM SMBG IN 15 CLINICAL TRIALS WITH SHORT-DURATION CGM. PRELIMINARY RESULTS FROM THE HYPO-RESOLVE DATABASE
DIABETES TECHNOL THE. Abstracts. 2023; 25(S2):A157-A157.-ATTD 2023 Conference; FEB 22-25, 2023; Berlin, GERMANY. [Poster]
Web of Science

 

Baumann, PM; Cigler, M; Hochfellner, D; Kuznetsov, D; Rosilio, M; Ibberson, M; Amiel, SA; Heller, S; Gall, MA; de Galan, B; Choudhary, P; Mader, JK How well does sensor-detected hypoglycaemia (SDH) from short-duration CGM reflect person-reported hypoglycaemia (PRH)?
WIEN KLIN WOCHENSCHR. Abstracts. 2023; 135(Suppl7):S753-S753.-51. Jahrestagung der ÖDG; NOV 16-18, 2023; Salzburg, AUSTRIA. [Poster]
Web of Science

 

Baumann, PM; Cigler, M; Kuznetsov, D; Rosilio, M; Hochfellner, D; Ibberson, M; Amiel, SA; Heller, S; Gall, MA; de Galan, B; Pieber, TR; Choudhary, P; Mader, JK How well does sensor-detected hypoglycaemia from short-duration CGM reflect person-reported hypoglycaemia?
DIABETOLOGIA. 2023; 66(SUPPL 1):S407-S408.-59th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD); OCT 02-06, 2023; Hamburg, GERMANY. [Oral Communication]
Web of Science

 

Bergenstal, R; Watt, SK; Matos, ALSA; Lingvay, I; Mader, JK; Nishida, T; Rosenstock, J CGM outcomes and hypoglycemia duration with once-weekly insulin icodec versus oncedaily insulin glargine U100 in insulin-naive T2D: ONWARDS 1 exploratory analysis
WIEN KLIN WOCHENSCHR. 2023; 135: S767-S768. [Poster]
Web of Science

 

Bergenstal, R; Watt, SK; Matos, ASA; Lingvay, I; Mader, JK; Nishida, T; Rosenstock, J CGM outcomes and hypoglycaemia duration with once-weekly insulin icodec versus once-daily insulin glargine u100 in insulin-naive type 2 diabetes: ONWARDS 1 exploratory analysis
DIABETOLOGIA. 2023; 66(SUPPL 1):S397-S397.-59th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD); OCT 02-06, 2023; Hamburg, GERMANY. [Oral Communication]
Web of Science

 

Cigler, M; Soholm, U; Abbink, E; Ali, N; Baumann, P; Pouwer, F; Broadley, M; Place, J; Farret, A; Renard, E; Evans, M; Chapman, D; Kennet, J; Brosen, JMB; Pedersen-Bjergaard, U; Mc Crimmon, R; Heller, S; Caunt, S; Speight, J; Divilly, P; Choudhary, P; Mader, JK The Hypo-METRICS App - a quantitative assessment of user experience
WIEN KLIN WOCHENSCHR. Abstracts. 2023; 135(Suppl7):S756-S757.-51. Jahrestagung der ÖDG; NOV 16-18, 2023; Salzburg, AUSTRIA. [Poster]
Web of Science

 

Danne, T; Hartivig, NV; Kaas, A; Knudsen, NN; Mader, JK Association between treatment adherence and continuous glucose monitoring outcomes in people with diabetes using smart insulin pens in a real-world setting
DIABETOLOGIA. 2023; 66(SUPPL 1):S434-S435.-59th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD); OCT 02-06, 2023; Hamburg, GERMANY. [Oral Communication]
Web of Science

 

Divilly, P; Mahmoudi, Z; Martine-Edith, G; Zaremba, N; de Galan, B; Pedersen-Bjergaard, U; McCrimmon, R; Renard, E; Heller, S; Evans, M; Mader, J; Speight, J; Amiel, S; Pouwer, F; Choudhary, P Factors associated with symptomatic hypoglycaemia are different from those for CGM hypoglycaemia in people living with type 1 diabetes: the Hypo-METRICS study
DIABETOLOGIA. 2023; 66(SUPPL 1):S407-S407.-59th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD); OCT 02-06, 2023; Hamburg, GERMANY. [Oral Communication]
Web of Science

 

Divilly, P; Mahmoudi, Z; Martine-Edith, G; Zaremba, N; Soholm, U; Broadley, M; De Galan, B; Pedersen-Bjergaard, U; Mccrimmon, R; Renard, E; Heller, S; Evans, M; Mader, J; Seibold, A; Speight, J; Amiel, S; Choudhary, P ASSOCIATION BETWEEN PERSON-REPORTED HYPOGLYCAEMIA AND TIME BELOW RANGE: THE HYPO-METRICS STUDY
DIABETES TECHNOL THE. 2023; 25: A59-A59. [Oral Communication]
Web of Science

 

Fritsch, M; Fröhlich-Reiterer, E; Plecko, B; Mader, J Therapy induced diabetic neuropathy - a rare, but painful complication in an adolescent with type 1 diabetes
Pediatric Diabetes. 2023; Suppl: -49 th Meeting ISPAD; OCT 18-21 , 2023; Rotterdam. [Poster]

 

Harer, C; Novak, E; Pandis, M; Mader, JK; Treiber, G Sheehan-Syndrom als postpartales Risiko bei mitochondrialem Diabetes mellitus
Journal für Klinische Endokrinologie und Stoffwechsel. 2023; 16(1):29-29.-25. Jahrestagung der ÖGES; April 26-28, 2023; Linz. [Oral Communication]

 

Hochfellner, DA; Poettler, T; Schoerghuber, M; Lukic, E; Yates, A; Keeling, I; Zimpfer, D; Roubik, L; Elsayed, H; Aberer, F; Berti, F; Lucarelli, F; Valgimigli, F; Mader, JK; Intravenous Continuous Glucose Monitoring in Hospitalized Patients in a Critical Care Unit: Safety and Efficacy of a Novel Intravascular Continuous Glucose Monitoring System - A Pilot Trial
DIABETES TECHNOLOGY MEETING; NOV 2-4, 2023; Burlingame, California, USA;. 2023. [Oral Communication]

 

Kaser, S; Sourij, H; Clodi, M; Aziz, F; Fasching, P; Fritsch, M; Kojzar, H; Ludvik, B; Mader, J; Resl, M; Rega-Kaun, G; Ress, C; Sourij, C; Stechemesser, L; Stingl, H; Tripolt, N; Wascher, T Characteristics of people with type 2 diabetes in Austrian primary care - data from the AUSTRO-PROFIT study
WIEN KLIN WOCHENSCHR. Abstracts. 2023; 135(Suppl7):S781-S782.-51. Jahrestagung der ÖDG; NOV 16-18, 2023; Salzburg, AUSTRIA. [Oral Communication]
Web of Science

 

Kingsnorth, A; Divilly, P; Mahmoudi, Z; Martine-Edith, G; Zaremba, N; Soholm, U; De Galan, B; Pedersen-Bjergaard, U; Mccrimmon, R; Renard, E; Heller, S; Evans, M; Mader, J; Amiel, S; Pouwer, F; Choudhary, P EVALUATING THE IMPACT OF DAILY STEP COUNT ON GLUCOSE INDICES ACROSS 10 WEEKS OF MONITORING: THE HYPO-METRICS STUDY
DIABETES TECHNOL THE. 2023; 25: A149-A149. [Oral Communication]
Web of Science

 

Kingsnorth, AP; Martine-Edith, G; Divilly, P; Pedersen-Bjergaard, U; McCrimmon, RJ; de Galan, B; Heller, S; Evans, M; Mader, J; Choudhary, P Exploring associations of step data with time in range and hypoglycaemia in people living with type 1 diabetes: The hypo-METRICS study
DIABETIC MED. 2023; 40: [Oral Communication]
Web of Science

 

Mader, J MONITORING OF DIABETIC FOOT DISEASE
DIABETES TECHNOL THE. 2023; 25: A34-A34. [Oral Communication]
Web of Science

 

Mader, JK; Fornengo, R; Hassoun, A; Heinemann, L; Kulzer, B; Monica, M; Nguyen, T; Sieber, J; Renard, E; Reznik, Y; Rys, P; Stozek-Tutro, A; Wilmot, EG Relationship between lipohypertrophy, glycemic control, and insulin dosing: a systematic meta-analysis
WIEN KLIN WOCHENSCHR. 2023; 135: S769-S769. [Poster]
Web of Science

 

Martine-Edith, G; Divilly, P; Zaremba, N; Soholm, U; Broadley, M; Baumann, P; de Galan, B; McCrimmon, RJ; Evans, M; Mader, JK; Amiel, SA; Speight, J; Pouwer, F; Choudhary, P Quantifying intensity of hypoglycaemia symptoms by diabetes type and hypoglycaemia awareness status: results from the Hypo-METRICS study
DIABETOLOGIA. 2023; 66(SUPPL 1):S409-S410.-59th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD); OCT 02-06, 2023; Hamburg, GERMANY. [Oral Communication]
Web of Science

 

Scheikl, K; Pöttler, T; Harer, CM; Schmitt, LM; Mecani, R; Mader, JK; Treiber, G Significant increase in diabetic ketoacidosis in adults with diabetes mellitus
WIEN KLIN WOCHENSCHR. 2023; 135: S779-S779. [Poster]
Web of Science

 

Soholm, U; Broadley, M; Zaremba, N; Divilly, P; Martine-Edith, G; Nefs, G; Mahmoudi, Z; Gomes, M; Mader, J; Cigler, M; Renard, E; Abbink, E; Baumann, PM; Heller, S; De Galan, B; Pedersen-Bjergaard, U; Evans, M; Pollard, D; Mccrimmon, R; Amiel, S; Hendrieckx, C; Speight, J; Choudhary, P; Pouwer, F IMPACT OF NOCTURNAL SYMPTOMATIC AND ASYMPTOMATIC PERSON-REPORTED HYPOGLYCAEMIA ON MORNING FUNCTIONING AMONG ADULTS WITH INSULIN-TREATED DIABETES: THE HYPO-METRICS STUDY
DIABETES TECHNOL THE. 2023; 25: A266-A267. [Oral Communication]
Web of Science

 

Sourij, H; Clodi, M; Aziz, F; Fasching, P; Fritsch, M; Kojzar, H; Ludvik, B; Mader, J; Resl, M; Rega-Kaun, G; Ress, C; Sourij, C; Stechemesser, L; Stingl, H; Wascher, T; Kaser, S Prevalence of undiagnosed glucose metabolism disorders during preventive examinations - data from the AUSTRO-PROFIT study
WIEN KLIN WOCHENSCHR. Abstracts. 2023; 135(Suppl7):S782-S782.-51. Jahrestagung der ÖDG; NOV 16-18, 2023; Salzburg, AUSTRIA. [Poster]
Web of Science

 

Tauschmann, M; Rabensteiner, B; Blauensteiner, N; Baumann, P; Rami-Merhar, B; Mader, J USE OF AID SYSTEMS VERSUS STANDARD SENSOR-AUGMENTED THERAPY DURING A 14-DAY DIABETES SUMMER CAMP: AN OBSERVATIONAL STUDY
DIABETES TECHNOL THE. 2023; 25: A141-A141. [Poster]
Web of Science

 

Alwan H, Ware J, Wilinska M, Boughton C, Allen J, Lakshman R, Nwokolo M, Hartnell S, Bally L, de Beaufort C, Besser R, Campbell F, Evans M, Fröhlich-Reiterer E, Ghatak A, Hofer S, Kapellen T, Leelarathna1 L, Mader JK, Narendran P, Rami-Mehrar B, Thabit H, Thankamony A, Denvir L, Davis N, Hovorka R,; on behalf of the AP@home, DAN05, DAN06 and KidsAP consortia Time spent in hypoglycaemia according to age and time of day: Observations during closed-loop insulin delivery
Diabetes Technology and Therapeutics 2022: Vol 24; Issue 1 p 5. 2022; -ATTD Advanced Technologies & Treatments for Diabetes CONFERENCE; 27–30 April 2022 ; Barcelona. [Poster]

 

Baumann, P; Cigler, M; Kuznetsov, D; Rosilio, M; Hochfellner, D; Ibberson, M; Amiel, S; Heller, S; Gall, MA; De Galan, B; Pieber, T; Choudhary, P; Mader, JK SENSOR-DETECTED HYPOGLYCAEMIA IN SHORT-DURATION CGM DATA FROM MULTIPLE CLINICAL TRIALS IN DIABETES. PRELIMINARY RESULTS FROM THE HYPO-RESOLVE DATABASE.
DIABETES TECHNOL THE. Abstracts from ATTD 2022. 2022; 24(S1):A31-A32.-15th International Conference on Advanced Technologies and Treatments for Diabetes; APR 27-30, 2022; Barcelona, SPAIN. [Poster]
Web of Science

 

Baumann, P; Hochfellner, DA; Cigler, M; Roubik, L; Pottler, T; Mader, JK Gender differences in within-day glycaemic variations in people with T1D. Insights from long-duration CGM data from a diabetes registry
WIEN KLIN WOCHENSCHR. 2022; 134(SUPPL 4):231-232. [Poster]
Web of Science

 

Baumann, PM; Hochfellner, DA; Cigler, M; Roubik, L; Pottler, T; Mader, JK Patterns of sensor-detected hypoglycaemia in long-duration CGM data from a diabetes registry
DIABETOLOGIA. 2022; 65(SUPPL 1):S323-S323. [Oral Communication]
Web of Science

 

Boughton, C; Hartnell, S; Thabit, H; Mubita, W; Draxlbauer, K; Poettler, T; Wilinska, M; Hood, K; Mader, J; Narendran, P; Leelarathna, L; Evans, M; Hovorka, R HYBRID CLOSED-LOOP GLUCOSE CONTROL COMPARED WITH SENSOR AUGMENTED PUMP THERAPY IN OLDER ADULTS WITH TYPE 1 DIABETES: A MULTICENTRE, MULTINATIONAL, RANDOMISED, CROSSOVER STUDY
DIABETES TECHNOL THE. Abstracts from ATTD 2022. 2022; 24(S1):A54-A55.-15th International Conference on Advanced Technologies and Treatments for Diabetes; APR 27-30, 2022; Barcelona, SPAIN. [Oral Communication]
Web of Science

 

Cigler, M; Baumann, P; Elsayed, H; Hochfellner, D; Pottler, T; Secco, K; Simic, A; Trajanoski, S; Groselj-Strele, A; Mader, J Improved HbA1c is associated with better glycemic control in continuous glucose monitoring systems, but glycemic control is not influenced by treatment type or CGM duration
WIEN KLIN WOCHENSCHR. 2022; 134(SUPPL 4):234-234. [Poster]
Web of Science

 

Divilly, P; Martine-Edith, G; Mahmoudi, Z; Zaremba, N; Soeholm, U; De Galan, B; Pedersen-Bjergaard, U; Mccrimmon, R; Renard, E; Heller, S; Evans, M; Mader, J; Seibold, A; Amiel, S; Choudhary, P RATES OF SENSOR DETECTED HYPOGLYCAEMIA AND PATIENT REPORTED HYPOGLYCAEMIA; PRELIMINARY DATA FROM THE HYPO-METRICS TRIAL
DIABETES TECHNOL THE. Abstracts from ATTD 2022. 2022; 24(S1):A44-A45.-15th International Conference on Advanced Technologies and Treatments for Diabetes; APR 27-30, 2022; Barcelona, SPAIN. [Oral Communication]
Web of Science

 

Harer, C; Hochfellner, D; Aberer, F; Mader, JK; Treiber, G Immune checkpoint inhibitor therapy-induced type 1 diabetes mellitus or precipitation of pre-symptomatic (stage 1) type 1 diabetes mellitus?
WIEN KLIN WOCHENSCHR. Abstracts der 50. Jahrestagung der Österreichischen Diabetes Gesellschaft. 2022; 134(SUPPL 4):242-242.-50. Jahrestagung der Österreichischen Diabetes Gesellschaft; NOV 17-19, 2022; Salzburg, AUSTRIA. [Poster]
Web of Science

 

Hochfellner, D; Baumann, P; Beck, P; Mader, J ALGORITHM-DRIVEN BASAL-BOLUS THERAPY IN HOSPITALIZED PATIENTS WITH TYPE 2 DIABETES: IMPLICATIONS FOR DISCHARGE THERAPY
DIABETES TECHNOL THE. Abstracts from ATTD 2022. 2022; 24(S1):A28-A28.-15th International Conference on Advanced Technologies and Treatments for Diabetes; APR 27-30, 2022; Barcelona, SPAIN. [Oral Communication]
Web of Science

 

Hochfellner, DA; Baumann, P; Reinhard, A; Pottler, T; Roubik, L; Kogler, S; Cigler, M; Treiber, G; Mader, J Switching from isCCGM without alarms to isCCGM with alarms: what is the benefit?
WIEN KLIN WOCHENSCHR. 2022; 134(SUPPL 4):244-244.-ÖDG Jahrestagung 2022; NOV 17-19; Salzburg, AUSTRIA. [Poster]
Web of Science

 

Hochfellner, DA; Baumann, PM; Reinhard, AK; Mader, JK Introduction of isCGM with glucose alarms to regular isCGM users under real-life conditions: What is the benefit?
DIABETOLOGIA. 2022; 65(SUPPL 1):S350-S350.-EASD 2022; SEP 19-23, 2022; Stockholm, SWEDEN. [Oral Communication]
Web of Science

 

Kastner, J; Poettler, T; Kopanz, J; Hochfellner, D; Siegl, R; Romey, M; Muchmore, D; Strasma, P; Mader, J CURRENT INSULIN INFUSION SET CRITERIA DO NOT REPRESENT REAL-LIFE SETTING AND MAY SKEW INFUSION SET FAILURE OUTCOMES IN EXTENDED-WEAR INFUSION SET STUDIES
DIABETES TECHNOL THE. Abstracts from ATTD 2022. 2022; 24(S1):A212-A212.-15th International Conference on Advanced Technologies and Treatments for Diabetes; APR 27-30, 2022; Barcelona, SPAIN. [Poster]
Web of Science

 

Lichtenegger, K; Scholle, L; Kopanz, J; Libiseller, A; Reinisch-Gratzer, J; Ambrosch, G; Donsa, K; Sinner, F; Pieber, T; Klampfl-Kenny, M; Mader, J Diabetes prevalence and quality of diabetes management before, during and after the implementation of digital decision support for mobile care and support
WIEN KLIN WOCHENSCHR. 2022; 134(SUPPL 4):248-248. [Poster]
Web of Science

 

Mader, J; Siegl, R; Reinhard, A; Kopanz, J; Simic, A; Hartmann, M; Banerjee, S; Kamecke, U; Rebrin, K PERFORMANCE EVALUATION OF SUBCUTANEOUS GLUCOSE MONITORING IN CLINICAL DEVELOPMENT-OPTICAL MEASUREMENT PROFUSA LUMEE GLUCOSE PLATFORM
DIABETES TECHNOL THE. Abstracts from ATTD 2022. 2022; 24(S1):A147-A148.-15th International Conference on Advanced Technologies and Treatments for Diabetes; APR 27-30, 2022; Barcelona, SPAIN. [Poster]
Web of Science

 

Mader, J; Tuca, A; Scholle, L; Pottler, T; Aberer, F; Reinhard, A; Herler, Y; Kopanz, J; Gamsey, S; Kamecke, U; Rebrin, K The Lumee hydrogel optical glucose sensor in clinical evaluation for assessment of data processing in people with insulin-treated diabetes
WIEN KLIN WOCHENSCHR. 2022; 134(SUPPL 4):249-250. [Oral Communication]
Web of Science

 

Martine-Edith, G; Divilly, P; Zaremba, N; Soeholm, U; Broadley, M; De Galan, B; Pedersen-Bjergaard, U; Mccrimmon, R; Renard, E; Heller, S; Evans, M; Mader, J; Speight, J; Seibold, A; Amiel, S; Pouwer, F; Choudhary, P NOVEL VISUAL TOOL TO ASSESS THE PREVALENCE OF HYPOGLYCAEMIA SYMPTOMS IN TYPE 1 DIABETES
DIABETES TECHNOL THE. Abstracts from ATTD 2022. 2022; 24: A71-A72.-15th International Conference on Advanced Technologies and Treatments for Diabetes; APR 27-30, 2022; Barcelona, SPAIN. [Oral Communication]
Web of Science

 

Pottler, T; Kastner, J; Kopanz, J; Hochfellner, D; Romey, M; Muchmore, D; Strasma, P; Mader, J Current insulin infusion set criteria do not represent real-life setting and may skew infusion set failure outcomes in extended wear infusion set studies
WIEN KLIN WOCHENSCHR. 2022; 134(SUPPL 4):255-255. [Oral Communication]
Web of Science

 

Schutz, A; Schutz-Fuhrmann, I; Jaschik, M; Treiber, G; Mader, J OPEN-SOURCE AUTOMATED INSULIN DELIVERY WITH INSULIN LISPRO COMPARED TO ULTRA-RAPID INSULIN IN A MAN WITH TYPE 1 DIABETES MELLITUS: A CASE REPORT
DIABETES TECHNOL THE. Abstracts from ATTD 2022. 2022; 24(S1):A103-A104.-15th International Conference on Advanced Technologies and Treatments for Diabetes; APR 27-30, 2022; Barcelona, SPAIN. [Poster]
Web of Science

 

Soeholm, U; Broadley, M; Divilly, P; Zaremba, N; Nefs, G; Carlton, J; Mader, J; Baumann, P; Gomes, M; Martine-Edith, G; Rath, D; Heller, S; Pedersen-Bjergaard, U; Mccrimmon, R; Renard, E; Evans, M; De Galan, B; Forkmann, T; Amiel, S; Hendrieckx, C; Speight, J; Choudhary, P; Pouwer, F PSYCHOMETRIC PROPERTIES OF HYPO-METRICS: A SMARTPHONE APPLICATION TO INVESTIGATE THE DAILY IMPACT OF HYPOGLYCAEMIA
DIABETES TECHNOL THE. 2022; 24: A216-A217. [Oral Communication]
Web of Science

 

Aberer, F; Moser, O; Sourij, C; Aziz, F; Ziko, H; Muller, A; Obermayer, AM; Kojzar, H; Pferschy, PN; Leitner, M; Lenz, J; Abbas, F; Banfic, T; Eckstein, ML; Wachsmuth, N; Tripolt, N; Kaser, S; Mader, JK; Sourij, H The immediate Impact of the COVID-19 Vaccination on the Time in Range and the Bolus Insulin Dose in People with Type 1 Diabetes - Subgroup Analysis of a multicenter Study
WIEN KLIN WOCHENSCHR. 2021; 133(SUPPL 6):222-222. [Oral Communication]
Web of Science

 

Aleppo, G; DeSalvo, DJ; Mader, JK; Lauand, F; Huyett, LM; Jantz, J; Chang, A; Vienneau, T; Ly, TT Glycemic improvement in 13,389 adults with type 1 diabetes (T1D) using the Omnipod (R) over the first 90 days of use
WIEN KLIN WOCHENSCHR. 2021; 133(SUPPL 6):232-232. [Oral Communication]
Web of Science

 

Barnard-Kelly, K; Franek, E; Vesper, I; Etter, T; Thienel, F; Mader, J PATIENT REPORTED PREFERENCES FROM THE PRO SOLO: NOVEL PATCH PUMP CLINICAL TRIAL
DIABETES TECHNOL THE. 2021; 23: A49-A50. [Oral Communication]
Web of Science

 

Barnard-Kelly, K; Oliver, N; Thienel, F; Franek, E; Kuensting, T; Dagenbach, N; Etter, T; Mader, JK Biomedical and patient reported outcomes from the PRO solo multi-national, multi-centre clinical trial.
DIABETOLOGIA. 2021; 64(SUPPL 1):294-295. [Oral Communication]
Web of Science

 

Baumann, PM; Cigler, M; Ziko, H; Kuznetsov, D; Rosilio, M; Hochfellner, DA; Ibberson, M; Amiel, SA; Heller, S; Gall, MA; de Galan, B; Choudhary, P; Mader, J Between- and within-subject variability of hypoglycaemia detected by short-duration CGM in multiple clinical trials in diabetes: variance decomposition of hypoglycaemic events in repeated CGM runs,
WIEN KLIN WOCHENSCHR. 2021; 133(SUPPL 6):233-233. [Poster]
Web of Science

 

Boughton, C; Hartnell, S; Thabit, H; Poettler, T; Herzig, D; Wilinska, M; Ashcroft, N; Sibayan, J; Cohen, N; Calhoun, P; Bally, L; Mader, J; Evans, M; Leelarathna, L REDUCTION OF HYPOGLYCAEMIA USING HYBRID CLOSED-LOOP WITH FASTER-INSULIN ASPART COMPARED WITH STANDARD-INSULIN ASPART IN ADULTS WITH TYPE 1 DIABETES: A DOUBLE-BLIND, MULTINATIONAL, RANDOMISED, CROSSOVER STUDY
DIABETES TECHNOL THE. 2021; 23: A72-A73. [Oral Communication]
Web of Science

 

Bytyqi, K; Baumann, PM; Hochfellner, D; Aberer, F; Simic, A; Treiber, G; Pottler, T; Holl, B; Fahrleitner-Pammer, A; Beck, P; Mader, J Feasibility to use a continuous glucose monitoring system to manage diabetes during hospitalisation
WIEN KLIN WOCHENSCHR. 2021; 133(SUPPL 6):211-212.-49. Jahrestagung ÖDG; NOV 18-20; Salzburg, AUSTRIA. [Poster]
Web of Science

 

Chen, N; Boughton, C; Hartnell, S; Fuchs, J; Allen, J; Wilinska, M; Thankamony, A; De Beaufort, C; Campbell, F; Frohlich-Reiterer, E; Hofer, S; Rami-Merhar, B; Ghatak, A; Randell, T; Besser, R; Elleri, D; Denvir, L; Trevelyan, N; Davis, N; Gurnell, E; Lindsay, R; Morris, D; Scott, E; Bally, L; Thabit, H; Leelarathna, L; Evans, M; Murphy, H; Mader, J; Hovorka, R DIFFERENCES IN USER ENGAGEMENT WITH THE CAMAPS FX HYBRID CLOSED-LOOP APP ACCORDING TO AGE AND USER CHARACTERISTICS
DIABETES TECHNOL THE. 2021; 23: A62-A63. [Poster]
Web of Science

 

Cigler, M; Elsayed, H; Ziko, H; Hochfellner, D; Kopanz, J; Pottler, T; Secco, K; Simic, A; Trajanoski, S; Groselj-Strele, A; Mader, JK Shorter Diabetes Duration and Residual Beta Cell Function are associated with better glycemic Control as measured by continuous Glucose Monitoring in People with Type 1 Diabetes
WIEN KLIN WOCHENSCHR. 2021; 133(SUPPL 6):212-212. [Oral Communication]
Web of Science

 

Fegerl, A; Leitgeb, S; Hochfellner, D; Mader, JK; Treiber, G Fehldiagnose Diabetes mellitus Typ 2
Journal für Klinische Endokrinologie und Stoffwechsel. 2021; 1/2021: -Jahrestagung der ÖGES OSDG und ANETS; 22. - 24. April 2021; virtuell. [Poster]

 

Groselj-Strele, A; Elsayed, H; Cigler, M; Ziko, H; Hochfellner, DA; Kopanz, J; Pottler, T; Secco, K; Simic, A; Trajanoski, S; Mader, JK Influence of Seasons on glycemic Control as measured with CGM Metrics in People with Type 1 Diabetes
WIEN KLIN WOCHENSCHR. 2021; 133(SUPPL 6):219-219. [Oral Communication]
Web of Science

 

Hochfellner, DA; Baumann, PM; Aberer, F; Simic, A; Bytyqi, L; Pottler, T; Holl, B; Fahrleitner-Pammer, A; Pieber, TR; Beck, P; Mader, J Basal-bolus Insulin Therapy through an electronic Decision Support System for stationary glycemic Control with Insulin degludec
WIEN KLIN WOCHENSCHR. 2021; 133(SUPPL 6):209-209. [Poster]
Web of Science

 

Kopanz, J; Mader, JK; Tuca, AC; Scholle, L; Hartmann, M; Roosen, MJ; Reinhard, AK; Herler, Y; Gamsey, S; Kamecke, U; Rebrin, K The Lumee hydrogel optical glucose sensor in clinical evaluation for safety and performance in people with insulin-treated diabetes
WIEN KLIN WOCHENSCHR. 2021; 133(SUPPL 6):218-219. [Oral Communication]
Web of Science

 

Kopanz, J; Scholle, L; Reinisch-Gratzer, J; Ambrosch, GC; Libiseller, A; Aberer, F; Pandis, M; Donsa, K; Truskaller, T; Pieber, T; Mader, J; Lichtenegger, K IMPROVED GLYCEMIC CONTROL AND PREVENTION OF ACUTE HOSPITAL ADMISSIONS BY USING A DIGITAL WORKFLOW AND DECISION SUPPORT SYSTEM IN HOME HEALTH CARE
DIABETES TECHNOL THE. 2021; 23: A103-A103. [Poster]
Web of Science

 

Kopanz, J; Scholle, LK; Lichtenegger, KM; Ambrosch; G; Libiseller, A; Aberer, F; Pandis, M; Donsa, K; Truskaller, T; Pieber, T; Mader, JK Sustained effect in diabetes management using a digital workflow and decision support system in home health care
-. 2021; -81st scientific sessions American Diabetes Association; JUN 25-29, 2021 ; Virtual. [Onlinepräsentation]

 

Mader, J; Simic, A; Roosen, M; Hartmann, M; Scholle, L; Siegl, R; Vardanyan, S; Pottler, T; Menzie, W; Gamsey, S; Rebrin, K; Kamecke, U GLUCOSE TRACKING WITH OPTICAL MEASUREMENT IN CLINICAL EVALUATION-PROFUSA LUMEE GLUCOSE PLATFORM
DIABETES TECHNOL THE. 2021; 23: A37-A38. [Oral Communication]
Web of Science

 

Mader, JK; Lingvay, I; Beck, BR; Koefoe, MM; Pettus, J; Wagner, L; Mathieu, C CGM Parameters for once a week Administration of Insulin icodec versus daily Administration of Insulin glargine U100 in insulin-naive Female Patients with Type 2 Diabetes
WIEN KLIN WOCHENSCHR. 2021; 133(SUPPL 6):200-201. [Oral Communication]
Web of Science

 

Moser, O; Sternad, C; Eckstein, ML; Aberer, F; Muller, A; Ziko, H; Mader, JK; Sourij, H Analysis of the Measurement Accuracy of the FreeStyle Libre 1 isCGM System based on the Rate of Change in Glucose - A multicenter, retrospective pooled Cohort Study
WIEN KLIN WOCHENSCHR. 2021; 133(SUPPL 6):229-230. [Oral Communication]
Web of Science

 

Nagl, K; Bozic, I; Rami-Merhar, B; Weimann, K; Berger, G; Mader, J TIME-IN-RANGE WITHOUT AUTOMATED INSULIN DELIVERY SYSTEMS IN CHILDREN WITH TYPE 1 DIABETES BEFORE AND DURING A DIABETES SUMMER CAMP - A GLASS CEILING?
DIABETES TECHNOL THE. 2021; 23: A186-A186. [Poster]
Web of Science

 

Pottler, T; Etter, T; Kaestel, H; Schutz-Fuhrmann, I; Stechemesser, L; Dagenbach, N; Ebenbichler, C; Vonbank, A; Weitgasser, R; Mader, J Comparison of Treatment Satisfaction with Pen-based Therapy versus the Accu-Chek (R) Solo and mylifeTM OmniPod (R) Insulin Pumps among pump-naive People with Type 1 Diabetes in Austria
WIEN KLIN WOCHENSCHR. 2021; 133(SUPPL 6):225-226. [Oral Communication]
Web of Science

 

Schutz, A; Schutz-Fuhrmann, I; Eichner, M; Stulnig, T; Mader, J Case Series about four pregnant Women with pre-existing Type 1 Diabetes mellitus using Do-it-Yourself-Artificial Pancreas Systems
WIEN KLIN WOCHENSCHR. 2021; 133(SUPPL 6):195-195. [Poster]
Web of Science

 

Schütz, A; Schütz-Fuhrmann, I; Jachik, MP; Treiber, GM; Mader, JK; Fallbericht: Vergleich der Glukoseeinstellung unter Verwendung von Insulin Lispro versus Ultra-Rapid Insulin Lispro bei einem Mann mit Diabetes mellitus Typ 1 unter Android-Artificial-Pancreas-System Therapie
Wiener Klinische Wochenschrift. 2021; 133: 193-236.-49.ÖDG Jahrestagung; NOV 18-20; Salzburg, AUSTRIA. [Poster]
FullText

 

Schutz, A; Schutz-Fuhrmann, I; Jaschik, MP; Treiber, GM; Mader, J Case Report: Comparison of Glucose Control using Insulin Lispro versus UltraRapid Insulin Lispro in a Man with Type 1 Diabetes mellitus under Android-based Artificial Pancreas System Therapy
WIEN KLIN WOCHENSCHR. 2021; 133(SUPPL 6):201-201. [Poster]
Web of Science

 

Schutz, A; Schutz-Fuhrmann, I; Mader, J CASE SERIES OF FOUR WOMEN WITH TYPE 1 DIABETES MELLITUS USING DO-IT-YOURSELF ARTIFICIAL PANCREAS SYSTEMS DURING PREGNANCY
DIABETES TECHNOL THE. 2021; 23: A77-A77. [Poster]
Web of Science

 

Secco, K; Ziko, H; Pottler, T; Hochfellner, D; Weitgasser, R; Schutz-Fuhrmann, I; Mader, JK Glycemic control in type 1 diabetes during COVID-19 pandemic
WIEN KLIN WOCHENSCHR. 2021; 133(SUPPL 6):220-220. [Keynote lecture]
Web of Science

 

Simic, A; Taucher, M; Hochfellner, D; Dietrich, M; Porttler, T; Aberer, F; Mader, J ACCURACY ASSESSMENT OF THE NEW GLUCOMEN (R) DAY CGM SYSTEM IN INDIVIDUALS WITH TYPE 1 DIABETES
DIABETES TECHNOL THE. 2021; 23: A117-A117. [Poster]
Web of Science

 

Simic, A; Taucher, M; Hochfellner, D; Pottler, T; Aberer, F; Mader, J Glucomen Day (R) CGM system accuracy assessment in individuals with type 1 diabetes
WIEN KLIN WOCHENSCHR. 2021; 133(SUPPL 6):200-200. [Poster]
Web of Science

 

Starchl, C; Dimai, H.P.; Amrein, K; Mader, J; Geiger, S; Fahrleitner-Pammer, A. Teriparatide after 38 months of treatment still effective and safe A case report.
ÖGKM-Osteoporoseforum; OKT 14-16, 2021; St. Wolfgang, AUSTRIA. 2021. [Poster]

 

Tauschmann, M; Fuchs, J; Nagl, K; Cvach, S; Mader, JK; Fritsch, M; Jasser-Nitsche, H; Faninger, K; Binder, E; Steichen, E; Abt, D; Allen, JM; Boughton, CK; Wilinska, ME; Sibayan, J; Thankamony, A; de Beaufort, C; Campbell, FM; Kapellen, TM; Frohlich-Reiterer, E; Hofer, SE; Rami-Merhar, B; Hovorka, R Cambridge Hybrid Closed-Loop in Young Children and Preschoolers with Type 1 Diabetes: A randomized, multi-national 4-Month Study
WIEN KLIN WOCHENSCHR. 2021; 133(SUPPL 6):203-203. [Oral Communication]
Web of Science

 

Treiber, G; Novak, E; Hantschel, E; Mader, J CHALLENGES WITH DIY LOOP IN PREGNANCY WITH TYPE 1 DIABETES
DIABETES TECHNOL THE. 2021; 23: A182-A183. [Poster]
Web of Science

 

Tripolt, N; Sourij, C; Aberer, F; Kojzar, H; Obermayer, A; Pferschy, P; Aziz, F; Muller, A; Abbas, F; Lenz, J; Mader, J; Pesto, L; Banfic, T; Leitner, M; Steinberger, M; Knoll, L; Goswami, N; Moser, O; Eckstein, M; Wachsmuth, N; Cvirn, G; Stradner, M; Schlenke, P; Kaser, S; Steinmetz, I; Sourij, H Immune Response to COVID-19 Vaccination for Patients with Diabetes mellitus - The Covac-DM Austria Study
WIEN KLIN WOCHENSCHR. 2021; 133(SUPPL 6):228-228. [Oral Communication]
Web of Science

 

Aberer, F; Hochfellner, D; Ziko, H; Sagmeister, MH; Cigler, M; Simic, A; Pottler, T; Sendlhofer, G; Beck, P; Mader, JK Efficiency and Safety of an electronic Decision Support System for Insulin Therapy in hospitalized Female Patients with Type 2 Diabetes.
WIEN KLIN WOCHENSCHR. 2020; 132: S334-S334. [Poster]
Web of Science

 

Aberer, F; Theiler-Schwetz, V; Hochfellner, D; Hausegger, B; Wiederstein-Grasser, I; Eller, P; Tomberger, G; Ellmerer, M; Bubalo, V; Mader, JK Examination of the Accuracy and Stability of an Arterial Sensor for Glucose Monitoring in a Porcine Model Using Glucose Clamp Technique.
Virtual Hospital Diabetes Meeting ; JUN 18, 2020; Virtual. 2020. [Onlinepräsentation]
FullText

 

Bozic, I; Nagl, K; Rami-Merhar, B; Mader, JK; Weimann, K; Berger, G Time-in-Range for 31 Children before and during a Diabetes Camp.
WIEN KLIN WOCHENSCHR. 2020; 132: S359-S359. [Poster]
Web of Science

 

Camerlingo, N; Vettoretti, M; Facchinetti, A; Mader, JK; Choudhary, P; Sparacino, G; Del Favero, S Determining the minimum duration of CGM monitoring to accurately estimate time below range.
DIABETOLOGIA. 2020; 63(SUPPL 1):S361-S362.-56th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD); SEP 21-25, 2020; ELECTR NETWORK. [Oral Communication]
Web of Science

 

Cigler, M; Ziko, H; Elsayed, H; Hochfellner, D; Pottler, T; Muller, A; Eckstein, ML; Knoll, L; Sourij, H; Mader, JK; Moser, O People with type 1 diabetes and impaired awareness of hypoglycaemia have a delayed reaction to perform a glucose scan during hypoglycaemia: a prospective observational study.
DIABETOLOGIA. 2020; 63(SUPPL 1):S359-S359.-56th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD); SEP 21-25, 2020; virtuell. [Poster]
Web of Science

 

Eckert, A; Mader, J; Altmeier, M; Gillessen, A; Dallmeier, D; Shah, V; Heyer, C; Hartmann, B; Holl, R Bone fractures in individuals with type 2 diabetes aged >= 50 years in the DPV registry: effect of glycaemic control and treatment.
DIABETOLOGIA. 2020; 63(SUPPL 1):S461-S461.-56th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD); SEP 21-25, 2020; ELECTR NETWORK. [Poster]
Web of Science

 

Eckert, A; Mader, J; Altmeier, M; Muhldorfer, S; Gillessen, A; Dallmeier, D; Shah, V; Heyer, C; Hartmann, B; Holl, RW Bone fractures in patients with type 2 diabetes aged >= 50 years in the DPV registry: effect of glycaemic control and treatment.
INTERNIST. Abstracts zum 126. Kongress der Deutschen Gesellschaft für Innere Medizin e.V.. 2020; 61(SUPPL 1):S5-S5.-126. Kongress der Deutschen Gesellschaft für Innere Medizin e.V.; APR 25-28, 2020; Wiesbaden, GERMANY. [Onlinepräsentation]
Web of Science

 

Eckstein, M; Ziko, H; Moser, O; Elsayed, H; Cigler, M; Hochfellner, D; Pottler, T; Mueller, A; Sourij, H; Mader, J DISCREPANCY OF GLYCAEMIC RANGES IN REGARD TO CGM METRICS FOR CLINICAL CARE VERSUS GUIDANCE FOR GLYCAEMIC TARGETS WITHIN THE RECENT CONSENSUS ON TIR.
DIABETES TECHNOL THE. 2020; 22: A106-A106. [Poster]
Web of Science

 

Fischer, LT; Aberer, F; Hochfellner, D; Knoll, L; Pottler, T; Mader, JK Prescribing Indications and metabolic Effects of PCSK9-Inhibitors in a tertiary Center - A retrospective Study.
WIEN KLIN WOCHENSCHR. 2020; 132: S349-S349.-ÖDG ; [Poster]
Web of Science

 

Fritsch, M; Frohlich-Reiterer, E; Wutzl, V; Holbing, E; Aigner, D; Mader, JK Treatment induced neuropathy (TIND) - eine seltene Komplikation bei einem Jugendlichen mit Typ 1 Diabetes.
WIEN KLIN WOCHENSCHR. 2020; 132: S361-S362. [Poster]
Web of Science

 

Haberl, HC; Pottler, T; Hochfellner, D; Aberer, F; Ziko, H; Simic, A; Bytyqi, L; Baumann, P; Samonigg, J; Beck, P; Fahrleitner-Pammer, A; Mader, JK Evaluation of the Sensor Performance of a blinded, professional continuous Glucose Measurement System in hospitalized Female Patients with Type 2 Diabetes.
WIEN KLIN WOCHENSCHR. 2020; 132: S360-S360.-Jahrestagung der österreichischen Diabetesgesellschaft ; [Poster]
Web of Science

 

Haberl, HC; Pottler, T; Hochfellner, DA; Aberer, F; Ziko, H; Bytyqi, L; Baumann, P; Samonigg, J; Beck, P; Fahrleitner-Pammer, A; Mader, JK Assessment of sensor performance of a blinded professional continuous glucose monitoring system in hospitalised patients with type 2 diabetes.
DIABETOLOGIA. 2020; 63(SUPPL 1):S348-S349.-56th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD); SEP 21-25, 2020; ELECTR NETWORK. [Poster]
Web of Science

 

Hochfellner, D; Rainer, R; Aberer, F; Lichtenegger, K; Beck, P; Fruhwald, F; Rosenkranz, A; Kamolz, LP; Mader, JK; Plank, J Safe Basal-Bolus-Insulin Therapy during Fasting Episodes in hospitalized People with Type 2 Diabetes through Decision Support Technology.
WIEN KLIN WOCHENSCHR. 2020; 132: S339-S340. [Oral Communication]
Web of Science

 

Hochfellner, D; Schondorff, P; Stumpe, T; Heschel, M; Pottler, T; Elsayed, H; Simic, A; Bytyqi, K; Augustin, T; Lueger, A; Mader, J COMPARISON OF INFUSION SET SURVIVAL OF THE NEWLY DEVELOPED ARTIFICIALLY CLOGGED LANTERN CATHETER VS. STANDARD INFUSION SET IN TYPE 1 DIABETES UNDER REAL-LIFE CONDITIONS.
DIABETES TECHNOL THE. The Official Journal of ATTD: Advanced Technologies & Treatments for Diabetes Conference. 2020; 22: A240-A241.-Advanced Technologies & Treatments for Diabetes Conference; FEB 19-20, 2020; Madrid, SPAIN. [Poster]
Web of Science

 

Hochfellner, D; Ziko, H; Elsayed, H; Cigler, M; Knoll, L; Pöttler, T; Aberer, F; Mader, J Glucose scan behaviour in people with type 1 diabetes using flash glucose monitoring in a real-world setting.
ENDOCRINE ABSTRACTS. 2020; 70(AEP458):-22nd European Congress of Endocrinology, European Society of Endocrinology (ESE); SEP 5-9, 2020 ; Bristol, UK. [Poster]
FullText

 

Hochfellner, D; Ziko, H; Elsayed, H; Cigler, M; Knoll, L; Pottler, T; Treiber, G; Simic, A; Aberer, F; Mader, J Scan-Behavior in People with Type-1-Diabetes and Flash-Glucose-Monitoring in a Real-World-Setting.
WIEN KLIN WOCHENSCHR. Abstracts 51.Jahrestagung der Österreichischen Gesellschaft für Innere Medizin. 2020; 132(SUPPL 2):76-76.-51.Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; SEP 24-26, 2020; Salzburg, AUSTRIA. [Onlinepräsentation]
Web of Science

 

Hochfellner, DA; Rainer, R; Aberer, F; Lichtenegger, KM; Beck, P; Fruhwald, F; Rosenkranz, AR; Kamolz, LP; Mader, JK; Plank, J Effective and safe basal-bolus insulin therapy during fasting episodes in hospitalised patients with type 2 diabetes using decision support technology.
DIABETOLOGIA. 2020; 63(SUPPL 1):S377-S378.-56th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD); SEP 21-25, 2020; ELECTR NETWORK. [Poster]
Web of Science

 

Hochfellner, DA; Ziko, H; Beck, P; Mader JK Improvement in Glycemic Control Using Algorithm-Guided Basal-Bolus Insulin Therapy in Hospitalized Patients with Type 2 Diabetes.
JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY. 2020; 14(5):945-969.-Virtual Hospital Diabetes Meeting, Diabetes Technology Society (DTS); JUN 18, 2020; Burlingame, CA, USA . [Poster]
FullText

 

Hochfellner, DA; Ziko, H; Sagmeister, MH; Elsayed, H; Cigler, M; Poettler, T; Aberer, F; Sendlhofer, G; Beck, P; Mader, JK Electronic Decision Support for Insulin Therapy Is Safe and Efficient in Inpatients with Type 2 Diabetes.
DIABETES. 2020; 69(S 1):-80th Scientific Sessions American Diabetes Association (ADA); JUN 12-16,2020; Chicago, IL, USA;. Doi: 10.2337/db20-24-OR [Oral Communication]
Web of Science FullText FullText_MUG

 

Kopanz, J; Libiseller, A; Lichtenegger, K; Donsa, K; Truskaller, T; Lackner, B; Aberer, F; Pandis, M; Reinisch-Gratzer, J; Ambrosch, G; Sinner, F; Pieber, T; Mader, J A DIGITAL WORKFLOW AND DECISION SUPPORT SYSTEM TO PREVENT DIABETES-RELATED ACUTE HOSPITAL ADMISSIONS AND INPATIENT STAYS (THE GLUCOTAB@MOBILECARE STUDY).
DIABETES TECHNOL THE. The Official Journal of ATTD: Advanced Technologies & Treatments for Diabetes Conference. 2020; 22: A110-A110.-Advanced Technologies & Treatments for Diabetes Conference; FEB 19-20, 2020; Madrid, SPAIN. [Poster]
Web of Science

 

Kopanz, J; Libiseller, A; Lichtenegger, K; Donsa, K; Truskaller, T; Lackner, B; Aberer, F; Pandis, M; Reinisch-Gratzer, J; Ambrosch, G; Sinner, F; Pieber, T; Mader, J EFFECTIVE, SAFE AND USER-ACCEPTED BASAL-INSULIN THERAPY IN ELDERLY PATIENTS WITH TYPE 2 DIABETES RECEIVING DIGITALY ASSISTED DOMICILIARY NURSING CARE - THE GLUCOTAB@MOBILECARE STUDY.
DIABETES TECHNOL THE. The Official Journal of ATTD: Advanced Technologies & Treatments for Diabetes Conference. 2020; 22: A109-A110.-Advanced Technologies & Treatments for Diabetes Conference; FEB 19-20, 2020; Madrid, SPAIN. [Poster]
Web of Science

 

Lichtenegger, K; Kopanz, J; Libiseller, A; Mader, J; Donsa, K; Truskaller, T; Bauer, N; Hahn, B; Sendlhofer, G; Beck, P; Feichtner, F; Sinner, F; Pieber, T IMPLEMENTATION OF A DIGITAL WORKFLOW AND DECISION SUPPORT SYSTEM CONFIRMS EFFICACY AND USER-SATISFACTION OF ROUTINE DIABETES CARE IN INPATIENTS WITH TYPE 2 DIABETES.
DIABETES TECHNOL THE. The Official Journal of ATTD: Advanced Technologies & Treatments for Diabetes Conference. 2020; 22: A111-A111.-Advanced Technologies & Treatments for Diabetes Conference; FEB 19-20, 2020; Madrid, SPAIN. [Poster]
Web of Science

 

Mader, JK; Oliver, N; Vesper, I; Kunsting, T; Barnard-Kelly, K First results from PRO Solo: patient reported outcomes from a clinical trial comparing a new patch pump with MDI and an established patch pump.
DIABETOLOGIA. 2020; 63(SUPPL 1):S341-S342.-56th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD); SEP 21-25, 2020; ELECTR NETWORK. [Poster]
Web of Science

 

Moser, O; Riddell, MC; Eckstein, ML; Adolfsson, P; Rabasa-Lhoret, R; van den Boom, L; Gillard, P; Norgaard, K; Oliver, NS; Zaharieva, DP; Battelino, T; De Beaufort, C; Bergenstal, RM; Buckingham, B; Cengiz, E; Deeb, A; Heise, T; Heller, S; Kowalski, AJ; Leelarathna, L; Mathieu, C; Stettler, C; Tauschmann, M; Thabit, H; Wilmot, EG; Sourij, H; Smart, CE; Jacobs, PG; Bracken, RM; Mader, JK Glucose Management during physical Activity/Sport by Using continuous Glucose Meters (CGM/isCGM) in Type 1 Diabetes - EASD/ISPAD Position Statement, supported by ADA and JDRF.
WIEN KLIN WOCHENSCHR. 2020; 132: S340-S341. [Onlinepräsentation]
Web of Science

 

Moser, O; Ziko, H; Eckstein, M; Elsayed, H; Cigler, M; Hochfellner, D; Poettler, T; Mueller, A; Sourij, H; Mader, J TIME IN RANGE (TIR) ACHIEVEMENT IN REGARD TO CLINICAL TARGETS IN PEOPLE WITH TYPE 1 DIABETES (PWT1D): A REAL WORLD SETTING.
DIABETES TECHNOL THE. The Official Journal of ATTD: Advanced Technologies & Treatments for Diabetes Conference. 2020; 22: A231-A231.-Advanced Technologies & Treatments for Diabetes Conference; FEB 19-20, 2020; Madrid, SPAIN. [Poster]
Web of Science

 

Moser, O; Ziko, H; Elsayed, H; Hochfellner, D; Pottler, T; Muller, A; Eckstein, M; Sourij, H; Mader, JK The FreeStyle Libre 1 isCGM System as the first objective Measuring Instrument for the Diagnosis of Hypoglycemia Unawareness in People with Type 1 Diabetes - A prospective Observational Study.
WIEN KLIN WOCHENSCHR. 2020; 132: S343-S344. [Poster]
Web of Science

 

Moser, O; Ziko, H; Elsayed, H; Hochfellner, DA; Poettler, T; Mueller, A; Eckstein, ML; Knoll, L; Sourij, H; Mader, JK People with Type 1 Diabetes and Impaired Awareness of Hypoglycemia Have a Delayed Reaction to Perform a Glucose Scan during Hypoglycemia: A Prospective Observational Study.
DIABETES. 2020; 69: -80th Scientific Sessions of the American-Diabetes-Association (ADA); JUN 12-16, 2020; ELECTR NETWORK. Doi: 10.2337/db20-157-OR [Onlinepräsentation]
Web of Science FullText FullText_MUG

 

Muller, A; Moser, O; Eckstein, ML; Ziko, H; Aberer, F; Treiber, G; Unteregger, C; Kojzar, H; Mader, JK; Sourij, C; Pferschy, P; Obermayer, A; Tripolt, N; Sourij, H Halving the Basal Insulin Dose before a Running Event in physically active Adults with Type 1 Diabetes minimizes the Risk of Hypoglycaemia - A prospective, clinical, controlled, Observational Study.
WIEN KLIN WOCHENSCHR. 2020; 132: S364-S364. [Onlinepräsentation]
Web of Science

 

Nagl, K; Berger, G; Aberer, F; Mader, J; Rami-Merhar, B PERFORMANCE OF CONTINUOUS GLUCOSE MONITORING SYSTEMS IN CHILDREN WITH TYPE 1 DIABETES DURING A DIABETES SUMMER CAMP.
DIABETES TECHNOL THE. The Official Journal of ATTD: Advanced Technologies & Treatments for Diabetes Conference. 2020; 22: A140-A140.-Advanced Technologies & Treatments for Diabetes Conference; FEB 19-20, 2020; Madrid, SPAIN. [Poster]
Web of Science

 

Novak, E; Häntschel, E; Mader, J; Stern, C; Cerva-Zivkovics, M; Eller, K; Treiber, G Herausforderungen im Management einer Schwangerschaft einer Patientin mit fortgeschrittener diabetischer Nephropathie bei Typ 1 Diabetes - ein Fallbericht.
Journal für Klinische Endokrinologie und Stoffwechsel. 2020; 13(1):11-11.-ÖGES Jahrestagung; Apr 15-17, 2020; Graz, Austria.

 

Schatzl, S; Tmava-Berisha, A; Scherkl, M; Kaser, S; Mader, JK; Fahrleitner-Pammer, A; Amrein,K The HypAUS study - First results of an Austrian prospective hypoparathyroidism registry.
22nd European Congress of Endocrinology. 2020; -European Congress of Endocrinology; SEP 5-9, 2020; Bristol, UNITED KINGDOM. [Poster]

 

Scholle, L; Kopanz, J; Reinisch-Gratzer, J; Ambrosch, GC; Libiseller, A; Aberer, F; Pandis, M; Donsa, K; Truskaller, T; Pieber, TR; Mader, JK; Lichtenegger, KM Can a digital Workflow System and Decision Support System for mobile Care improve Blood Glucose Control and prevent acute Hospital Admissions?
WIEN KLIN WOCHENSCHR. 2020; 132: S343-S343.-Jahrestagung der österreichischen Diabetesgesellschaft ; [Poster]
Web of Science

 

Semlitsch, B; Omoregbee, S; Sendlhofer, G; Mader, JK; Wedrich, A Perioperative Insulin Management for the Prevention of postoperative Metabolic Disorders.
WIEN KLIN WOCHENSCHR. 2020; 132: S333-S334. [Poster]
Web of Science

 

Simic, A; Ziko, H; Pottler, T; Hochfellner, D; Samonigg, J; Cigler, M; Beck, P; Aberer, F; Mader, JK A retrospective assessment of blinded continuous glucose monitor accuracy during inpatient management of adults with type 2 diabetes.
WIEN KLIN WOCHENSCHR. 2020; 132: S363-S363. [Poster]
Web of Science

 

Treiber, G; Verheyen, N; Verheyen, S; Mader, JK; Sourij, H "Atypical" Diabetes - There´s more than Type 1 and Type 2-A Case Report.
WIEN KLIN WOCHENSCHR. Abstracts 51. Jahrestagung der Österreichischen Gesellschaft für Innere Medizin. 2020; 132(SUPPL 2):69-69.-51.Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; SEP 24-26, 2020; Salzburg, AUSTRIA.
Web of Science FullText

 

van den Boom, L; Ziko, H; Mader, JK Safely finishing a half marathon by an adult with type 1 diabetes being on a commercially-available hybrid closed-loop system.
WIEN KLIN WOCHENSCHR. 2020; 132: S336-S336. [Poster]
Web of Science

 

Aberer, F; Sourij, H; Mader, JK Das Köbberling Syndrom - ein unterdiagnostiziertes Syndrom
http://www.oeges.at/wp/wp-content/uploads/02_hauptprogramm_web.pdf. 2019; -ÖGES Jahrestagung; APR 24-26, 2019; Graz. [Poster]

 

Elsayed, H; Bytyqi, K; Simic, A; Cigler, M; Hochfellner, D; Ziko, H; Knoll, L; Pottler, T; Aberer, F; Mader, J Influence of C-Peptide Status on Frequency and Mean Duration of Hypoglycemia, Time in Blood Sugar Target Range and HbA1c in Type 1 Diabetics using Flash Glucose Monitoring in clinical Routine
WIEN KLIN WOCHENSCHR. 2019; 131(SUPPL 5):S471-S471. [Oral Communication]
Web of Science

 

Harer, C; Prietl, B; Mader, JK; Lechner, E; Leitgeb, S; Fröhlich-Reiterer, E; Treiber, G; Pieber, TR CHARACTERISATION OF IMMUNE RESPONSE AND RESIDUAL BETA CELL FUNCTION IN FEMALE AND MALE PATIENTS WITH NEW ONSET TYPE 1 DIABETES.
Hauptprogramm zur 24. Jahrestagung der ÖGES gemeinsam mit der OSDG und der ANETS. 2019; -24. Jahrestagung der ÖGES gemeinsam mit der OSDG und ANETS; APR 24-26, 2019; Graz, AUSTRIA. [Poster]

 

Hochfellner, D; Ziko, H; Ajsic, A; Pandis, M; Beck, P; Mader, JK HOW DOES INPATIENT DIABETES MANAGEMENT AFFECT DISCHARGE SUGGESTIONS?
DIABETES TECHNOL THE. 2019; 21: A67-A68. [Poster]
Web of Science FullText

 

Hochfellner, DA; Ziko, H; Beck, P; Sendlhofer, G; Mader, J Benefits of a Diabetes-Management-System in inpatient Care.
WIEN KLIN WOCHENSCHR. 2019; 131: S441-S441. [Poster]
Web of Science

 

Hochfellner, DA; Ziko, H; Elsayed, H; Simic, A; Cigler, M; Knoll, L; Pottler, T; Aberer, F; Mader, J Flash Glucose Monitoring in Routine Clinical Use in Patients with Type 1 Diabetes
WIEN KLIN WOCHENSCHR. 2019; 131(SUPPL 5):S470-S470. [Poster]
Web of Science

 

Kopanz, J; Libiseller, A; Lichtenegger, KM; Donsa, K; Truskaller, T; Augustin, T; Aberer, F; Pandis, M; Reinisch-Gratzer, J; Ambrosch, GC; Pieber, TR; Mader, JK GLUCOTAB@MOBILECARE: ACCEPTANCE, USABILITY, SAFETY AND EFFICACY OF THE TABLET-BASED BASAL-INSULIN ALGORITHM FOR GLYCEMIC MANAGEMENT IN PATIENTS WITH TYPE-2-DIABETES RECEIVING HOME NURSING CARE - STUDY PROTOCOL
DIABETES TECHNOL THE. 2019; 21: A72-A72. [Poster]
Web of Science

 

Kopanz, J; Libiseller, A; Lichtenegger, KM; Donsa, K; Truskaller, T; Augustin, T; Aberer, F; Pandis, M; Reinisch-Gratzer, J; Ambrosch, GC; Sinner, F; Pieber, TR; Mader, JK GlucoTab@MobileCare – Elektronisches Diabetesmanagement für die mobile Hauskrankenpflege (Studienprotokoll)
14. GEMEINSAMER ÖSTERREICHISCH-DEUTSCHER GERIATRIEKONGRESS, 59. KONGRESS DER ÖSTERREICHISCHEN GESELLSCHAFT FÜR GERIATRIE UND GERONTOLOGIE; APR 25-27; Vienna, AUSTRIA. 2019. [Poster]

 

Kopanz, J; Libiseller, A; Lichtenegger, KM; Donsa, K; Truskaller, T; Lackner, B; Aberer, F; Pandis, M; Reinisch-Gratzer, J; Ambrosch, GC; Sinner, F; Pieber, TR; Mader, JK GlucoTab@MobileCare - Clinical Endpoints of a Proof-of-Concept Study of a Digital Workflow and Decision Support System for Diabetes Management in Mobile Home Health Care
WIEN KLIN WOCHENSCHR. 2019; 131(SUPPL 5):S466-S467. [Oral Communication]
Web of Science

 

Kopanz, J; Libiseller, A; Lichtenegger, KM; Donsa, K; Truskaller, T; Lackner, B; Aberer, F; Pandis, M; Reinisch-Gratzer, J; Ambrosch, GC; Sinner, F; Pieber, TR; Mader, JK Akzeptanz, Sicherheit und Wirksamkeit eines digitalen Basalinsulin Algorithmus bei geriatrischen PatientInnen mit Typ-2-Diabetes in der mobilen Hauskrankenpflege
Netzwerk Altersmedizin Steiermark Jahreskongress; OKT 10-12; Graz, AUSTRIA. 2019. [Poster]

 

Kopanz, J; Lichtenegger, KM; Konig, C; Feichtner, F; Libiseller, A; Mader, JK; Donsa, K; Sendlhofer, G; Sinner, F; Pieber, TR Does the implementation of an electronic workflow support system improve quality of routine diabetes care in inpatients with type 2 diabetes?.
DIABETOLOGIA. 2019; 62: S395-S395.-55th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD); SEP 16-20, 2019; Barcelona, SPAIN. [Poster]
Web of Science

 

Kopanz, J; Lichtenegger, KM; König, C; Feichtner, F; Libiseller, A; Mader, JK; Donsa, K; Sendlhofer, G; Sinner, F; Pieber, TR Evaluierung der Struktur-, Prozess-, und Ergebnisqualität des GlucoTab®-Systems im Routineeinsatz zur Unterstützung des Diabetesmanagements für PatientInnen mit Typ 2 Diabetes in einem regionalen Krankenhaus
Diabetologie und Stoffwechsel 2019; 14(S 01): S10-S11. 2019; -DDG Kongress (Deutsche Diabetes Gesellschaft); Mai 29 - JUN 1; Berlin, GERMANY. [Poster]
FullText

 

Kopanz, J; Lichtenegger, KM; Konig, C; Libiseller, A; Mader, JK; Donsa, K; Truskaller, T; Bauer, N; Hahn, B; Sendlhofer, G; Beck, P; Sinner, F; Feichtner, F; Pieber, TR The GlucoTab® System in Routine Use to Support Diabetes Management for Patients with Diabetes Mellitus Type 2 in a regional Hospital.
WIEN KLIN WOCHENSCHR. 2019; 131(SUPPL 5):S467-S467. [Poster]
Web of Science

 

Libiseller, A; Kopanz, J; Lichtenegger, KM; Donsa, K; Truskaller, T; Lackner, B; Aberer, F; Pandis, M; Reinisch-Gratzer, J; Ambrosch, GC; Sinner, F; Pieber, TR; Mader, JK GlucoTab@MobileCare - The Potential of Decision Support to Reduce Hospital Admissions and inpatient Admissions
WIEN KLIN WOCHENSCHR. 2019; 131(SUPPL 5):S469-S469. [Poster]
Web of Science

 

Lichtenegger, KM; Aberer, F; Tuca, AC; Donsa, K; Holl, B; Schaupp, L; Beck, P; Fruhwald, F; Plank, J; Pieber, TR; Mader, JK A clinical Decision Support System for Basal Bolus Insulin Therapy in Routine Inpatient Care: Proven Efficacy, Safety, and User Adherence
WIEN KLIN WOCHENSCHR. 2019; 131(SUPPL 5):S466-S466. [Oral Communication]
Web of Science

 

Lichtenegger, KM; Aberer, F; Tuca, AC; Donsa, K; Höll, B; Schaupp, L; Beck, P; Fruhwald, F; Plank, J; Pieber, TR; Mader, JK A Clinical Decision Support System for Basal-Bolus Insulin Therapy is moving to Hospital Routine Care: Efficacy, Safety and Usability confirmed.
Diabetes 2019 Jun; 68(Supplement 1). 2019; -79th Scientific Session, American Diabetes Association; JUN 07-11, 2019; San Francisco. [Poster]

 

Mader, JK Aktuelle Leitlinien der oralen Diabetestherapie
Allgemeinmedizin Update Refresher; JAN 30 - FEB 2, 2019; Graz, AUSTRIA. 2019. [Oral Communication]

 

Mader, JK Dyslipidämie - Therapieempfehlungen
Allgemeinmedizin - Update Refresher; JAN 30 - FEB 2, 2019; Graz, AUSTRIA. 2019. [Oral Communication]

 

Simic, A; Elsayed, H; Ziko, H; Hochfellner, D; Cigler, M; Knoll, L; Pottler, T; Aberer, F; Mader, JK The effect of glucose scanning frequency on HbA1c in individuals with type 1 diabetes using FGM
WIEN KLIN WOCHENSCHR. 2019; 131(SUPPL 5):S482-S482. [Keynote lecture]
Web of Science

 

Ziko, H; Hochfellner, D; Elsayed, H; Simic, A; Cigler, M; Knoll, L; Pottler, T; Aberer, F; Mader, JK Influence of Flash Glucose Monitoring on Glycemic Target Achievement
WIEN KLIN WOCHENSCHR. 2019; 131(SUPPL 5):S487-S487. [Poster]
Web of Science

 

Ajsic, A; Krasser, MC; Juliussen, R; Schøndorff, PK; Heschel, M; Pöttler, T; Schwarzenbacher, D; Augustin, T; Pieber, TR; Treiber, G; Mader, JK Assessment of Infusion Set Survival of the Newly Developed Lantern Catheter in Type 1 Diabetes by Glucose Clamp Technique.
Diabetes. 2018; 67(S1):-78th Scientific Sessions of the American Diabetes Association (ADA); JUN 22-26, 2018; Orlando, USA. [Poster]
FullText

 

Ajsic, A; Krasser, MC; Juliussen, R; Schondorff, PK; Heschel, M; Pottler, T; Schwarzenbacher, D; Augustin, T; Pieber, TR; Treiber; Mader, JK Examination of a prolonged Wearing Period of the newly developed Insulin Infusion Lantern Catheter in Patients with Type 1 Diabetes mellitus
WIEN KLIN WOCHENSCHR. 2018; 130: 360-360. [Poster]
Web of Science

 

Cigler, M; Pandis, M; Juliussen, R; Schondorff, PK; Heschel, M; Pottler, T; Augustin, T; Schwarzenbacher, D; Pieber, RT; Treiber, G; Mader, JK ASSESSMENT OF INFUSION SET SURVIVAL OF THE NEWLY DEVELOPED LANTERN CATHETER IN TYPE 1 DIABETES BY GLUCOSE CLAMP TECHNIQUE (A PILOT STUDY)
DIABETES TECHNOL THE. 2018; 20: A126-A127. [Poster]
Web of Science

 

Drechsler, K; Pottler, T; Elsayed, H; Kiesling, L; Aberer, F; Mader, J A Questionnaire Survey on treatment-associated Errors from the Perspective of Patients with Type 2 Diabetes in an internistic Normal Ward
WIEN KLIN WOCHENSCHR. 2018; 130: 365-365. [Poster]
Web of Science

 

Drechsler, KS; Pöttler, T; Elsayed, H; Kiesling, L; Aberer, F; Mader, JK Eine Fragebogenerhebung zu therapieassoziierten Fehlern aus der Sicht von PatientInnen mit Typ 2 Diabetes auf einer internistischen Normalstation
Wien Klin Wochenschr. 2018; 130(Suppl 6): 343-374.-46. Jahrestagung der österreichischen Diabetesgesellschaft (ÖDG) ; NOV 15-17, 2018; Salzburg, AUSTRIA. [Poster]

 

Kojzar, H; Frohlich-Reiterer, E; Mader, JK; Pottler, T; Elsayed, H; Jasser-Nitsche, H; Rami-Merhar, B; Fritsch, M; Nagl, K; Hofer, S; Abt, D; Binder, E; Streichen, E; Acerini, CL; de Beaufort, C; Campbell, F; Kapellen, T; Lawton, J; Roze, S; Sibayan, J; Sonesson, A; Allen, J; Tauschmann, M; Musolino, G; Barber, N; Wilinska, ME; Hovorka, R Use of the artificial Pancreas in Infants with Diabetes mellitus Type 1 KidsAP01
WIEN KLIN WOCHENSCHR. 2018; 130: 347-348. [Oral Communication]
Web of Science

 

Leelarathna, L; Thabit, H; Bally, L; Wilinska, ME; Mader, JK; Pieber, TR; Evans, M; Hovorka, R A Novel Composite Glucose Index (COGI) for Evaluating Closed-Loop Performance in Type 1 Diabetes.
Diabetes. 2018; 67(S1):-78th Scientific Sessions of the American Diabetes Association (ADA); JUN 22-26, 2018; Orlando, USA. [Poster]
FullText

 

Mader, JK; Ajsic, A; Krasser, MC; Juliussen, R; Schondorff, PK; Heschel, M; Pottler, T; Schwarzenbacher, D; Augustin, T; Pieber, TR; Treiber, G Assessment of infusion set survival of the newly developed coated Lantern catheter in type 1 diabetes by glucose clamp technique
DIABETOLOGIA. 2018; 61: S395-S395.-54th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD); OCT 01-05, 2018; Berlin, GERMANY. [Poster]
Web of Science

 

Rainer, R; Elsayed, H; Aberer, F; Beck, P; Pieber, TR; Donsa, K; Plank, J; Mader, JK Diabetes Management in Hospitalized Patients with Type 2 Diabetes (T2D) during Fasting Periods.
Diabetes. 2018; 67(S1):-78th Scientific Sessions of the American Diabetes Association (ADA); JUN 22-26, 2018; Orlando, USA.
FullText

 

Rainer, R; Elsayed, H; Aberer, F; Beck, P; Pieber, TR; Donsa, K; Plank, J; Mader, JK Blood Glucose Management in hospitalized Patients with Type 2 Diabetes mellitus during Nursing Phases - A retrospective Study
WIEN KLIN WOCHENSCHR. 2018; 130: 348-348. [Oral Communication]
Web of Science

 

Ruan, Y; Bally, L; Thabit, H; Mader, J; Kojzar, H; Dellweg, S; Benesch, C; Hartnell, S; Leelarathna, L; Wilinska, M; Evans, M; Arnolds, S; Pieber, T; Hovorka, R HYPOGLYCAEMIA OCCURENCE AND RECOVERY DURING HOME USE OF CLOSED-LOOP INSULIN DELIVERY AND SENSOR-AUGMENTED PUMP THERAPY IN ADULTS WITH TYPE 1 DIABETES
DIABETES TECHNOL THE. 2018; 20: A59-A60.-ATTD; Vienna, Austria. [Poster]
Web of Science

 

Ruan, Y; Bally, L; Thabit, H; Mader, JK; Kojzar, H; Dellweg, S; Benesch, C; Hartnell, S; Leelarathna, L; Wilinska, ME; Evans, ML; Arnolds, S; Pieber, TR; Hovorka, R OVERTREATMENT OF HYPOGLYCAEMIA IN ADULTS WITH TYPE 1 DIABETES DOES NOT APPEAR TO DETERIORATE GLYCAEMIC CONTROL DURING CLOSED-LOOP INSULIN DELIVERY
DIABETES TECHNOL THE. 2018; 20: A62-A63. [Poster]
Web of Science

 

Thabit, H; Leelarathna, L; Wilinska, ME; Benesch, C; Arnolds, A; Mader, JK; Pieber, TR; Evans, M; Hovorka, R Looking Beyond HbA1c—Evaluating Glycaemic Control during Closed-Loop Use in Type 1 Diabetes.
Diabetes. 2018; 67(S1):-78th Scientific Sessions of the American Diabetes Association (ADA); JUN 22-26, 2018; Orlando, USA. [Poster]
FullText

 

Aberer, F; Holzgruber, J; Tripolt, NJ; Mader, JK; Pieber, TR; Greinix ,H; Zebisch, A; Woelfler, A; Sourij, H A pilot trial to investigate efficacy and safety of an automized decision support system for the treatment of steroid induced hyperglycemia in patients with acute Graft-versus-host disease
Diabetes.. 2017; 66(S1):A669-A669.-77th Scientific Sessions of the American Diabetes Association (ADA); JUN 9-13, 2017; San Diego, CA, USA.

 

Aberer, F; Holzgruber, J; Tripolt, NJ; Zebisch, A; Greinix, H; Sill, H; Mader, JK; Pieber, TR; Wölfler, A; Sourij, H Efficacy and safety of an insulin decision support system in the treatment of steroid hyperglycaemia in patients with graft-versus- host-disease: a randomised pilot trial.
Diabetologia. 2017; 60(S1):S323-S324.-53rd Annual Meeting of the European Association for the Study of Diabetes (EASD); SEP 11-15, 2017; Lisbon, PORTUGAL. [Poster]
Web of Science

 

Aberer, F; Mader, JK; Stauber, M; Neumeister, P; Oulhaj, Abderrahim; Zebisch, A; Pieber, TR; Greinix, H; Sill, H; Woelfler, A; Sourij, H Early Hyperglycemia after Initiation of Glucocorticoid Therapy Predicts Adverse Outcome in Patients with Acute Graft-vs.-Host Disease.
Diabetes.. 2017; 66(S1):A24-A25.-77th Scientific Sessions of the American Diabetes Association (ADA); JUN 9-13, 2017; San Diego, CA, USA. [Oral Communication]

 

Aberer, F; Mader, JK; Stauber, M; Tripolt, N; Holzgruber, J; Zebisch, A; Pieber, TR; Neumeister, P; Greinix, H; Sill, H; Wölfler, A; Sourij, H Early hyperglycaemia after initiation of glucocorticoid therapy predicts adverse outcome in patients with acute graft-versus-host disease.
4th International Hospital Diabetes Meeting. 2017; MAY 19-20, 2017; Atlanta, USA. [Poster]

 

Aberer, F; Poettler, T; Sourij, H; Tripolt, NJ; Becvar, S; Leitgeb, S; Pieber, TR; Novak, E; Mader, JK Insulin Pump Therapy in Patients with Diabetes Mellitus Type 2: A Survey of Patient Expectations.
Diabetes. 2017; 66(S1):A622-A622.-77th Scientific Sessions of the American Diabetes Association (ADA); JUN 9-13, 2017; San Diego, CA, USA.

 

Bally, L; Thabit, H; Hartnell, S; Tauschmann, M; Mader, JK; Kojzar, H; Wilinska, ME; Pieber, TR; Evans, ML; Hovorka, R Closed-loop insulin delivery in well controlled adults with type 1 diabetes: A free-living day-and-night randomised cross-over trial.
Diabetes Technology & Therapeutics. 2017; 19(S01):A-38-A-38.-10th International Conference of Advanced Technologies and Treatments for Diabetes (ATTD); FEB 15-18, 2017; Paris, FRANCE. [Poster]

 

Beck, P; Lichtenegger, KM; Mader, JK; Donsa, K; Höll, B; Spat, S; Plank, J; Pieber, TR CLINICAL DECISION SUPPORT FOR THE Management of type 2 diabetes in hospital wards - Development and evaluation of a medical device software system.
Diabetes Technology & Therapeutics. 2017; 19(S01):A-24-A-24.-10th International Conference of Advanced Technologies and Treatments for Diabetes (ATTD); FEB 15-18, 2017; Paris, FRANCE. [Oral Communication]

 

Donsa, K; Mader, JK; Beck, P; Lichtenegger, KM; Pieber, TR Expectation Meets Reality! Computerization of In-Hospital Diabetes Management Significantly Reduces Medication Errors.
4th International Hospital Diabetes Meeting; MAY 19-20, 2017; Atlanta, USA. 2017. [Poster]

 

Drechsler, K; Aberer, F; Trummer, C; Schwetz, V; Pandis, M; Glantschnig, K; Kiesling, L; Lanz, C; Pilz, S; Sourij, H; Mader, JK Therapy-associated Errors in an internal Normal Ward from the Diabetics Point of View - A Questionnaire Survey
WIEN KLIN WOCHENSCHR. 2017; 129: 180-180. [Poster]
Web of Science

 

Drechsler, K; Aberer, F; Trummer, C; Schwetz, V; Pandis, M; Glantschnig, K; Kiesling, L; Lanz, C; Sourij, H; Mader, JK Therapieassoziierte Fehler aus Sicht von DiabetikerInnen auf einer internistischen Normalstation – eine Fragebogenerhebung
Wiener klinische Wochenschrift 2017; 128 (Suppl. 4) . 2017; 180-180.-45. Jahrestagung der Österreichischen Diabetesgesellschaft (ÖDG); NOV 16-18; Salzburg. [Poster]

 

Holzgruber, J; Aberer, F; Mader, JK; Horvath, K; Tripolt, NJ; Pieber, TR; Sourij, H Retrospektive Datenerhebung zu Therapieregimen bei PatientInnen mit steroidinduzierter Hyperglykämie
Wiener klinische Wochenschrift 2017; 129 (Suppl. 4) . 2017; (4):170-170.-45. Jahrestagung der Österreichischen Diabetesgesellschaft (ÖDG); NOV 16-18; Salzburg. [Poster]

 

Holzgruber, J; Aberer, F; Mader, J; Horvath, K; Tripolt, N; Pieber, T; Sourij, H Retrospective Data Collection on Treatment Regimens in Patients with steroid-induced Hyperglycemia
WIEN KLIN WOCHENSCHR. 2017; 129: 170-170. [Poster]
Web of Science

 

Kojzar, H; Frohlich-Reiterer, E; Mader, J; Hofer, S; Rami-Merhar, B; de Beaufort, C; Acerini, CL; Campell, F; Kapellen, T; Hovorka, R KidsAP - The artificial pancreas in children aged 1 to 7 years with type 1 diabetes
WIEN KLIN WOCHENSCHR. 2017; 129: 162-162.-45. Jahrestagung der Österreichischen Diabetesgesellschaft; Nov 16-18; Salzburg. [Oral Communication]
Web of Science

 

Kojzar, H; Fröhlich-Reiterer, E; Mader, JK; Hofer, S; Rami-Merhar, B; de Beaufort, C; Acerini, CL; Campell, F; Kapellen, T; Hovorka, R KidsAP – The artificial pancreas in children aged 1 to 7 years with type 1 diabetes.
Wiener Klinische Wochenschrift. 2017; 129(Supp4):S162-S162.-45. Jahrestagung der Österreichischen Diabetesgesellschaft (ÖDG); NOV 16-18, 2017; Salzburg, AUSTRIA. [Poster]

 

Leelarathna, L; Thabit, H; Bally, L; Mader, JK; Hartnell, S; Willinska, ME; Dellweg, S; Benesch, C; Holzer, M; Kojzar, H; Qerimi-Hyseni, J; Evans, ML; Arnolds, S; Pieber, TR; Hovorka, R Comparison of Closed-Loop Performance in Individuals with Lower and Higher HbA1c.
Diabetes. 2017; 66(S1):A272-A273.-77th Scientific Sessions of the American Diabetes Association (ADA); JUN 9-13, 2017; San Diego, CA, USA. [Poster]

 

Leelarathna, L; Thabit, H; Hartnell, S; Willinska, M; Dellweg, S; Benesch, C; Mader, JK; Holzer, M; Evans, M; Arnolds, S; Pieber, TR; Hovorka, R Relationship between glucose variability and glycaemic control during sensor augmented pump therapy (SAP) and closed loop (CL) insulin delivery in adults with type 1 diabetes (T1D).
Diabetes Technology & Therapeutics. 2017; 19(S01):A-71-A-71.-10th International Conference of Advanced Technologies and Treatments for Diabetes (ATTD); FEB 15-18, 2017; Paris, FRANCE. [Poster]

 

Leelarathna, L; Thabit, H; Willinska, ME; Dellweg, S; Mader, JK; Hartnell, S; Benesch, C; Holzer, M; Kojzar, H; Evans, ML; Arnolds, S; Pieber, TR; Hovorka, R; On behalf of AP@home consortium Determining duration of closed-loop studies: evidence from a randomised day-and-night three month trial.
Diabetologia. 2017; 60(S1):S324-S325.-53rd Annual Meeting of the European Association for the Study of Diabetes; SEP 11-15, 2017; Lisbon, PORTUGAL. [Poster]
Web of Science

 

Lilly, L; Mader, JK; Aberer, F; Warner, J; Augustin, T PAQ Insulin delivery device significantly increases the percentage of time in target range.
Diabetes Technology & Therapeutics. 2017; 19(S01):A-105-A-106.-10th International Conference of Advanced Technologies and Treatments for Diabetes (ATTD); FEB 15-18, 2017; Paris, FRANCE. [Poster]

 

Mader, JK; Aberer, F; Pöttler, T; Novak, E; Warner, J; Trautmann, M; Pieber, TR PAQ, ein einfaches Insulinabgabegerät für Basis-Bolus-Therapie, erhöht die Zeit im Blutzuckerzielbereich signifikant.
Diabetologie und Stoffwechsel. 2017; 12(S1):S53-S53.-Diabetes Kongress 2017; MAY 24-27, 2017; Hamburg, GERMANY. [Poster]

 

Mader, JK; Aberer, F; Pöttler, T; Novak, E; Warner, J; Trautmann, M; Pieber, TR PAQ - ein einfaches Insulinabgabegerät für Basis-Bolus-Therapie erhöht die Zeit im Blutzuckerzielbereich signifikant.
J Klin Endokrinol Stoffw. 2017; 10(S1):6-7.-Joint Annual Meeting of the ÖGES (Österreichische Gesellschaft für Endokrinologie und Stoffwechsel) and the OSDG (Österreichische Schilddrüsengesellschaft); MAR 22-24, 2017; Linz, AUSTRIA. [Oral Communication]

 

Mader, JK; Donsa, K; Aberer, F; Lichtenegger, K; Lanz, C; Smajic, E; Hoell, B; Beck, P; Pieber, TR; Plank, J Increase in time in target when using a basal-bolus algorithm for Insulin dosing with insulin glargine U300 during hospital stay.
Endocrine Abstracts. 2017; 49: -19th European Congress of Endocrinology (ECE); MAY 20-23, 2017; Lisbon, PORTUGAL. [Poster]
FullText

 

Mader, JK; Donsa, K; Aberer, F; Lichtenegger, KM; Lanz, C; Smajic, E; Hoell, B; Beck, P; Pieber, TR; Plank, J Increase in Time in Target when Using a Basal-Bolus Algorithm for Insulin Dosing with insulin glargine U300 during Hospital Stay.
4th International Hospital Diabetes Meeting; MAY 19-20, 2017; Atlanta, USA. 2017. [Poster]

 

Mader, JK; Donsa, K; Aberer, F; Lichtenegger, KM; Sourij, H; Höll, B; Lanz, C; Beck, P; Pieber, TR; Plank, J Welche Faktoren beeinflussen die Entscheidung über die Fortsetzung der Insulintherapie bei Entlassung aus dem Krankenhaus bei Patienten mit Diabetes mellitus Typ 2?
Diabetologie und Stoffwechsel. 2017; 12(S1):S72-S72.-Diabetes Kongress 2017; MAY 24-27, 2017; Hamburg, GERMANY. [Poster]

 

Mader, JK; Donsa, K; Aberer, F; Smajic, E; Lanz, C; Lichtenegger, KM; Spat, S; Hoell, B; Beck, P; Pieber, TR; Plank, J GlucoTab-based Basal-Bolus Insulin Therapy for Inpatient Glycemic Control Using an Ultra-Long-Acting Insulin Analog.
Diabetes. 2017; 66(S1):A277-A277.-77th Scientific Sessions of the American Diabetes Association (ADA); JUN 9-13, 2017; San Diego, CA, USA. [Poster]

 

Mader, JK; Donsa, K; Aberer, F; Smajic, E; Lichtenegger, KM; Hoell, B; Beck, P; Pieber, TR; Plank, J Algorithm based basal-bolus insulin therapy for inpatient glycaemic control using a novel long acting insulin analogue.
International Diabetes Federation (IDF) Congress; DEC 4-8, 2017; Abu Dhabi, UNITED ARAB EMIRATES. 2017. [Poster]

 

Mader, JK; Donsa, K; Aberer, F; Smajic, E; Lichtenegger, KM; Lanz, C; Holl, B; Beck, P; Pieber, TR; Plank, J GlucoTab((R))-based Basic Bolus Insulin Therapy with Insulin glargin U300 increases the Time in the Target Area in hospitalized Female Patients with Type 2 Diabetes mellitus
WIEN KLIN WOCHENSCHR. 2017; 129: 171-171. [Poster]
Web of Science

 

Mader, JK; Donsa, K; Aberer, F; Smajic, E; Lichtenegger, KM; Lanz, C; Höll, B; Beck, P; Pieber, TR; Plank, J GlucoTab®-basierte Basis-Bolus Insulintherapie mit Insulin glargin U300 erhöht die Zeit im Zielbereich bei hospitalisierten PatientInnen mit Diabetes mellitus Typ 2
Wiener klinische Wochenschrift, Ausgabe 129 (Suppl. 4) . 2017; 171-171.-45. Jahrestagung der Österreichischen Diabetesgesellschaft (ÖDG); NOV 16-18; Salzburg. [Oral Communication]

 

Mader, JK; Donsa, K; Lichtenegger, KM; Aberer, F; Sourij, H; Höll, B; Beck, P; Pieber, TR; Plank, J Welche Faktoren beeinflussen die Entscheidung über die Fortsetzung der Insulintherapie bei Entlassung aus dem Krankenhaus bei Patienten mit Diabetes mellitus Typ 2?
J Klin Endokrinol Stoffw. 2017; 10(S1):6-6.-Joint Annual Meeting of the ÖGES (Österreichische Gesellschaft für Endokrinologie und Stoffwechsel) and the OSDG (Österreichische Schilddrüsengesellschaft); MAR 22-24, 2017; Linz, AUSTRIA. [Oral Communication]

 

Mader, JK; Hermanns, N; Lilly, L; Aberer, F; Poettler, T; Lanz, C; Warner, J; Pieber, T PAQ Insulin delivery device improves glycemic control and diabetes treatment satisfaction in adults wit type 2 diabetes.
Diabetes Technology & Therapeutics. 2017; 19(S01):A-119-A-119.-10th International Conference of Advanced Technologies and Treatments for Diabetes (ATTD); FEB 15-18, 2017; Paris, FRANCE. [Poster]

 

Mader, JK; Lilly, LC; Aberer, F; Poettler, T; Novak, E; Lanz, C; Trautmann, ME; Warner, J; Pieber, TR PAQ, 3-Month Treatment in Adults with Type 2 Diabetes.
Diabetes. 2017; 66(S1):A277-A277.-77th Scientific Sessions of the American Diabetes Association (ADA); JUN 9-13, 2017; San Diego, CA, USA. [Poster]

 

Muenzker, J; Zenz, S; Moser, O; Motschnig, M; Puffing, A; Elsayed, H; Baumann, P; Schadler, HP; Pieber, TR; Sourij, H; Mader, JK Glucagon response in patients with type 1 diabetes during meal- related hypoglycaemia and hyperinsulinaemic, hypoglycaemic clamp conditions.
Diabetologia. 2017; 60(S1):S234-S234.-53rd Annual Meeting of the European Association for the Study of Diabetes (EASD); SEP 11-15, 2017; Lisbon, PORTUGAL. [Poster]
Web of Science

 

Pandis, M; Elsayed, H; Münzker, J; Puffing, A; Motschnig, M; Kojzar, H; Schadler, HP; Pieber, TR; Sourij, H; Treiber, G; Mader, JK Standardised evaluation of a retrospectively versus prospectively calibrated continuous glucose monitoring systems at the research centre and at home.
International Diabetes Federation (IDF) Congress; DEC 4-8, 2017; Abu Dhabi, UNITED ARAB EMIRATES. 2017. [Poster]

 

Pandis, M; Elsayed, H; Munzker, J; Puffing, A; Motschning, M; Kojzar, H; Schadler, HP; Pieber, TR; Sourij, H; Treiber, G; Mader, JK Standardized Evaluation of a retrospective versus prospectively calibrated continuous Glucose System at the Research Center and at Home
WIEN KLIN WOCHENSCHR. 2017; 129: 173-173. [Poster]
Web of Science

 

Pandis, M; Elsayed, H; Münzker, J; Puffing, A; Motschning, M; Kojzar, H; Schadler, HP; Pieber, TR; Sourij, H; Treiber, G; Mader, JK Standardisierte Auswertung eines retrospektiv versus prospektiv kalibrierten kontinuierlichen Glukosesystems im Forschungszentrum und zu Hause
Wiener Klinische Wochenschrift. 2017; 129(Supp4):S173-S173.-45. Jahrestagung der Österreichischen Diabetesgesellschaft (ÖDG); NOV 16-18, 2017; Salzburg, AUSTRIA. [Oral Communication]

 

Pandis, M; Mader, J; Haas, W; Boulgaropoulos, B; Baumann, P; Horvath, K; Pieber, T; Sourij, H; Plank, J; Koehler, G LONGTERM FOLLOW-UP OF A COHORT WITH A HISTORY OF DIABETIC FOOT ULCER IN AUSTRIA.
14th Meeting of the Diabetic Foot Study Group 2017; September 8-10, 2017; Porto, PORTUGAL. 2017. [Poster]

 

Pöttler, T; Lilly, LC; Aberer, F; Novak, E; Lanz, C; Trautmann, ME; Warner, J; Pieber, TR; Mader, JK 3 month treatment with a simple 3-day insulin delivery device in adults with type 2 diabetes.
International Diabetes Federation (IDF) Congress; DEC 4-8, 2017; Abu Dhabi, UNITED ARAB EMIRATES. 2017. [Poster]

 

Pottler, T; Lilly, LC; Aberer, F; Trautmann, M; Warner, J; Pieber, TR; Mader, JK Results of three Months of Insulin Therapy with PAQ((R)) in Female Patients with Type 2 Diabetes
WIEN KLIN WOCHENSCHR. 2017; 129: 173-173. [Poster]
Web of Science

 

Pöttler, T; Lilly, LC; Aberer, F; Trautmann, M; Warner, J; Pieber, TR; Mader, JK Ergebnisse von drei Monaten Insulintherapie mit PAQ bei PatientInnen mit Typ 2 Diabetes
Wiener klinische Wochenschrift, Ausgabe 129 (Suppl. 4) . 2017; 173-173.-45. Jahrestagung der Österreichischen Diabetesgesellschaft (ÖDG); NOV 16-18; Salzburg. [Oral Communication]

 

Schmid, SM; Lanzinger, S; Karges, W; Bergis, D; Seufert, J; Kerner, W; Mader, JK; Zimny, S; Hummel, M; Rosenbauer, J; Holl, RW Event rates and risk factors for diabetic ketoacidosis in adult type 1 diabetes: analysis from the German/Austrian DPV registry based on 48,067 patients.
Diabetologia. 2017; 60(S1):S154-S154.-53rd Annual Meeting of the European Association for the Study of Diabetes (EASD); SEP 11-15, 2017; Lisbon, PORTUGAL. [Poster]
Web of Science

 

Seufert, J; Lanzinger, S; Schmid, S; Karges, W; Bergis, D; Kerner, W; Hummel, M; Zimny, S; Mader, JK; Rosenbauer, J; Holl, RW Epidemiologie diabetischer Ketoazidosen im Verlauf des Typ-1-Diabetes bei Erwachsenen: Daten der DPV-Initiative bei 45.764 Patienten.
Diabetologie und Stoffwechsel. 2017; 12(S1):S6-S6.-Diabetes Kongress 2017; MAY 24-27, 2017; Hamburg, Germany. [Poster]

 

Stauber, M; Aberer, F; Oulhaj, A; Mader, JK; Zebisch, A; Pieber, TR; Neumeister, P; Greinix, HT; Sill, H; Sourij, H; Wolfler, A Early hyperglycaemia after initiation of glucocorticoid therapy predicts adverse outcome in patients with acute graft-versus-host disease
BONE MARROW TRANSPL. 2017; 52: S285-S285.
Web of Science

 

Aberer, F; Hajnsek, M; Rumpler, M; Zenz, S; Puffing, A; Augustin, T; Baumann, P; Sinner, F; Sourijl, H; Pieber, TR; Mader, JK Standardised evaluation of three continuous glucose monitoring systems mimicking real-life conditions.
DIABETOLOGIA. 2016; 59: S411-S412.-52nd Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD); SEP 12-16, 2016; Munich, GERMANY. [Oral Communication]
Web of Science

 

Aberer, F; Holzgruber, J; Mader, JK; Wölfler, A; Greinix, H; Tripolt, N; Pieber, TR; Sourij, H Pilotstudie zur Überprüfung der Machbarkeit und Effizienz einer normnahen Blutzuckereinstellung mittels eines automatisierten Entscheidungsunterstützungsalgorithmus in der Insulintherapie von Patienten mit Graft-versus-host Erkrankung
Wiener klinische Wochenschrift . 2016; 44(6):410-410.-Jahrestagung der Österreichischen Diabetes Gesellschaft (ÖDG); NOV 17,19, 2016; Salzburg . [Poster]

 

Aberer, F; Kremser, S; Zebisch, A; Mader, JK; Sill, H; Greinix, H; Zinke-Cerwenka, W; Pieber, TR; Oulhaj, A; Wölfler, A; Sourij, H Hyperglycemia during the First Month after Allogeneic Hematopoietic Stem Cell Transplantation Is an Independent Risk Factor for Overall Survival in Patients with Acute Myeloid Leukemia.
Diabetes. 2016; 65(S1):A410-A411.-76th Scientific Sessions of the American Diabetes Association (ADA); JUN 10-14, 2016; New Orleans, LA, USA. [Poster]

 

Aberer, F; Mader, JK; Wolfler, A; Greinix, H; Tripolt, N; Pieber, TR; Sourij, H Pilot Study for Verifying the Feasibility and Efficiency of a standard Blood Glucose Control using an automated Decision Support Algorithm in the Insulin Therapy of Patients with Graft-versus-host Disease
WIEN KLIN WOCHENSCHR. 2016; 128: S407-S407.-44. Jahrestagung der Österreichischen Diabetesgesellschaft (ÖDG); NOV 17-19, 2016; Salzburg, AUSTRIA. [Poster]
Web of Science

 

Aberer, F; Stauber, M; Zebisch, A; Greinix, H; Sill, H; Mader, JK; Oulhaj, A; Pieber, TR; Wölfler, A; Sourij, H In-Hospital Hyperglycemia Is Associated with Adverse Outcome in Patients with Acute or Chronic Graft vs. Host Disease after Hematopoeietic Stem Cell Transplantation.
Diabetes. 2016; 65(S1):A390-A390.-76th Scientific Sessions of the American Diabetes Association (ADA); JUN 10-14, 2016; New Orleans, LA, USA. [Poster]

 

Cigler, M; Schwetz, V; Aberer, F; Zenz, S; Lueger, A; Eller, P; Pieber, TR; Sourij, H; Mader, JK Retrospective Analysis of glycemic Derailments in Diabetes in the internal Emergency Department at the LKH University Hospital in Graz
WIEN KLIN WOCHENSCHR. 2016; 128: S410-S410. [Oral Communication]
Web of Science

 

Hajnsek, M; Rumpler, M; Mader, JK; Pieber, TR Optical Glucose Sensor for Single-Port Glucose Monitoring.
Diabetes. 2016; 65(S1):A224-A225.-76th Scientific Sessions of the American Diabetes Association (ADA); JUN 10-14, 2016; New Orleans, LA, USA. [Poster]

 

Kojzar, H; Ruan, Y; Thabit, H; Leelarathna, L; Hartnell, S; Willinska, ME; Dellweg, S; Benesch, C; Mader, JK; Holzer, M; Evans, ML; Pieber, TR; Arnolds, S; Hovorka, R Time to peak Insulin Action Duration influences the glycemic Outcome in Type 1 Diabetes during the Home Phase with Closed Loop Insulin Delivery
WIEN KLIN WOCHENSCHR. 2016; 128: S423-S423. [Poster]
Web of Science

 

Mader, JK Mobile health in diabetes.
Medica Education Conference; NOV 14-17, 2016; Düsseldorf, GERMANE. 2016. [Keynote lecture]

 

Mader, JK; Donsa, K; Neubauer, KM; Aberer, F; Schaupp, L; Sourij, H; Spat, S; Holl, B; Beck, P; Pieber, TR; Plank, J What are the main Factors Influencing the Decision to continue Insulin Therapy during Discharge of the Patients with Type 2 Diabetes mellitus from the Hospital?
WIEN KLIN WOCHENSCHR. 2016; 128: S400-S401. [Poster]
Web of Science

 

Mader, JK; Donsa, K; Neubauer, KM; Aberer, F; Schaupp, L; Sourij, H; Spat, S; Hoell, B; Beck, P; Pieber, TR; Plank, J Factors Influencing Continuation of Insulin Therapy in Patients with Diabetes Mellitus Type 2 at Hospital Discharge.
Diabetes. 2016; 65(S1):A248-A249.-76th Scientific Sessions of the American Diabetes Association (ADA); JUN 10-14, 2016; New Orleans, LA, USA. [Poster]

 

Mader, JK; Donsa, K; Neubauer, KM; Pieber, TR; Plank, J Welche Faktoren beeinflussen die Entscheidung über die Fortsetzung der Insulintherapie bei Entlassung aus dem Krankenhaus bei Typ 2 Diabetes?
Wien Klin Wochenschr.. 2016; 128(S05):S381-S281.-47. Jahrestagung der Österreichischen Gesellschaft für Innere Medizin (OEGIM); SEP 22-24, 2016; Salzburg, AUSTRIA. [Poster]
Web of Science

 

Mader, JK; Hajnsek, M; Aberer, F; Rumpler, M; Zenz, S; Puffing, A; Elsayed, H; Baumann, P; Sinner, F; Pieber, TR Standardized Assessment of three continuous Glucose Monitoring Systems under realistic Conditions
WIEN KLIN WOCHENSCHR. 2016; 128: S400-S400. [Poster]
Web of Science

 

Mader, JK; Lilly, LC; Aberer, F; Poettler, T; Becvar, S; Lanz, C; Trautmann, M; Pieber, TR PAQ®, A Simple 3-Day Basal/Bolus Insulin Delivery Device for People with Type 2 Diabetes.
DIABETES TECHNOL THE. 2016; 18: A109-A109.-9th International Conference of Advanced Technologies and Treatments for Diabetes (ATTD) ; FEB 3-6, 2016; Milan, ITALY. [Poster]
Web of Science

 

Mader, JK; Lilly, LC; Aberer, F; Poettler, T; Becvar, S; Lanz, C; Trautmann, M; Pieber, TR PAQ® 3-Month Observation Study in Adults with Type 2 Diabetes.
Diabetes. 2016; 65(S1):A262-A262.-76th Scientific Sessions of the American Diabetes Association (ADA); JUN 10-14, 2016; New Orleans, LA, USA. [Poster]

 

Mader, JK; Lilly, LC; Aberer, F; Pottler, T; Becvar, S; Lanz, C; Trautmann, M; Pieber, TR Application of PAQ®, an Insulin Dosage Device for Patients with Type 2 Diabetes mellitus, for 3 Months
WIEN KLIN WOCHENSCHR. Wiener Klinische Wochenschrift. 2016; 128(Supp 6):S399-S400.-44. Jahrestagung der Österreichischen Diabetes Gesellschaft (ÖDG); NOV 17-19, 2016; Salzburg, AUSTRIA. [Oral Communication]
Web of Science

 

Mader, JK; Lilly, LC; Aberer, F; Pöttler, T; Becvar, S; Lanz, C; Trautmann, M; Pieber, TR PAQ® - 3 Month Observation Study in Adults with Type 2 Diabetes.
16th Annual Diabetes Technology Meeting (DTM); NOV 10-12, 2016; Bethesda, MD, USA. 2016. [Poster]

 

Mader, JK; Zenz, S; Baumann, P; Sourij, H; Pieber, TR Vergleichbare Glukagonantwort bei Patienten mit langer vs. kurzer Typ 1 Diabetes Laufdauer.
Wien Klin Wochenschr. 2016; 128(S05):S381-S382.-47. Jahrestagung der Österreichischen Gesellschaft für Innere Medizin (OEGIM); SEP 22-24, 2016; Salzburg, AUSTRIA. [Poster]
Web of Science

 

Neubauer, KM; Mader, JK; Aberer, F; Tuca, A; Donsa, K; Augustin, T; Höll, B; Schaupp, L; Beck, P; Plank, J; Pieber, TR Wirksamkeit, Sicherheit und Benutzerfreundlichkeit eines Entscheidungsunterstützungssystems für eine Basis-Bolusinsulintherapie in der stationären Routineversorgung.
Wiener Klinische Wochenschrift. 2016; 44(Supp 6):S397-S398.-44. Jahrestagung der Österreichischen Diabetes Gesellschaft (ÖDG); NOV 17-19, 2016; Salzburg, AUSTRIA. [Poster]

 

Neubauer, KM; Mader, JK; Aberer, F; Tuca, A; Donsa, K; Augustin, T; Höll, B; Schaupp, L; Beck, P; Plank, J; Pieber, TR Efficacy, Safety, and Usability of a Clinical Decision Support System for Basal-Bolus Insulin Therapy in Hospital Routine Care.
Diabetes. 2016; 65(S1):A4-A4.-76th Scientific Sessions of the American Diabetes Association (ADA); JUN 10-14, 2016; New Orleans, LA, USA. [Oral Communication]

 

Ruan, Y; HOOD Thabit, H; Leelarathna, L; Hartnell, S; Wilinska, ME; Dellweg, S; Benesch, C; Mader, JK; Holzer, M; Kojzar, H; Evans, ML; Arnolds, S; Pieber, T; Hovorka, R Insulin Pharmacodynamics and Outcomes during Home Use of Closed-Loop Insulin Delivery in Adults with Type 1 Diabetes.
Diabetes. 2016; 65(S1):A255-A255.-76th Scientific Sessions of the American Diabetes Association (ADA); JUN 10-14, 2016; New Orleans, LA, USA. [Poster]

 

Rumpler, M; Hajnsek, M; Mader, JK; Sinner, F; Pieber, TR SPIDIMAN: Clinical Trial of a Single-Port Glucose Sensor on a Commercial Insulin Infusion Set.
DIABETES TECHNOL THE. 2016; 18: A28-A28.-9th International Conference of Advanced Technologies and Treatments for Diabetes (ATTD); FEB 3-6, 2016; Milan, ITALY. [Oral Communication]
Web of Science

 

Tuca, AC; Neubauer, KM; Mader, JK; Aberer, F; Lumenta, DB; Bauer, B; Donsa, K; Augustin, T; Holl, B; Schaupp, L; Beck, P; Plank, J; Pieber, TR; Kamolz, LP Treatment of Patients with Type 2 Diabetes mellitus using a clinical Decision Support System at a plastic surgical Ward
WIEN KLIN WOCHENSCHR. Wiener Klinische Wochenschrift. 2016; 128(Supp 6):S412-S413.-44. Jahrestagung der Österreichischen Diabetes Gesellschaft (ÖDG); NOV 17-19, 2016; Salzburg, AUSTRIA. [Poster]
Web of Science

 

Zenz, S; Baumann, P; Brunner, M; Puffing, A; Rumpler, M; Wolf, M; Hajnsek, M; Sourij, H; Pieber, TR; Mader, JK Glucagon response in C-peptide positive vs C-peptide negative patients with type 1 diabetes under hypoglycaemic clamp vs real-life setting.
Diabetologia. 2016; 59(Suppl1):S404-S404.-52nd Annual Meeting of the European Association for the Study of Diabetes (EASD); SEP 12-16, 2016; Munich, GERMANY. [Poster]
Web of Science

 

Zenz, S; Baumann, P; Brunner, M; Puffing, A; Rumpler, M; Wolf, M; Hajnsek, M; Sourij, H; Pieber, TR; Mader, JK Comparison of the Glucagon Response with C-peptide positive vs. C-peptide negative Female Patients with Type 1 Diabetes mellitus in a hypoglycaemic Clamp vs. Real-Life Experiment
WIEN KLIN WOCHENSCHR. 2016; 128: S413-S413. [Oral Communication]
Web of Science

 

Zenz, S; Baumann, P; Brunner, M; Puffing, A; Wolf, M; Rumpler, M; Hajnsek, M; Sourij, H; Pieber, TR; Mader, JK Glucagon Response in C-Peptide Positive vs. C-Peptide Negative Patients with Type 1 Diabetes under Hypoglycemic Clamp vs. Real-Life Setting.
Proceedings of the 76th Scientific Sessions of the American Diabetes Association (ADA) - Late Breaking Abstracts. 2016; -76th Scientific Sessions of the American Diabetes Association (ADA); JUN 10-14, 2016; New Orleans, LA, USA. [Poster]

 

Aberer, F; Lilly, LC; Pöttler, T; Becvar, S; Lanz, C; Novak, E; Trautmann, M; Pieber, TR; Mader, JK Überprüfung der Effizienz und Sicherheit eines einfachen Insulinabgabegerätes (PaQ) bei Patienten mit Diabetes mellitus Typ 2.
Wiener Klinische Wochenschrift. 2015; 127(Supp 4):S136-S136.-43. Jahrestagung der Österreichischen Diabetes Gesellschaft (ÖDG); NOV 19-21, 2015; Salzburg, AUSTRIA. [Poster]
Web of Science

 

Aberer, F; Mader, JK; Kremser, S; Zinke-Cerwenka, W; Greinix, H; Pieber, TR; Zebisch, A; Sill, H; Oulhaj, A; Wölfler, A; Sourij, H Glykämie nach allogener Stammzelltransplantation bei Patienten mit akuter myeloischer Leukämie (AML) ist ein unabhängiger Prädiktor für das Überleben.
Wiener Klinische Wochenschrift. 2015; 127(Suppl 4 ):S135-S135.-43. Jahrestagung der Österreichischen Diabetes Gesellschaft (ÖDG); NOV 19-21, 2015; Salzburg, AUSTRIA. [Poster]
Web of Science

 

Aberer, F; Stauber, MN; Mader, JK; Greinix, H; Oulhaj, A; Wölfler, A; Sourij, H Assoziation zwischen Hyperglykämie und ungünstigem Outcome bei Patienten mit akuter oder chronischer Graft-versus-Host Erkrankung (GvHD) nach allogener Stammzelltransplantation.
Wiener Klinische Wochenschrift. 2015; 127(Supp 4):S156-S157.-43. Jahrestagung der Österreichischen Diabetes Gesellschaft (ÖDG); NOV 19-21, 2015; Salzburg, AUSTRIA. [Oral Communication]
Web of Science

 

Donsa, K; Neubauer, KM; Mader, JK; Holl, B; Spat, S; Beck, P; Aberer, F; Plank, J; Pieber, TR; Schaupp, L CONTINUOUS GLUCOSE MONITORING ASSESSING THE CLINICAL IMPACT OF AN ALGORITHM DRIVEN BASAL-BOLUS INSULIN REGIMEN IN NON-CRITICALLY ILL INPATIENTS WITH T2DM
DIABETES TECHNOL THE. 2015; 17: A24-A25. [Oral Communication]
Web of Science

 

Donsa, K; Schaupp, L; Neubauer, KM; Mader, JK; Höll, B; Spat, S; Beck, P; Plank, J; Pieber, TR Continuous Glucose Monitoring compared with Point of Care Testing in Hospitalized Type 2 Diabetes Patients on Basal-Bolus Insulin Therapy.
3rd International Hospital Diabetes Meeting; MAY 8-9, 2015; San Francisco, USA. 2015. [Poster]

 

Holzer, M; Thabit, H; Leelarathna, L; Dellweg, S; Mader, JK; Hartnell, S; Benesch, C; Kojzar, H; Heinemann, L; Wilinska, M; Pieber, TR; Arnolds, S; Evans, M; Hovorka, R 12-wöchige Tag-und-Nacht Closed-Loop Insulinabgabe bei erwachsenen Typ 1 Diabetikern im Alltag: eine offene multizentrische multinationale prospektive randomisierte Crossover-Studie.
Wiener Klinische Wochenschrift. 2015; 127(Supp 4):S145-S145.-43. Jahrestagung der Österreichischen Diabetes Gesellschaft (ÖDG); NOV 19-21, 2015; Salzburg, AUSTRIA. [Poster]
Web of Science

 

Kojzar, H; Thabit, H; Leelarathna, L; Wilinska, ME; Elleri, D; Allen, JM, Lubina-Solomon, A; Walkinshaw, E; Stadler, M; Choudhary, P; Holzer, M; MAder, JK; Dellweg, S; Benesch, C; Pieber, TR; Arnolds, S; Heller, SR; Amiel, SA; Dunger, D; Evans, ML; Hovorka, R Genauigkeit und Performance von kontinuierlichem Glukosemonitoring bei drei Closed-Loop-Studienmit Heimphase unter normalen Lebensbedingungen.
Wiener Klinische Wochenschrift. 2015; 127(Supp 4):S145-S146.-43. Jahrestagung der Österreichischen Diabetes Gesellschaft (ÖDG); NOV 19-21, 2015; Salzburg, AUSTRIA. [Poster]
Web of Science

 

Laimer, M; Melmer, A; Mader, J; Schutz-Fuhrmann, I; Rose-Engels, H; Gotz, G; Pfeiffer, M; Hermann, J; Stettler, C; Holl, R WAVY BASAL RATE PROFILES IN INSULIN PUMP THERAPY ASSOCIATE WITH INCREASED RISK FOR ACUTE COMPLICATIONS IN TYPE 1 DIABETES-CROSS-SECTIONAL ANALYSIS FROM THE DPV REGISTRY
DIABETES TECHNOL THE. 2015; 17: A12-A13. [Oral Communication]
Web of Science

 

Leitgeb, S; Ribitsch, A; Pöttler, T; Novak, E; Mader, J; Pieber, T; Treiber, G; Geschlechtsspezifische Unterschiede diabetischer Spätkomplikationen bei übergewichtigen und adipösen Patienten mit Diabetes Typ 1
Diabetologie und Stoffwechsel 2015. 2015; 10(S 01):S10-S10.-50. Diabetes Kongress der Deutschen Diabetes Gesellschaft ; MAI 13-16, 2015; Berlin, GERMANY. [Poster]

 

Mader, JK; Aberer, F; Lilly, LC; Neubauer, K; Spat, S; Höll, B; Warner, J; Donsa, K; Schaupp, L; Pieber, TR; Sourij, H; Plank, J Evaluation of a decision support tool for insulin dose finding in patients with type 2 diabetes on continuous subcutaneous insulin infusion.
World Diabetes Congress (IDF); Nov 30 – Dec 4, 2015; Vancouver, CANADA. 2015. [Poster]

 

Mader, JK; Donsa, K; Neubauer, KM; Aberer, F; Höll, B; Spat, S; Beck, P; Schaupp, L; Plank, J; Pieber, TR Insulin therapy initialization using the GlucoTab system.
3rd International Hospital Diabetes Meeting; MAY 8-9, 2015; San Francisco, USA. 2015. [Poster]

 

Mader, JK; Haas, W; Ribitsch, A; Samonigg, J; Höller, V; Horvath, K; Köhler, G; Sourij, H; Pieber, TR; Plank, J Langzeit Follow-up diner Kohorte von Patienten mit diabetischem Fußsyndrom in der Steiermark.
Wiener Klinische Wochenschrift. 2015; 127(Supp 4):S134-S134.-43. Jahrestagung der Österreichischen Diabetes Gesellschaft (ÖDG); NOV 19-21, 2015; Salzburg, AUSTRIA. [Poster]
Web of Science

 

Mader, JK; Haas, W; Ribitsch, A; Samonigg, J; Horvath, K; Köhler, G; Sourij, H; Pieber, TR; Plank, J 10-year follow-up of a cohort with a history of diabetic foot ulcers in Austria.
World Diabetes Congress (IDF); Nov 30 – Dec 4, 2015; Vancouver, CANADA. 2015. [Poster]

 

Mader, JK; Haas, W; Ribitsch, A; Samonigg, J; Horvath, K; Köhler, G; Sourij, H; Pieber, TR; Plank, J Long-Term follow-up of a Cohort with a History of Diabetic Foot Ulcer in Austria.
Diabetes. 2015; 64(S1):A182-A182.-75th Scientific Sessions of the American Diabetes Association (ADA); JUN 5-9, 2015; Boston, USA. [Poster]

 

Mader, JK; Lilly, L; Aberer, F; Poettler, T; Trautmann, M; Pieber, T PAQ, A SIMPLE 3-DAY INSULIN DELIVERY DEVICE, IMPROVES GLYCEMIC CONTROL
DIABETES TECHNOL THE. 2015; 17: A13-A13. [Oral Communication]
Web of Science

 

Mader, JK; Lilly, LC; Aberer, F; Pöttler, T; Lanz, C; Trautmann, M; Pieber, TR PaQ®, ein einfaches Insulindosierungsgerät für Basis-Bolus-Therapie bei Patientinnen mit Typ 2 Diabetes, verbessert die Blutzuckereinstellung.
Diabetologie und Stoffwechsel. 2015; 10(S 01):S86-S86.-50. Diabetes Kongress der Deutschen Diabetes Gesellschaft (DDG); MAY 13-16, 2015; Berlin, GERMANY. [Poster]

 

Mader, JK; Lilly, LC; Aberer, F; Pöttler, T; Trautmann, M; Pieber, TR A Study to Assess the Performance of PaQ®, a Simple 3-Day Basal Bolus Insulin Delivery Device after 12 Weeks of Treatment in People with Type 2 Diabetes.
Diabetes. 2015; 64(S1):A272-A272.-75th Scientific Sessions of the American Diabetes Association (ADA); JUN 5-9, 2015; Boston, USA. [Poster]

 

Mader, JK; Neubauer, KM; Schaupp, L; Aberer, F; Donsa, K; Augustin, T; Spat, S; Hoell, B; Beck, P; Plank, J; Pieber, TR Glycemic control by using GlucoTab® in insulin-naïve and insulin-treated hospitalized patients with type 2 diabetes mellitus.
15th Annual Diabetes Technology Meeting (DTM) ; OCT 22-24, 2015; Bethesda, MD, USA. 2015. [Poster]

 

Mader, JK; Neubauer, KM; Schaupp, L; Aberer, F; Donsa, K; Augustin, T; Spat, S; Höll, B; Beck, P; Plank, J; Pieber, TR Blutzuckermanagement mittels GlucoTab-System bei insulinnaiven versus insulinvorbehandelten Patienten mit Diabetes mellitus Typ 2.
Wiener Klinische Wochenschrift. 2015; 127(Suppl 4):S134-S134.-43. Jahrestagung der Österreichischen Diabetes Gesellschaft (ÖDG); NOV 19-21, 2015; Salzburg, AUSTRIA. [Poster]
Web of Science

 

Mader, JK; Sourij, H; Laimer, M; Debong, F; Schandl, B; Pieber, R INFLUENCE OF FREQUENT USE OF MOBILE HEALTH TECHNOLOGY ON BLOOD GLUCOSE CONTROL IN PATIENTS WITH TYPE 1 DIABETES
DIABETES TECHNOL THE. 2015; 17: A124-A125. [Poster]
Web of Science

 

Mader, JK; Thabit, H; Leelarathna, L; Wilinska, ME; Elleri, D; Allen, JM; Lubina-Solomon, A; Walkinshaw, E; Stadler, M; Choudhary, P; Dellweg, S; Benesch, C; Pieber, TR; Arnolds, S; Heller, SR; Amiel, SA; Dunger, D; Evans, ML; Hovorka, R Accuracy and performance of continuous glucose monitoring during three closed-loop home studies under free-living conditions.
J Klin Endokrinol Stoffw. 2015; 8(S1):8-8.-Joint Annual Meeting of the ÖGES (Österreichische Gesellschaft für Endokrinologie und Stoffwechsel) and the OSDG (Österreichische Schilddrüsengesellschaft); MAR 18-20, 2015; Innsbruck, AUSTRIA. [Poster]

 

Neubauer, KM; Aberer, F; Mader, JM; Holl, B; Schaupp, L; Spat, S; Beck, P; Donsa, K; Plank, J; Pieber, TR SAFETY AND EFFICACY OF STANDARDISED GLYCAEMIC MANAGEMENT BY USING THE GLUCOTAB SYSTEM FOR PATIENTS WITH DIABETES MELLITUS TYPE 2 AT DIFFERENT HOSPITAL WARDS
DIABETES TECHNOL THE. 2015; 17: A26-A26. [Oral Communication]
Web of Science

 

Neubauer, KM; Mader, JK; Aberer, F; Schaupp, L; Donsa, K; Augustin, T; Beck, P, Pieber; TR, Plank, J Wirksamkeit und Sicherheit von standardisierter Insulintherapie bei hospitalisierten Patienten im Alter von <70 und ≥ 70 Nahen mit Diabetes mellitus Typ 2.
Wiener Klinischen Wochenschrift. 2015; 127(Supp 4):S148-S148.-43. Jahrestagung der Österreichischen Diabetes Gesellschaft (ÖDG); NOV 19-21, 2015; Salzburg, AUSTRIA. [Poster]
Web of Science

 

Neubauer, KM; Mader, JK; Aberer, F; Schaupp, L; Donsa, K; Augustin, T; Beck, P; Pieber, TR; Plank, J Efficacy and safety of standardised glycaemic control in adult and geriatric hospitalised patients with type 2 diabetes mellitus.
Diabetologia. 2015; 58(Suppl 1):S445-S445.-51st Annual Meeting of the European Association for the Study of Diabetes (EASD); SEP 14-18, 2015; Stockholm, SWEDEN. [Poster]
Web of Science

 

Neubauer, KN; Mader, JK; Aberer, F; Höll, B; Donsa, K; Schaupp, L; Spat, S; Beck, P; Plank, J; Pieber, TR Standardized Glycemic Management with a Computerized Workflow and Decision Support System for non-critically ill Inpatients with Type 2 Diabetes.
3rd International Hospital Diabetes Meeting; May 8-9, 2015; San Francisco, USA. 2015. [Poster]

 

Ribitsch, A; Haas, W; Mader, JK; Samonigg, J; Horvath, K; Köhler, G; Sourij, H; Pieber, TR; Plank, J Long-term follow-up of a cohort with a history of diabetic foot ulcer in Austria.
Diabetologia. 2015; 58(Suppl 1):S512-S512.-51st Annual Meeting of the European Association for the Study of Diabetes (EASD); SEP 14-18, 2015; Stockholm, SWEDEN. [Poster]
Web of Science

 

Schwetz, V; Eisner, F; Schilcher, G; Pieber, TR; Mader, JK; Eller, P Metformin-assoziierte Laktat- und Ketoazidose in zwei kritisch kranken Patientinnen.
Wiener Klinische Wochenschrift. 2015; 127(Suppl 4 ):S135-S136.-43. Jahrestagung der Österreichischen Diabetes Gesellschaft (ÖDG); NOV 19-21, 2015; Salzburg, AUSTRIA. [Poster]
Web of Science

 

Thabit, H; Leelarathna, L; Dellweg, S; Mader, JK; Hartnell, S; Benesch, C; Kojzar, H; Holzer, M; Heinemann, L; Wilinska, ME; Pieber, TR; Arnolds, S; Evans, ML; Hovorka, R; AP@Home consortium Twelve-week unsupervised day-and-night closed loop insulin delivery during free daily living in adults with type 1 diabetes: a multicentre randomised cross-over study
DIABETOLOGIA. 2015; 58: S478-S478.-51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD); SEP 14-18, 2015; Stockholm, SWEDEN. [Poster]
Web of Science

 

Zlamal-Fortunat, S; Schütz-Fuhrmann, I; Stadler, M; Laimer, M; Hofer, S; Rami-Merhar, B; Weitgasser, R; Mader, JK; Fröhlich-Reiterer, E; Holl, RW Auswertung des österreichischen Insulinpumpenregisters März 2015.
Wiener Klinische Wochenschrift. 2015; 127(Supp 4):S154-S154.-43. Jahrestagung der Österreichischen Diabetes Gesellschaft (ÖDG); NOV 19-21, 2015; Salzburg, AUSTRIA. [Oral Communication]
Web of Science

 

Bruin, G; Dragatin, C; Aigner, B; Polus, F; Calonder, C; Froeliger, C; Tiffner, K; Bodenlenz, M; Mader, J; Korsatko, S; Ratzer, M; Pieber, T; Loesche, C; Sinner, F The anti IL-17A IgG1 antibody distributes in dermal interstitial fluid as demonstrated by using dermal open flow microperfusion after a single 300 mg subcutaneous administration; assessment in healthy volunteers and patients with moderate-to-severe plaque psoriasis
J INVEST DERMATOL. 2014; 134: S18-S18.-Annual Meeting of the Society-for-Investigative-Dermatology (SID); MAY 07-10, 2014; Albuquerque, NM. [Poster]
Web of Science

 

Donsa, K; Neubauer, KM; Mader, JK; Höll, B; Spat, S; Tschapeller, B; Beck, P; Plank, J; Pieber, TR; Schaupp, L Are we missing something? Continuous glucose monitoring compared with POCT among hospitalised type 2 diabetes patients on basal-bolus insulin therapy
DIABETES TECHNOLOGY & THERAPEUTICS. 2014; 16(S1):A7-A7.-7th International Conference on Advanced Technologies and Treatments for Diabetes; FEB 5-8, 2014; Vienna, AUSTRIA. [Oral Communication]
Web of Science

 

Donsa, K; Beck, P; Plank, J; Schaupp, L; Mader, JK; Truskaller, T; Tschapeller, B; Höll, B; Spat, S; Pieber, TR A Toolbox to Improve Algorithms for Insulin-Dosing Decision Support
eHealth2014 – Health Informatics Meets eHealth. 2014; 248-248.-eHealth Summit Austria; MAY 22-23, 2014; Vienna, AUSTRIA. [Oral Communication]
FullText

 

Hermanns, N; Lilly, LC; Mader, JK; Aberer, F; Pachatz, J; Korsatko, S; Warner, J; Pieber, TR Use of PaQ (R), a simple 3-day basal/bolus insulin delivering device, reduces barriers to insulin therapy in patients withy type 2 diabetes
DIABETES TECHNOLOGY & THERAPEUTICS. 2014; 16(S1):A19-A19.-7th International Conference of Advanced Technologies and Treatments for Diabetes; FEB 5-8, 2014; Vienna, AUSTRIA. [Oral Communication]
Web of Science

 

Höll, B; Spat, S; Beck, P; Neubauer, KM; Mader, JK; Schaupp, L; Chiarugi, F; Pieber,TR GlucoTab (R) Automatic decision support for treatment of patients with diabetes type 2 in hospital.
DIABETES TECHNOLOGY & THERAPEUTICS. 2014; 16(S1):A114-A114.-7th International Conference of Advanced Technologies and Treatments for Diabetes; FEB 5-8, 2014; Vienna, AUSTRIA. [Poster]
Web of Science

 

Horvath, K; Pürstl, M; Mader, J; Augustin, T; Pieber, T Evaluation des ambulante Insulinisierungsprozesses von Patienten mit Typ 2 Diabetes mellitus an einem tertiären Zentrum
Wiener Klinische Wochenschrift. 2014; 126(S04):S182-S182.-42. Jahrestagung der Österreichischen Diabetes Gesellschaft (ÖDG); NOV 20-22, 2014; Salzburg, AUSTRIA. [Poster]
Web of Science

 

Kardas, P; Beck, P; Bromuri, S; Chiarugi, F; Enzmann, M; Höll, B; Keller, O; Lane, S; Mader, J; Marchesini, O; Mougiakakou, S; Neubauer, K; Pieber, TR; Plößnig, M; Puricel, SG; Schaupp, L; Spat, S 7th Framework program Funded eHealth systems for diabetes
DIABETES TECHNOLOGY & THERAPEUTICS. 2014; 16(S1):A1-A1.-7th International Conference on Advanced Technologies and Treatments for Diabetes; FEB 5-8, 2014; Vienna, AUSTRIA. [Oral Communication]
Web of Science

 

Kropff, J; Bruttomesso, D; Doll, W; Farret, A; Galasso, S; Luijf, YM; Mader, JK; Place, J; Boscari, F; Pieber, TR; Renard, E; DeVries, JH Standardised procedure for the assessment of new-to-market continuous glucose monitoring (CGM) systems (Space2).
Diabetologia. 2014; 57(Supp.1):S419-S419.-50th Annual Meeting of the European Diabetes Association (EASD) Vienna; SEP 15-19, 2014; Vienna, AUSTRIA. [Poster]
Web of Science

 

Kropff, J; Doll, W; Mader, JK; Pieber, T; Farret, A; Place, J; Renard, E; Boscari, F; Bruttomesso, D; Galasso, S; DeVries, JH Standardized procedure for the assessment of new-to-market continuous glucose monitoring (CGM) systems (SPACE2).
DIABETES TECHNOLOGY & THERAPEUTICS. 2014; 16(S1):A34-A35.-7th International Conference of Advanced Technologies and Treatments for Diabetes; FEB 5-8, 2014; Vienna, AUSTRIA. [Poster]
Web of Science

 

Leelarathna, L; Dellweg, S; Mader, JK; Allen, JM; Benesch, C; Doll, W; Ellmerer, M; Hartnell, S; Heinemann, L; Kojzar, H; Michalewski, L; Nodale, M; Thabit, H; Wilinska, ME; Pieber, TR; Arnolds, S; Evans, ML; Hovorka, R; on behalf of the AP@home consortium. Factors Affecting the Performance of Day and Night Artificial Pancreas Under Real-World Conditions in Adults with Type 1 Diabetes.
Diabetes. 2014; 63(Supp.1):A241-A241.-74th Scientific Sessions of the American Diabetes Association (ADA); JUN 13-17, 2014 ; San Francisco, CA, USA. [Poster]

 

Leelarathna, L; Dellweg, S; Mader, JK; Allen, JM; Benesch, C; Doll, W; Ellmerer, M; Hartnell, S; Heinemann, L; Kojzar, H; Michalewski, L; Nodale, M; Thabit, H; Wilisnka, ME; Pieber, TR; Arnolds, S; Evans, ML; Hovorka, R; on behalf of the AP@home consortium. Day and Night Home Closed-Loop Insulin Delivery in Adults with Type 1 Diabetes: Three-Centre, Randomised, Crossover Study.
Diabetes. 2014; 63(Supp.1):A61-A62.-74th Scientific Sessions of the American Diabetes Association (ADA); JUN 13-17, 2014 ; San Francisco, CA, USA. [Oral Communication]

 

Leelarathna, L; Thabit, H; Elleri, D; Allen, JM; Lubina-Solomon, A; Mader, JK; Benesch, C; Stadler, M; Pieber, TR; Arnolds, S; Heller, SR; Amiel, SA; Dunger, DB; Evans, ML; Hovorka, R Accuracy of Continuous Glucose Monitoring (CGM) under free-living conditions during three home closed loop studies.
Diabetologia. 2014; 57(Supp.1):S406-S407.-50th Annual Meeting of the European Diabetes Association (EASD) ; SEP 15-19, 2014; Vienna, AUSTRIA. [Poster]
Web of Science

 

Mader, JK Zuckerkrankheit, Stoffwechsel und Höhe.
19. Alpinsportmedizinisches Symposium; SEP 26, 2014; Dachstein/Ramsau, AUSTRIA. 2014. [Oral Communication]

 

Mader, JK What's App in Diabetes?
Tagung der Gesellschaft für Pharmazeutische Medizin (GPMed); Mar 20, 2014; Vienna, AUSTRIA. 2014. [Oral Communication]

 

Mader, JK Simple insulin infusion for people with type 2 diabetes - PaQ® Study Results.
7th International Conference of Advanced Technologies and Treatments for Diabetes (ATTD); FEB 5-8, 2014; Vienna, AUSTRIA. 2014. [Oral Communication]

 

Mader, JK Therapieoptimierung durch Bolusrechner: ICT-Therapie.
Jahrestagung der Österreichischen Diabetes Gesellschaft (ÖDG); NOV 20-22, 2014; Salzburg, AUSTRIA. 2014. [Oral Communication]

 

Mader, JK Was gibt es Neues? Intelligente Technik bei Diabetes mellitus .
Jahrestagung der Österreichischen Diabetes Gesellschaft (ÖDG); NOV 20-22, 2014; Salzburg, AUSTRIA. 2014. [Oral Communication]

 

Mader, JK Accu-Chek Insight – neue Technologien für individuelle Patientenbedürfnisse.
Diabetes Kongress 2014 - 49. Jahrestagung der Deutschen Diabetesgesellschaft (DDG); MAY 28- 31, 2014; Berlin, GERMANY. 2014. [Oral Communication]

 

Mader, JK Endokrinologische Notfälle auf der ICU .
25. Grazer Fortbildungstage; OCT 6, 2014; Graz, AUSTRIA. 2014. [Oral Communication]

 

Mader, JK; Kropff, J; Doll, W; Kojzar, H; Pieber, TR; Farret, A; Place, J; Renard, E; Boscari, F; Bruttomesso, D; Galasso, S; DeVries, JH Verwendung eines standardisierten Protokolls zur Bewertung der Genauigkeit und Zuverlässigkeit der zwei am häufigsten verwendeten kontinuierlichen Glukosemonitoringsysteme
Wiener Klinische Wochenschrift. 2014; 126(S04):S190-S190.-42. Jahrestagung der Österreichischen Diabetes Gesellschaft (ÖDG); NOV 20-22, 2014; Salzburg, AUSTRIA. [Poster]
Web of Science

 

Mader, JK; Kropff, J; Doll, W; Pieber, TR; Farret, A; Place, J; Renard, E; Boscari, F; Bruttomesso, D; Galasso, S; De Vries, JH Verwendung eines standardisierten Protokolls zur Bewertung der Genauigkeit und Zuverlässigkeit der zwei am häufigsten verwendeten kontinuierlichen Glukosemonitoringsysteme.
Diabetologie und Stoffwechsel. 2014; 9(Supp.1):S36-S36.-Diabetes Kongress 2014 - 49. Jahrestagung der Deutschen Diabetesgesellschaft (DDG); MAY 28-31, 2014; Berlin, GERMANY. [Oral Communication]

 

Mader, JK; Leelarathna, L; Dellweg, S; Allen, JM; Benesch, C; Doll, W; Ellmerer, M; Hartnell, S; Heinemann, L; Kojzar, H; Holzer, M; Michalewski, L; Nodale, M; Thabit, H; Wilinska, ME; Pieber, TR; Arnolds, S; Evans, ML; Hovorka, R Tag und Nacht automatisierte Closed-Loop Insulintherapie bei Erwachsenen mit Typ 1 Diabetes: eine randomisierte Crossover-Studie in 3 europäischen Zentren
Wiener Klinische Wochenschrift. 2014; 126(S04):S180-S180.-42. Jahrestagung der Österreichischen Diabetes Gesellschaft (ÖDG); NOV 20-22, 2014; Salzburg, AUSTRIA. [Oral Communication]
Web of Science

 

Mader, JK; Neubauer, KM; Aberer, F; Schaupp, L; Donsa, K; Spat, S; Hoell, B; Augustin, T; Beck, P; Plank, J; Pieber, TR Basal bolus insulin therapy in hospitalised patients with diabetes mellitus type 2 using two algorithms embedded in a tablet PC.
Endocrine Abstracts. 2014; 35: -16th European Congress of Endocrinology; MAY 3-7, 2014; Wroclaw, POLAND. [Poster]
FullText

 

Mader, JK; Neubauer, KM; Schaupp, L; Aberer, F; Donsa, K; Spat, S; Hoell, B; Beck, P; Plank, J; Pieber, TR Glycemic control and risk of hypoglycemia in hospitalized patients with diabetes mellitus type 2 at different wards using the GlucoTab system
Diabetes Technology Meeting; Nov 6-8, 2014; Bethesda, USA. 2014. [Poster]

 

Mader, JK; Neubauer, KM; Schaupp, L; Aberer, F; Augustin, T; Spat, S; Hoell, B; Beck, P; Plank, J; Pieber, TR Evaluation of glycemic control using an algorithm for basal bolus insulin therapy in hospitalised patients with diabetes mellitus type 2
DIABETES TECHNOLOGY & THERAPEUTICS. 2014; 16(S1):A8-A81.-7th International Conference of Advanced Technologies and Treatments for Diabetes; FEB 5-8, 2014; Vienna, AUSTRIA. [Oral Communication]
Web of Science

 

Mader, JK; Neubauer, KM; Schaupp, L; Aberer, F; Augustin, T; Spat, S; Höll, B; Beck, P; Plank, J; Pieber, TR Evaluierung der Blutzuckereinstellung mittels eines Algorithmus für Basis-Bolus-Therapie bei Patienten mit Diabetes mellitus Typ 2 im Krankenhaus.
Journal für Klinische Endokrinologie und Stoffwechsel. 2014; 7(S1):7-7.-19. Jahrestagung der Österreichischen Gesellschaft für Endokrinologie und Stoffwechsel; APR 3-4, 2013; Vienna, AUSTRIA. [Oral Communication]

 

Mader, JK; Neubauer, KM; Schaupp, L; Aberer, F; Donsa, K; Augustin, T; Höll, B; Spat, S; Beck, P; Plank, J; Pieber, TR Vergleich von zwei Algorithmen zur Basis-Bolus-Insulintherapie bei Patienten mit Diabetes mellitus Typ 2 im Krankenhaus.
Diabetologie und Stoffwechsel. 2014; 9(Supp.1):S8-S9.-Diabetes Kongress 2014 - 49. Jahrestagung der Deutschen Diabetes Gesellschaft (DDG); MAY 28-31, 2014; Berlin, GERMANY. [Oral Communication]

 

Mader, JK; Neubauer, KM; Schaupp, L; Aberer, F; Donsa, K; Augustin, T; Spat, S; Hoell, B; Beck, P; Plank, J; Pieber, TR Comparison of two algorithms for basal bolus insulin therapy in hospitalised patients with diabetes mellitus type 2.
EASD Diabetes Technology 2014; FEB 26-27, 2014; Düsseldorf, GERMANE. 2014. [Poster]

 

Mader, JK; Neubauer, KM; Schaupp, L; Aberer, F; Donsa, K; Augustin, T; Spat, S; Hoell, B; Beck, P; Plank, J; Pieber, TR Assessment of glycaemic control and risk of hypoglycaemia for two basal-bolus algorithms in hospitalised patients with diabetes mellitus type 2.
Diabetologia. 2014; 57(Supp.1):S402-S402.-50th Annual Meeting of the European Diabetes Association (EASD); SEP 15-19, 2014; Vienna, AUSTRIA. [Poster]
Web of Science

 

Mader, JK; Neubauer, KM; Schaupp, L; Aberer, F; Donsa, K; Augustin, T; Spat, S; Hoell, B; Beck, P; Plank, J; Pieber, TR. Assessment of Glycemic Control and Risk of Hypoglycemia for Two Basal-Bolus Algorithms in Hospitalized Patients with Diabetes Mellitus Type 2.
Diabetes. 2014; 63(Supp.1):A238-A239.-74th Scientific Sessions of the American Diabetes Association (ADA); Jun 13-17, 2014 ; San Francisco, CA, USA. [Poster]

 

Mader, JK; Neubauer, KM; Schaupp, L; Aberer, F; Donsa, K; Augustin, T; Spat, S; Höll, B; Beck, P; Plank, J; Pieber, TR Bewertung der Blutzuckereinstellung und des Hypoglykämierisikos unter Verwendung von zwei Algorithmen zur Basis-Bolus-Insulintherapie bei hospitalisierten Patienten mit Diabetes mellitus Typ 2.
Wiener Klinische Wochenschrift. 2014; 126(S04):S181-S181.-42. Jahrestagung der Österreichischen Diabetes Gesellschaft (ÖDG); NOV 20-22, 2014; Salzburg, AUSTRIA. [Poster]
Web of Science

 

Mader, JK; Ribitsch, A; Horvath, K; Kump, P; Lipp, RW; Pieber, TR; Treiber, G Medical treatment of adult nesidioblastosis - a case report.
Wiener Klinische Wochenschrift. 2014; 126(Suppl3):S155-S156.-14th International workshop on multiple endocrine neoplasia and other rare endocrine tumors (World MEN); SEP 25-27, 2014; Vienna, AUSTRIA. [Poster]
Web of Science

 

Mader, JK; Ribitsch, A; Sourij, H; Horvath, K; Pieber, TR; Treiber, G Pasireotide as Treatment option for recurrent Hypoglycemia in adult Nesidioblastosis
WIEN KLIN WOCHENSCHR. 2014; 126(17-18):565-566.-ÖGIM; SEP 25-27, 2014; Salzburg. [Poster]
Web of Science

 

Mazze, R; Strock, E; Mader, J; Lilly, L; Aberer, F; Pieber, T PaQ®, a simple 3-day basal/bolus insulin delivery device, may optimise insulin delivery in type 2 diabetes as determined by continuous glucose monitoring.
Diabetologia. 2014; 57(Supp.1):S413-S413.-50th Annual Meeting of the European Diabetes Association (EASD); SEP 15-19, 2014; Vienna, AUSTRIA. [Poster]

 

Neubauer, K; Mader, J; Höll, B; Schaupp, L; Beck, P; Spat, S; Augustin, T; Aberer, F; Plank, J; Pieber, T GlucoTab – a Tablet-based Workflow and Decision Support System to Achieve Safe Glycemic Control for Basal Bolus Insulin Therapy in Hospitalized Patients with Type 2 Diabetes
ZMF10th Anniverary; JUL 17-18, 2014; Graz, AUSTRIA. 2014. [Oral Communication]

 

Neubauer, KM; Mader, JK; Hoell, B; Schaupp, L; Beck, P; Spat, S; Augustin, T; Aberer, F; Plank, J; Pieber, TR. GlucoTab: A Tablet-based Workflow and Decision Support System to Achieve Safe Glycemic Control for Basal-Bolus Insulin Therapy in Hospitalized Patients with Type 2 Diabetes.
Diabetes. 2014; 63(Supp.1):A603-A603.-74th Scientific Sessions of the American Diabetes Association (ADA); Jun 13-17, 2014 ; San Francisco, CA, USA.

 

Neubauer, KM; Mader, JK; Höll, B; Schaupp, L; Beck, P; Spat, S; Aberer, F; Schwagerle, G; Plank, J; Buttinger, M; Pieber, TR GlucoTab - Software basierte Arbeitsprozess- und Entscheidungsunterstützung für sichere gylkämische Kontrolle durch Basal-Bolus Insulintherapie bei hospitalisierten PatientInnen mit Typ-2-Diabetes
Wiener Klinische Wochenschrift. 2014; 126(S04):S182-S182.-42. Jahrestagung der Österreichischen Diabetes Gesellschaft (ÖDG); NOV 20-22, 2014; Salzburg, AUSTRIA. [Oral Communication]
Web of Science

 

Neubauer, KM; Mader, JK; Schaupp, L, Höll, B; Spat, S; Augustin, T; Beck, P; Buttinger, M; Plank, J; Pieber, TR Tablet-based workflow and decision support of in-hospital glycaemic management - perceptions of nurses and physicians.
DIABETES TECHNOLOGY & THERAPEUTICS. 2014; 16(S1):A140-A140.-7th International Conference of Advanced Technologies and Treatments for Diabetes; FEB 5-8, 2014; Vienna, AUSTRIA. [Poster]
Web of Science

 

Neubauer, KM; Schaupp, L; Mader, JK; Spat, S; Höll, B; Aberer, F; Beck, P; Augustin, T; Plank, J; Pieber, TR Health Care Professionals’ Adherence and Satisfaction using the GlucoTab – A computerized Workflow and Decision Support System for in-hospital Glucose Management
Diabetes Technology Meeting; Nov 6-8, 2014; Bethesda, USA. 2014. [Poster]

 

Reithofer,V; Ribitsch,A; Mader,J; Pieber,TR; Treiber, G Der Einfluss von Übergewicht und Adipositas auf die Schwangerschaft bei Patientinnen mit Typ 1 Diabetes
Wiener Klinische Wochenschrift. 2014; -15.Jahrestagung der Österreichischen Adipositasgesellschaft; OKT 24-25, 2014; Vienna, Austria. [Poster]

 

Ribitsch, A; Kienreich, T; Mader, JK; Horvath, K; Pieber, TR; Treiber, G Verwendung von Insulinpumpentherapie und klinische Charakteristik von Erwachsenen-Patienten mit Typ 1 Diabetes.
Wiener Klinische Wochenschrift. 2014; 126(S04):S178-S179.-42. Jahrestagung der Österreichischen Diabetes Gesellschaft (ÖDG); NOV 20-22, 2014; Salzburg, AUSTRIA. [Poster]

 

Ribitsch, A; Kienreich, T; Mader, JK; Horvath, K; Pieber, TR; Treiber, G Applications of Insulin Pumping Treatment and clinical Characteristics of Adult-Patients with Type 1 Diabetes
WIEN KLIN WOCHENSCHR. 2014; 126: S178-S179.-42. Jahrestagung der Österreichischen Diabetes Gesellschaft; NOV ; Salzburg, AUSTRIA. [Poster]
Web of Science

 

Ribitsch, A; Mader, JK; Köhler, G; von Lewinski, D; Pieber, TR; Treiber, G Gute Genesung nach Diabetes Typ 1 Manifestation mit schwerer Ketoazidose, Insult, Rhabdomyolyse, akutem Nierenversagen und septischem Schock.
Wiener Klinische Wochenschrift. 2014; 126(S04):S178-S178.-42. Jahrestagung der Österreichischen Diabetes Gesellschaft (ÖDG); NOV 20-22, 2014; Salzburg, AUSTRIA. [Poster]
Web of Science

 

Ribitsch, A; Reithofer, V; Mader, J; Pieber, TR; Treiber, G The impact of increasing rates of overweight in pregnant women with Type 1 Diabetes
46th Annual Meeting of DPSG; OCT 2-4, 2014; Budapest, Ungarn. 2014. [Poster]

 

Ribitsch, Anja; Kienreich, Tina; Mader, Julia K; Höller, Vera; Köhler, Gerd; Horvath, Karl; Pieber, Thomas R; Treiber, Gerlies Zunahme von Übergewicht und Adipositas bei Diabetes mellitus Typ 1 zeigt unterschiedliche Trends zwischen Frauen und Männern
7. Jahrestagung der Österreichischen Gesellschaft für geschlechtsspezifische Medizin; 28.3.2014; Wien, Austria. 2014. [Poster]

 

Ribitsch,A; Kienreich, T; Mader,J; Höller, V;Köhler, G; Horvath, K; Pieber,T; Treiber,G. Übergewicht und Adipositas bei Patienten mit Diabetes Typ 1 zeigt ein unterschiedliches Profil zwischen Frauen und Männern
Wiener Klinische Wochenschrift. 2014; -15. Jahrestagung der ÖAG; Okt 24-25, 2014; Wien, Austria. [Poster]

 

Strock, E; Mader, JK; Lilly, LC; Aberer, F; Pieber, TR; Mazze, R. PaQ®, a Simple 3-Day Basal/Bolus Insulin Delivery Device, May Optimize Insulin Delivery in Type 2 Diabetes as Determined by Continuous Glucose Monitoring.
Diabetes. 2014; 63(Supp.1):A602-A602.-74th Scientific Sessions of the American Diabetes Association (ADA); JUN 13-17, 2014 ; San Francisco, CA, USA.

 

Svehlikova, E; Tuca, A; Höller, V; Mader, J; Obermayer-Pietsch, B; Freisinger, O; Tadler, F; Ernst, B; Wilms, B; Thurnheer, M; Schultes, B; Pieber, TR Die Verbesserung der Betazellfunktion bei morbid adipösen Patienten mit Typ 2 Diabetes nach Magenbypassoperationen ist mit einer verbesserten Insulinverarbeitung in der Betazelle verbunden.
Wiener Klinische Wochenschrift. 2014; 126(S04):S185-S185.-42. Jahrestagung der Österreichischen Diabetes Gesellschaft (ÖDG); NOV 20-22, 2014; Salzburg, AUSTRIA. [Oral Communication]
Web of Science

 

Tuca, A; Schober, MM; Korsatko, S; Mader, J; Bauer, G; Smolle, KH; Wurzer, P; Ellmerer, M; Pieber TR Evaluation of three point of care glucose-meters in critically ill patients at a medical intensive care unit.
Wiener Klinische Wochenschrift. 2014; 126(S04):S193-S193.-42. Jahrestagung der Österreichischen Diabetes Gesellschaft (ÖDG); NOV 20-22, 2014; Salzburg, AUSTRIA. [Poster]
Web of Science

 

Aberer, F; Lilly, L; Mader, JK; Pachatz, J; Korsatko, S; Dambso, P; Pieber, TR; PaQ, ein einfach anzuwendendes Insulinabgabegerät zur Basis/Bolustherapie für Patienten mit Typ 2 Diabetes.
Diabetologie und Stoffwechsel. 2013; 8(S01):60-60.-Diabetes Kongress 2013 - 48. Jahrestagung der Deutschen Diabetesgesellschaft (DDG); MAY 8-11, 2013; Leipzig, GERMANY. [Poster]

 

Aberer, F; Mader, JK; Lucarelli, F; Scuffi, C; Kojzar, H; Korsatko, S; Valgimigli, F; Pieber, TR Optimierung der Blutzuckerkontrolle durch ein auf Mikrodialyse basierendes System zur Verwendung bei hospitalisierten Patienten.
Wiener Klinische Wochenschrift. 2013; 125(Supp.2):S18--41. Jahrestagung der Österreichischen Diabetes Gesellschaft (ÖDG); NOV 21-23, 2013; Salzburg, AUSTRIA. [Oral Communication]

 

Bruin, G; Dragatin, C; Aigner, B; Polus, F; Calonder, C; Froeliger, C; Tiffner, K; Bodenlenz, M; Mader, JK; Korsatko, S; Ratzer, M; Pieber, TR; Loesche, C; Sinner, F; Secukinumab, a novel anti-IL-17A antibody can be quantified in skin after a single dose by dermal open flow microperfusion
22nd Congress of the European Academy of Dermatology and Venereology; OCT 2-6, 2013; Istanbul, Turkey. 2013. [Poster]

 

Bruin, G; Dragatin, C; Aigner, B; Polus, F; Calonder, C; Froeliger, C; Tiffner, K; Bodenlenz, M; Mader, J; Korsatko, S; Ratzer, M; Pieber, TR; Loesche, C; Sinner, F; Absolute levels of the novel anti-IL-17A antibody, secukinumab, in skin can be quantified by dermal open flow microperfusion (dOFM).
J INVEST DERMATOL. 2013; 133: S52-S52.-International Investigative Dermatology Meeting; MAY 08-11, 2013; Edinburgh, SCOTLAND. [Poster]
Web of Science

 

Doll, WK; Mader, JK; Ellmerer, M; Pieber, TR; CLOSING THE LOOP IN DIABETES: SAFETY CONSIDERATIONS FOR MOVING FROM THE CLINICAL RESEARCH CENTER TO THE HOME ENVIRONMENT.
DIABETES TECHNOL THER. DIABETES TECHNOLOGY AND THERAPEUTICS15: A78-A78. NEW ROCHELLE: MARY ANN LIEBERT INC; [Poster]
Web of Science

 

Hermanns, N; Lilly, L; Mader, JK; Aberer, F; Pachatz, J; Korsatko, S; Warner, J; Pieber, T Use of PaQ®, a Simple 3-Day Basal/Bolus Insulin Delivery Device, Reduces Barriers to Insulin Therapy in Patients With Type 2 Diabetes.
Diabetes 62. 2013; 62(S1):A205-A205.-73rd Scientific Sessions of the American Diabetes Association (ADA); JUN 21-25, 2013; Chicago, USA. [Poster]

 

Hermanns, N; Mader, JK; Lilly, LC; Aberer, F; Kojzar, H; Korsatko, S; Warner, J; Pieber, TR PaQ, ein einfach anzuwendendes Insulinabgabegerät zur Basis/Bolustherapie für Patienten mit Typ 2 Diabetes.
Wiener Klinische Wochenschrift. 2013; 125(Supp.2):S8-S9.-41. Jahrestagung der Österreichischen Diabetes Gesellschaft (ÖDG); NOV 21-23, 2013; Salzburg, AUSTRIA. [Poster]

 

Höller, V; Haas, W; Tripolt, NJ; Plank, J; Ribitsch, A; Mader, JK; Treiber, G; Pieber, TR; Köhler, G Langzeitprognose von PatientInnen mit einem diabetischen Fußsyndrom.
Wiener Klinische Wochenschrift. 2013; 125(Supp.2):S20-S21.-41. Jahrestagung der Österreichischen Diabetes Gesellschaft (ÖDG); NOV 21-23, 2013; Salzburg, AUSTRIA. [Poster]

 

Ingwersen, S; Klim, S; Jensen, L; Kiyomi, F; Mader, J; Heller, S; Pieber, T Pharmacokinetic properties of liraglutide when used as adjunct to insulin treatment in subjects with type 1 diabetes
World Diabetes Congress (IDF); DEC 2-6, 2013; Melbourne, AUSTRALIA. 2013. [Poster]

 

Klim, S; Ingwersen, SH; Jensen, L; Kiyomi, F; Mader, J; Heller, S; Pieber, TR Liraglutide demonstrates similar pharmacokinetic properties in patients with type 1 and type 2 diabetes.
Diabetologia 2013. 2013; 56(S1):S404-S404.-49th Annual Meeting of the European Association for the Study of Diabetes (EASD); SEP 23-27, 2013; Barcelona, SPAIN. [Poster]
Web of Science

 

Kojzar, H; Mader, JK; Aberer, F; Lilly, LC; Korsatko, S; Damsbo, P; Pieber, TR PaQ, ein einfach anzuwendendes Insulinabgabegerät zur Basis/Bolustherapie für Patienten mit Typ 2 Diabetes.
Wiener Klinische Wochenschrift. 2013; 125(Supp.2):S9-S10.-41. Jahrestagung der Österreichischen Diabetes Gesellschaft (ÖDG); NOV 21-23, 2013; Salzburg, AUSTRIA. [Poster]

 

Kojzar, H; Urschitz, M; Lehki, B; Mader, JK; Ehrmann, M; Ellmerer, M; Pieber, TR; Regittnig, W; im Namen des AP@home-Konsortiums Subkutane Bolusgabe mit Insulinpumpe bei Typ-1-Diabetikern – Auswirkung der Boluslänge auf die Absorptionskinetik von schnell wirksamem Insulin.
Wiener Klinische Wochenschrift. 2013; 125(Supp.2):S14-S15.-41. Jahrestagung der Österreichischen Diabetes Gesellschaft (ÖDG); NOV 21-23, 2013; Salzburg, AUSTRIA. [Oral Communication]

 

Lucarelli, F; Scuffi, C; Mader, JK; Aberer, F; Korsatko, S; Pieber, TR; Valgimigli, F; OPTIMISING THE GLUCOSE SAMPLING PERFORMANCE OF AN INTRAVASCULAR MICRODIALYSIS-BASED CONTINUOUS GLUCOSE MONITORING DEVICE FOR USE IN HOSPITAL SETTINGS.
DIABETES TECHNOL THER. DIABETES TECHNOLOGY AND THERAPEUTICS15: A13-A13. NEW ROCHELLE: MARY ANN LIEBERT INC; [Oral Communication]
Web of Science

 

Luijf, YM; DeVries, JH; Mader, JK; Doll, W; Place, J; Renard, E; Bruttomesso, D; Avogaro, A; Benesch, C; Heinemann, L; ACCURACY AND RELIABILITY OF CURRENT CGM SYSTEMS: A DIRECT COMPARISON.
DIABETES TECHNOL THER. DIABETES TECHNOLOGY AND THERAPEUTICS15: A13-A14. NEW ROCHELLE: MARY ANN LIEBERT INC; [Oral Communication]
Web of Science

 

Mader, JK; Dolic, A; Haas, W; Pieber, TR; Treiber, G Wound healing and recurrence of lesions in patients with diabetic foot ulcers in a tertiary center.
Konferenzband. 2013; -11th Annual Meeting of the Diabetic Foot Study Group (DFSG); SEP 20-22, 2013; Sitges, SPAIN. [Poster]

 

Mader, JK; Lilly, LC; Aberer, F; Pachatz, J; Korsatko, S; Damsbo, P; Pieber, TR PaQ, a simple 3-day basal/bolus insulin delivery device, in patients with type 2 diabetes.
Proceedings BMT (Biomedizinische Technik) 2013. 2013; -Dreiländertagung der Deutschen, Schweizerischen und Österreichischen Gesellschaft für Biomedizinische Technik (BMT); SEP 19-21, 2013; Graz, AUSTRIA. [Oral Communication]

 

Mader, JK; Dolic, A; Treiber, G; Haas, W; Horvath, K; Pieber, TR Wound healing and recurrence of lesions in patients with diabetic foot ulcers in a tertiary center
World Diabetes Congress (IDF); DEC 2-6, 2013; Melbourne, AUSTRALIA. 2013. [Poster]

 

Mader, JK; Horki, V; Horvath, K; Haas, W; Köhler, G; Pieber, TR; Treiber, G Wundheilungs- und Rezidivraten bei PatientInnen mit diabetischen Fussulzera an einem tertiären Zentrum.
Wiener Klinische Wochenschrift. 2013; 125(Supp.2):S3-S4.-41. Jahrestagung der Österreichischen Diabetes Gesellschaft (ÖDG); NOV 21-23, 2013; Salzburg, AUSTRIA. [Poster]

 

Mader, JK; Lilly, LC; Aberer, F; Kojzar, H; Korsatko, S; Strock, E; Mazze, R; Damsbo, P; Pieber, TR A Feasibility Assessment of PaQ®, a Simple 3-Day Basal/Bolus Insulin Delivery Device, in Patients with Type 2 Diabetes.
Diabetologia 2013. 2013; 56(S1):S445-S445.-49th Annual Meeting of the European Association for the Study of Diabetes (EASD); SeP 23-27, 2013; Barcelona, SPAIN. [Poster]
Web of Science

 

Mader, JK; Lilly, LC; Aberer, F; Kojzar, H; Korsatko, S; Strock, E; Mazze, R; Damsbo, P; Pieber, TR A Feasibility Assessment of PaQ®, a Simple 3-Day Basal/Bolus Insulin Delivery Device, in Patients with Type 2 Diabetes
World Diabetes Congress (IDF); DEC 2-6, 2013; Melbourne, AUSTRALIA. 2013. [Poster]

 

Mader, JK; Lilly, LC; Aberer, F; Kojzar, K; Korsatko, S; Damsbo, P; Pieber, TR PaQ, A Simple 3-Day Basal/Bolus Insulin Delivery Device - Feasibility of Use and Performance in Patients with Type 2 Diabetes
13th Annual Diabetes Technology Meeting; OCT 31- NOV 2, 2013; San Francisco, USA. 2013. [Poster]

 

Mader, JK; Lilly, LC; Aberer, F; Pachatz, J; Korsatko, S; Damsbo, P; Pieber, TR; PAQ, A SIMPLE 3-DAY BASAL/BOLUS INSULIN DELIVERY DEVICE, IN PATIENTS WITH TYPE 2 DIABETES.
DIABETES TECHNOL THER. DIABETES TECHNOLOGY AND THERAPEUTICS15: A14-A14. NEW ROCHELLE: MARY ANN LIEBERT INC; [Oral Communication]
Web of Science

 

Mader, JK; Lilly, LC; Aberer, F; Pachatz, J; Korsatko, S; Strock, E; Mazze, R; Damsbo, P; Pieber, TR A Feasibility Assessment of PaQ®, a Simple 3-Day Basal/Bolus Insulin Delivery Device, in Patients With Type 2 Diabetes.
Diabetes. 2013; 62(S11):-73rd Scientific Sessions of the American Diabetes Association (ADA); JUN 21-25, 2013; Chicago, USA. [Poster]

 

Mader, JK; Lilly, LC; Warner, JL; Pieber, TR; GLYCEMIC MANAGEMENT USING SIMPLE CONTINUOUS SUBCUTANEOUS INSULIN INFUSION IN PATIENTS WITH TYPE 2 DIABETES.
DIABETES TECHNOL THER. DIABETES TECHNOLOGY AND THERAPEUTICS15: A138-A138. NEW ROCHELLE: MARY ANN LIEBERT INC; [Oral Communication]
Web of Science

 

Mader, JK; Lucarelli, F; Scuffi, C; Aberer, F; Korsatko, S; Valgimigli, F; Pieber; TR. Optimising the glucose sampling performance of an intravascular microdialysis-based continuous glucose monitoring device for use in hospital settings.
Proceedings BMT (Biomedizinische Technik) 2013. 2013; -Dreiländertagung der Deutschen, Schweizerischen und Österreichischen Gesellschaft für Biomedizinische Technik (BMT); SEP 19-21, 2013; Graz, AUSTRIA. [Oral Communication]

 

Mader, JK; Neubauer, K; Schaupp, L; Augustin, T; Spat, S; Höll, B; Beck, P; Pieber, TR; Plank, J Anwenderakzeptanz von Insulindosierungsvorschlägen eines auf Basis-Bolustherapie basierenden Algorithmus bei hospitalisierten Patienten mit Diabetes mellitus Typ 2.
Diabetologie und Stoffwechsel. 2013; Supplement 1(8):79-80.-Diabetes Kongress 2013 - 48. Jahrestagung der Deutschen Diabetesgesellschaft (DDG); MAY 8-11, 2013; Leipzig, GERMANY. [Poster]

 

Mader, JK; Neubauer, K; Schaupp, L; Augustin, T; Spat, S; Holl, B; Beck, P; Pieber, TR; Plank, J; USER ADHERENCE TO DOSING ADVICE OF AN ALGORITHM FOR BASAL BOLUS INSULIN THERAPY IN HOSPITALISED PATIENTS WITH DIABETES MELLITUS TYPE 2.
DIABETES TECHNOL THER. DIABETES TECHNOLOGY AND THERAPEUTICS15: A14-A15. NEW ROCHELLE: MARY ANN LIEBERT INC; [Oral Communication]
Web of Science

 

Mader, JK; Neubauer, KM; Schaupp, L; Augustin, T; Beck, P; Spat, S; Höll, B; Treiber, G; Fruhwald, FM; Pieber, TR; Plank, J Effektivität und Anwendbarkeit eines Algorithmus für Basis-Bolus-Insulintherapie bei hospitalisierten Patienten mit Typ 2 Diabetes.
Wiener Klinische Wochenschrift 2013. 2013; 125(Supp.2):S4-S4.-41. Jahrestagung der Österreichischen Diabetes Gesellschaft (ÖDG); NOV 21-23, 2013; Salzburg, AUSTRIA. [Oral Communication]

 

Mader, JK; Neubauer, KM; Schaupp, L; Augustin, T; Beck, P; Spat, S; Höll, B; Fruhwald, F; Pieber, TR; Plank, J Efficacy and Usability of a Workflow Integrated Algorithm for Basal-Bolus Insulin Therapy in Hospitalized Type 2 Diabetes Patients
13th Annual Diabetes Technology Meeting; OCT 31- NOV 2, 2013; San Francisco, USA. 2013. [Oral Communication]

 

Mader, JK; Neubauer, KM; Schaupp, L; Augustin, T; Beck, P; Spat, S; Höll, B; Treiber, G; Fruhwald, F; Pieber, TR; Plank, J Efficacy, Usability and Sequence of Operations of a Workflow-Integrated Algorithm for Basal-Bolus Insulin Therapy in Hospitalized Type 2 Diabetes Patients.
Diabetes. 2013; 62(S1):A81-A81.-73rd Scientific Sessions of the American Diabetes Association (ADA),; JUN 21-25, 2013; Chicago, USA. [Oral Communication]

 

Neubauer, KM; Mader, JK; Plank, J; Schaupp, L; Buttinger, M; Höll, B; Spat, S; Beck, P; Pieber, TR Implementierung des Reaction Algorithmus für stationäres Blutzuckermanagement – Erfahrungen der Pflegepersonen.
Wiener Klinische Wochenschrift. 2013; 125(Supp.2):S11-S11.-41. Jahrestagung der Österreichischen Diabetes Gesellschaft (ÖDG) ; NOV 21-23, 2013; Salzburg, AUSTRIA. [Poster]

 

Neubauer, KM; Mader, JK; Plank, J; Schaupp, L; Buttinger, M; Holl, B; Spat, S; Tschapeller, B; Beck, P; Pieber, TR; NURSES' EXPERIENCES ON IMPLEMENTING THE REACTION ALGORITHM FOR GLYCAEMIC MANAGEMENT AT A GENERAL WARD.
DIABETES TECHNOL THER. DIABETES TECHNOLOGY AND THERAPEUTICS15: A132-A132. NEW ROCHELLE: MARY ANN LIEBERT INC; [Poster]
Web of Science

 

Pieber, TR; Schaupp, L; Neubauer, KM; Mader, JK; Augustin, T; Spat, S; Hoell, B; Beck, P; Plank, J; REACTION ALGORITHM AS AN IMPROVED PROTOCOL FOR IN-HOSPITAL MANAGEMENT OF TYPE 2 DIABETES.
DIABETES TECHNOL THER. DIABETES TECHNOLOGY AND THERAPEUTICS15: A18-A18. NEW ROCHELLE: MARY ANN LIEBERT INC; [Oral Communication]
Web of Science

 

Regittnig, W; Urschitz, M; Lehki, B; Mader, J; Ehrmann, M; Kojzar, H; Ellmerer, M; Pieber, TR Absorption Kinetics of Insulin Following Subcutaneous Bolus Administration With Different Bolus Duration.
Diabetes. 2013; 62(S11):A247-A247.-73rd Scientific Sessions of the American Diabetes Association (ADA); JUN 21-25, 2013; Chicago, USA. [Poster]

 

Ribitsch, A; Kienreich, T; Mader, JK; Hueter, N; Semlitsch, B; Köhler, G; Horvath, K; Pieber, TR; Treiber, G Übergewicht und Adipositas bei Diabetes mellitus Typ 1 ist verbunden mit erhöhter Rate an diabetischen Spätkomplikationen.
Wiener Klinische Wochenschrift. 2013; 125(Supp.2):S19-S19.-41. Jahrestagung der Österreichischen Diabetes Gesellschaft (ÖDG); NOV 21-23, 2013; Salzburg, AUSTRIA. [Poster]

 

Ribitsch, A; Mader, JK; Hueter, N; Semlitsch, B; Köhler, G; Horvath, K; Pieber, TR; Treiber, G Zunehmender Anstieg an Übergewicht und Adipositas bei Typ 1 Diabetes und Schwangerschaft – eine weitere Herausforderung im Glukosemanagement.
Wiener Klinische Wochenschrift. 2013; 125(Supp.2):S8-S8.-41. Jahrestagung der Österreichischen Diabetes Gesellschaft (ÖDG); NOV 21-23, 2013; Salzburg, AUSTRIA. [Poster]

 

Ribitsch, A; Tauschmann, M; Horki, V; Mader, J; Koehler, G; Horvath,K; Pieber, TR; Treiber,G; Increasing rates of overweight in women with type 1 diabetes at pregnancy onset
Journal of Diabetes. 2013; 5(1):16-202.-5th International Congress on Prediabetes and Metabolic Syndrome; APR 18-20, 2013; Vienna, AUSTRIA. [Poster]

 

Schaupp, L; Neubauer, KM; Mader, JK; Augustin, T; Spat, S; Hoell, B; Beck, P; Plank, J; Pieber, TR; CONTINUOUS GLUCOSE MONITORING IN HOSPITALISED PATIENTS AT THE GENERAL WARD.
DIABETES TECHNOL THER. DIABETES TECHNOLOGY AND THERAPEUTICS15: A134-A134. NEW ROCHELLE: MARY ANN LIEBERT INC; [Poster]
Web of Science

 

Schaupp, L; Neubauer, KM; Mader, JK; Augustin, T; Spath, S; Höll, B; Beck, P; Plank, J; Pieber, TR Kontinuierliches Glukosemonitoring bei hospitalisierten Patienten mit Typ-2-Diabetes während Basis-Bolus-Insulintherapie.
Wiener Klinische Wochenschrift. 2013; 125(Supp.2):S15-S15.-41. Jahrestagung der Österreichischen Diabetes Gesellschaft (ÖDG); NOV 21-23, 2013; Salzburg, AUSTRIA. [Poster]

 

Spat, S; Höll, B; Neubauer, K; Schaupp, L; Beck, P; Mader, J; Pieber, T GlucoTab: Ein tablet-basiertes, mobiles Entscheidungsunterstützungs- und Workflowmanagementsystem zur Behandlung von Diabetes Typ 2 auf der Allgemeinstation.
58. Jahrestagung der Deutschen Gesellschaft für Medizinische Informatik, Biometrie und Epidemiologie (GMDS); SEP 1-5, 2013; Lübeck, GERMANE. 2013. [Poster]
FullText

 

Treiber, G; Ribitsch,A; Mader,JK; Tauschmann, M; Semlitsch, B; Horvath, K; Pieber,TR. Increasing rates of overweight in pregnant women with longstanding type 1 diabetes
DIP: Diabetes, Hypertension, Metabolic Syndrome and Pregnancy; MAR 14-16, 2013; Florenz, ITALY. 2013. [Poster]

 

Birngruber, T; Mader, JK; Mautner, SI; Köhler, G; Sinner, F; Pieber, TR. Microfocus computed tompography - A novel method to assess insulin distribution in subcutaneous adipose tissue.
Konferenzband. 2012; -Diabetes Technology Meeting; NOV 8-10, 2012; Bethesda, USA. [Poster]

 

Bock, G; Haas, W; Ribitsch, A; Horki, V; Mader, J; Horvath, K; Pieber, T; Koehler, G; PATIENT AWARENESS OF THE DEVASTATING RISK OF AMPUTATION IN DIABETIC FOOT SYNDROME IS CRUCIAL FOR THE OUTCOME: REPORT OF TWO CASES
EWMA Journal. 2012; 12(2):265-265.-European Wound Management Association (EWMA); May 23-25; Vienna, Austria. [Poster]

 

De Vries, JH; Avogaro, A; Benesch, C; Bruttomesso, D; Caldwell, K; Cobelli, C; Doll, W; Del Favero, S; Heinemann; L; Hovorka, R; Leelarathna, L; Luijf, YM; Mader, JK; Magni, L; Nodale, M; Place, J; Pieber, TR; Renard, E; Toffanin, C Vergleich von zwei Closed-loop-Algorithmen mit Open-loop Kontrolle bei Patienten mit Typ 1 Diabetes.
Wiener klinische Wochenschrift. 2012; 124(Sup. 1):21-21.-40. Jahrestagung der Österreichischen Diabetesgeselleschaft; NOV 15-17, 2012; Salzburg, AUSTRIA. [Oral Communication]

 

DeVries, JH; Avogaro, A; Benesch, C; Bruttomesso, D; Caldwell, K; Cobelli, C; Doll, W; Del Favero, S; Heinemann, L; Hovorka, R; Leelarathna, L; Luijf, YM; Mader, J; Magni, L; Nodale, M; Place, J; Renard, E; Toffanin, C; on behalf of the AP@home consortium Comparison of Two Closed Loop Algorithms with Open Loop Control in Type 1 Diabetes.
Proceedings of the 72 Scientific Sessions of the American Diabetes Association. 2012; A60-A60.-72nd Scientific Sessions of the ADA (American Diabetes Association); JUN 8-12, 2012; Philadelphia, USA. [Oral Communication]

 

Di Palma, F; A, Avogaro; Benesch, C; Bruttomesso, D; DeVries, JH; Doll, W; De Nicolao, G; Del Favero, S; Heinemann, L; Hovorka, R; Leelarathna, L; Luijf, YM; Mader, J; Nodale, M; Place, J; Renard, E; Soru, P; Toffanin, C; Magni, L; Cobelli, C; on behalf of the AP@home consortium Impact of different timing of insulin delivery in a 23-hour clinical trial with the International Artificial Pancreas (iAP) control algorithm.
Konferenzband. 2012; -1st American Diabetes Association Middle East Congress; DEC 4-6, 2012; Dubai, UNITED ARAB EMIRATES. [Oral Communication]

 

Heise, T; Nosek, L; Coester, HV; Mader, JK; Roepstorff, C; Segel, S; Lassota, N; Haahr, HL. Bei einmal täglicher Gabe des ultralangwirksamen Insulin Degludec wird der Steady State innerhalb von zwei bis drei Tagen erreicht.
Wiener klinische Wochenschrift. 2012; 124(Sup. 1):12-12.-40. Jahrestagung der Österreichischen Diabetesgeselleschaft; NOV 15-17, 2012; Salzburg, AUSTRIA. [Oral Communication]

 

Heller, SR; Pieber, TR; Korsatko, S; Köhler, G; Deller, S; Bock, G; Zahiragic, S; Mader, J; Roepstorff, C; Rasmussen, S; Haahr, H A higher counter-regulatory hormone response is seen with insulin degludec than insulin glargine in response to induced hypoglycaemia in type 1 diabetes.
55th Annual meeting of the Japanese Diabetes Society (JDS); MAY 17-19, 2012; Yokohama, JAPAN. 2012. [Poster]

 

Höll, B; Spat, S;Petritsch, G; Beck, P; Mader, JK; Neubauer, KM; Plank, J; Pieber, TR GlucoTab: A portable glucose management system supporting in-hospital glycaemic control for patients with type 2 diabetes.
Konferenzband. 2012; -International Hospital Diabetes Meeting; OCT 12-13, 2012; Cambridge, USA. [Poster]

 

Koehler, G; Haas, W; Mader, J; Tauschmann, M; Horki, V; Bock, G; Pieber, T; DEVELOPMENT OF THE AGE STRUCTURE OF PATIENTS WITH DIABETIC FOOT SYNDROME OVER 10 YEARS
EWMA Journal. 2012; 12(2):146-146.-European Wound Management Association (EWMA) ; May 23-25; Vienna, Austria. [Poster]

 

Koehler, G; Schrenk, W; Haas, W; Mader, J; Horki, V; Tauschmann, M; Bock, G; Pieber, T; The Outcome of Charcotfoot in a tertiary centre in Austria in the years 2005-2010.
DFSG; SEP 28-30,2012; Potsdam, Germany. 2012. [Poster]

 

Koehler, G; Schrenk, W; Haas, W; Mader, J; Horki, V; Tauschmann, M; Bock, G; Pieber, T; The outcome of the charcot foot in a tertiary centre in Austria in the years 2005-2010
EWMA Journal. 2012; 12(2):28-28.-European Wound Management Association (EWMA); May 23-25; Vienna, Austria. [Oral Communication]

 

Koehler, G; Schrenk, W; Haas, W; Mader, J; Horki, V; Tauschmann, M; Bock, G; Pieber, TR The Outcome of the Charcotfoot in a tertiary centre in Austria in the years 2005-2010
10th Scientific Meeting of Diabetic Foot Study Group ; SEP 28-29, 2012; Potsdam, Deutschland. 2012. [Poster]

 

Korsatko, S; Deller, S; Mader, J; Glettler, K; Köhler, G; Bock, G; Urschitz, M; Wolf, M; Hastrup, H; Sondergaard, F; Haahr, H; Pieber, TR. Ultralange, pharmakokinetische und pharmakodynamische Eigenschaften von Insulin Degludec bei jungen und älteren ProbandInnen mit Typ 1 Diabetes sind vergleichbar.
Wiener klinische Wochenschrift. 2012; 124(Sup. 1):8-9.-40. Jahrestagung der Österreichischen Diabetesgeselleschaft; NOV 15-17, 2012; Salzburg, AUSTRIA. [Oral Communication]

 

Korsatko, S; Deller, S; Mader, J; Glettler, K; Köhler, G; Bock, G; Urschitz, M; Wolf, M; Hastrup-Nielsen, H; Søndergaard, F; Haahr, HL; Pieber, TR Ultra-long pharmacokinetic properties of insulin degludec in younger adults are preserved in geriatric subjects with type 1 diabetes.
Diabetologia. 2012; 55(S1):379-380.-48th Annual Meeting of the European Association for the Study of Diabetes (EASD); OCT 1-5, 2012; Berlin, GERMANY. [Poster]

 

Korsatko, S; Deller, S; Mader, JK; Glettler, K; Koehler, G; Bock, G; Urschitz, M; Wolf, M; Hastrup, H; Sondergaard, F; Haahr, HL; Pieber, TR. Ultra-long pharmacokinetic properties of insulin degludec in younger adults preserved in geriatric subjects with T1DM.
Konferenzband. 2012; -9th IDF-WPR (International Diabetes Federation – West Pacific Region) Congress & 4th AASD Scientific Meeting; NOV 24-27, 2012; Kyoto, JAPAN. [Poster]

 

Korsato, S; Deller, S; Mader, J; Glettler, K; Köhler, G; Bock, G; Urschitz, M; Wolf, M; Hastrup-Nieslen, H; Sondergaard, F; Haahr, H; Pieber, T. Ultra-long pharmacokinetic properties of insulin degludec in younger adults are preserved in geriatric subjects with type 1 diabetes
Poster & Oral Presentation Guide and Abstract Book. 2012; A259-A259.-American Association of Clinical Endocrinologists 21st Annual Scientific and Clinical Congress; MAY 23-27, 2012; Philadelphia, USA. [Oral Communication]

 

Leb-Stöger, U; Haas, W; Köhler, G; Brodmann, M; Bock, G; Svehlikova, E; Mader, J; Pilger, E; Pieber, TR. Diabetic foot clinic: Set-up of interdisciplinary cooperation: 1 year of evaluation
EWMA Journal. 2012; 12(2):92-92.-Europaean Wound Management Association (EWMA); May 23-25; Vienna, Austria. [Oral Communication]

 

Luijf, YM; De Vries, JH; Mader, JK; Doll, W; Pieber, TR; Place, J; Renard, E; Bruttomesso, D; Filippi, A; Avogaro, A; Benesch, C; Heinemann, L. Genauigkeit und Verläßlichkeit von aktuell erhältlichen kontinuierlichen Glukosemonitoringsystemen (CGM) - ein direkter Vergleich.
Wiener klinische Wochenschrift. 2012; 124(Sup. 1):10-10.-40. Jahrestagung der Österreichischen Diabetesgeselleschaft; NOV 15-17, 2012; Salzburg, AUSTRIA. [Poster]

 

Mader, JK; Olynec, J; Köhler; G; Horvath, K; Pieber, TR; Bock; G; Einsatz der Insulinpumpentherapie während der Schwangerschaft von Frauen mit Diabetes mellitus Typ 1.
Geburtshilfe und Frauenheilkunde. 2012; 5: 345-448.-Jahrestagung der Österreichischen Gesellschaft für Gynäkologie und Geburtshilfe (OEGGG); Jun 6-9, 2012; Graz, Austria. [Poster]

 

Mader, J; Birngruber, T; Deller S; Korsatko, S; Boysen, S; Mautner, S; Augustin, T; Sinner, F; Pieber, TR. Verbesserte pharmakodynamische Eigenschaften von Insulin aspart durch eine veränderte Applikationsmethode bei Patienten mit Typ 1 Diabetes
Wiener klinische Wochenschrift. 2012; 124(Sup. 1):17-18.-40. Jahrestagung der Österreichischen Diabetesgeselleschaft; NOV 15-17, 2012; Salzburg, AUSTRIA. [Poster]

 

Mader, j; Bock, G; Plank, J; Prettenthaler, J; Smolle, KH; Pieber, T; Koehler, G; MULTIPLE, MASSIVE SKIN ULCERATIONS BY ACUTE POLYARTICULAR GOUT – A CASE REPORT
EWMA. 2012; 12(2):266-266.-European Wound Management Association (EWMA); May 23-25; Vienna, Austria. [Poster]

 

Mader, J; Heller, S; Wilhelm, B; Pieber, T Induzierte Hypoglykämie bei Typ 1 Diabetikern: Vergleich mit Insulin degludec (IDeg) und Insulin glargin (IGlar)
Diabetologie und Stoffwechsel, Supplement. 2012; 7(S1):55-55.-Diabetes Kongress 2012 - 47. Jahrestagung der DDG; MAY 16-19, 2012; Stuttgart, GERMANY. [Poster]

 

Mader, JK Single-port - Subcutaneous glucose monitoring at the site of insulin delivery
Diabetes Technology Meeting; NOV 8-10; Bethesda, Maryland. 2012. [Oral Communication]

 

Mader, JK; Birngruber, T; Deller, S; Korsatko, S; Boysen, S; Mautner, S; Augustin, T; Pieber, TR Enhanced pharmacodynamic properties of insulin aspart due to a modified injection strategy in subjects with type 1 diabetes.
Proceedings of the 72 Scientific Sessions of the American Diabetes Association. 2012; A233-A233.-72nd Scientific Sessions of the ADA (American Diabetes Association); JUN 8-12, 2012; Philadelphia, USA. [Poster]

 

Mader, JK; Lucarelli, F; Scuffi, C; Friedrich, S; Korsatko, S; Ellmerer, M; Köhler, G; Valgimigli, F; Pieber, TR Bewertung der Sicherheit und Genauigkeit des GlucoMenDay-Systems zur kontinuierlichen subkutanen Gluksoemessung bei Patienten mit Typ-1-Diabetes
Diabetologie und Stoffwechsel, Supplement. 2012; 7(S1):47-47.-Diabetes Kongress 2012 - 47. Jahrestagung der DDG; MAY 16-19, 2012; Stuttgart, GERMANY. [Poster]

 

Mader, JK; Lucarelli, F; Scuffi, C; Friedrich, S; Korsatko, S; Ellmerer, M; Valgimigli, F; Pieber, TR Overcoming CGM calibration issues: GlucoMen(R)Day with embedded Autocal Software
Abstractband. 2012; -5th International Conference on Advanced Technologies & Treatments for Diabetes; FEB 8-11, 2012; Barcelona, SPAIN. [Poster]

 

Mader, JK; Lucarelli, F;Scuffi, C; Friedrich, S; Korsatko, S; Ellmerer, M; Valgimigli, F;Pieber, TR GlucoMen®Day continuous glucose monitor: assessment of safety and accuracy performance in type-1-diabetic patients.
7th Congress of the Central European Diabetes Association; JUN 28-30, 2012; Budapest, Hungary. 2012. [Poster]

 

Mader, JK; Neubauer, K; Aberer, L; Spat, S; Höll, B; Schaupp, L; Plank, J; Pieber, TR: Einfluss von Blutzuckerübertragungsfehlern auf die Insulindosis bei Verwendung eines Kontrollalgorithmus bei hospitalisierten Patienten mit Typ 2 Diabetes
Wiener klinische Wochenschrift. 2012; 124(Sup. 1):13-13.-40. Jahrestagung der Österreichischen Diabetesgeselleschaft; NOV 15-17, 2012; Salzburg, AUSTRIA. [Poster]

 

Mader, JK; Neubauer, K; Schaupp, L; Plank, J; Pieber, TR Influence of Blood Glucose Transcription Errors on Insulin Dosing using a Control Algorithm in Hospitalized Type 2 Diabetic Patients.
Konferenzband. 2012; -International Hospital Diabetes Meeting; OCT 12-13, 2012; Cambridge, USA. [Poster]

 

Mader,JK; Korsatko, S; Bock, G; Feichtner, F; Pachler, C; Plank, J; Ellmerer, M; Pieber, TR; CONTINUOUS SUBCUTANEOUS GLUCOSE MONITORING IN DIFFERENT GROUPS OF CRITICALLY ILL PATIENTS
Konferenzband. 2012; -5th International Conference on Advanced Technologies & Treatments for Diabetes; FEB 8-11, 2012; Barcelona, SPAIN. [Poster]

 

Neubauer, K; Mader, J; Plank, J; Schaupp, L; Beck, P; Augustin, T; Narath, S; Pieske, B; Pieber, T Persistent Hyperglycemia in Hospitalized Patients with Diabetes Despite Considerable Operating Expense.
Proceedings of the 72 Scientific Sessions of the American Diabetes Association. 2012; A628-A628.-72nd Scientific Sessions of the ADA (American Diabetes Association); JUN 8-12, 2012; Philadelphia, USA.

 

Neubauer, KM; Mader, JK; Plank, J; Tschapeller, B; Buttinger, M; Schneeberger, M; Schaupp, L; Pieber, TR. Kenntnisse, Einstellungen und Wünsche der Pflegepersonen zu Blutzuckermanagement im stationären Bereich: eine Fragebogenerhebung
Wiener klinische Wochenschrift. 2012; 124(Sup. 1):2-2.-40. Jahrestagung der Österreichischen Diabetesgeselleschaft; NOV 15-17, 2012; Salzburg, AUSTRIA. [Poster]

 

Pachler, C; Mader, J; Toller, W; Fruhwald, S; Metabolischer Effekte zweier kommerzieller parenteraler Ernährungen an kritisch kranken Patienten
A+IC News. 2012; 1(62):37-37.-AIC Jahrestagung der Österreich. Ges. für Anästhesiologie, Reanimation und Intensivmedizin; Sep 13-15; Klagenfurt. [Poster]

 

Renard, EM; DeVries, JH; Hovorka, R; Doll, W; Heinemann, L; Cobelli, C; Magni, L; Farret, A; Luijf, YM; Leelarathna, L; Mader, JK; Benesch, C; Bruttomesso, D; Di Palma, F; Nodale, M Time in hypoglycaemia in patients with type 1 diabetes is dramatically reduced when insulin infusion is driven by two closed-loop algorithms in a randomised clinical trial.
Diabetologia. 2012; 55(S1):86-86.-48th Annual Meeting of the European Association for the Study of Diabetes (EASD); OCT 1-5, 2012; Berlin, GERMANY. [Oral Communication]

 

Ribitsch, A; Haas, W; Köhler, G; Valentin, T; Mader, JK; Pieber,TR; Bock,G; THE PATHOGEN SPECTRUM OF INFECTED NEUROPATHIC ULCERS DIFFERS BETWEEN MEN AND WOMEN – INVESTIGATION IN A DIABETIC FOOT CLINIC IN A TERTIARY CENTRE
EWMA Journal. 2012; 12(2):301-301.-EWMA; May 23-25; Vienna, Austria. [Poster]

 

Ribitsch, A; Tauschmann, M; Horki, V; Mader, J; Semlitsch, B; Horvath, K; Pieber, T; Bock, G Possible effects of Immunoglobulin A Deficiency in the management of Type 1 Diabetes Mellitus in Pregnancy-2 Case Reports
WIEN KLIN WOCHENSCHR. 2012; 124(15-16):569-569. [Poster]
Web of Science

 

Ribitsch, A; Tauschmann, M; Horki, V; Mader, J; Semlitsch, B; Horvath, K; Pieber, T; Bock, G; Mögliche Auswirkungen eines Immunglobulin A-Mangels auf das Management des Diabetes mellitus Typ 1 in der Schwangerschaft - 2 Fallberichte
Wiener Klinische Wochenschrift. 2012; 124(15-16.):-43.Jahrestagung der Österreichischen Gesellschaft für Innere Medizin; ; SEP 20-22; Graz, Austria. [Poster]

 

Tuca, A; Schaupp, L; Mader, J; Plank, J; Ratzer, M; Köhler, G; Bodenlenz, M; Smolle, KH; Pieber, TR; Ellmerer, M; Korsatko, S. Comparison of microdialysis based glucose measurements in subcutaneous adipose tissue in patients with severe sepsis at the ICU.
Wiener klinische Wochenschrift. 2012; 124(Sup. 1):8-8.-40. Jahrestagung der Österreichischen Diabetesgeselleschaft; NOV 15-17, 2012; Salzburg, AUSTRIA. [Oral Communication]

 

Amrein, K; Pieber, T; Fahrleitner-Pammer, A; Amegah-Sakotnik, A; Urbanic, T; Mader, JK; Wagner, D; Zollner-Schwetz, I; Putz-Bankuti, C; Langmann A 2011 - The Gender Gap Continues
Endocr Rev 32: P3-202 . 2011; -The Endocrine Society's 93rd Annual Meeting; JUN 4-7, 2011; Boston, USA. [Poster]

 

Amrein, K; Putz-Bankuti, C; Amegah-Sakotnik, A; Urbanic, T; Mader, J; Wagner, D; Prandl, E; Sareban, N; Amrein, S; Langmann, A THE “GENDER GAP” IN TOP-RANK PUBLICATIONS OF DIFFERENT MEDICAL SPECIALTIES
Wiener Intensivmedizinische Tage2011; -WIT; Feb 16-19, 2011; Vienna, AUSTRIA . [Poster]

 

Amrein, K; Putz-Bankuti, C; Amegah-Sakotnik, A; Urbanic, T; Mader, JK, Wagner, D; Pieber, TR; Prandl, E; Sareban, N; Zollner-Schwetz, I; Amrein, S; Langmann, A; Fahrleitner-Pammer, A Gender Disparity in editorial boards of major medical journals
Abstracts ÖGGSM – Österreichische Gesellschaft für geschlechtsspezifische Medizin Jahrestagung2011; -ÖGGSM – Österreichische Gesellschaft für geschlechtsspezifische Medizin Jahrestagung; APR 8-9, 2011 ; Vienna, AUSTRIA . [Oral Communication]

 

Amrein, K; Putz-Bankuti, C; Amegah-Sakotnik, A; Urbanic, T; Mader, JK; Wagner, D; Pieber, TR; Zollner-Schwetz, I; Fahrleitner-Pammer, A WOMEN IN ACADEMIC MEDICINE
J Klin Endokrinol Stoffw2011; -ÖGES Jahrestagung; MAY 12-13, 2011; Vienna, AUSTRIA . [Poster]

 

Amrein, K; Putz-Bankuti, C; Mader, JK; Amegah-Sakotnik, A; Urbanic, T; Wagner, D; Prandl, E; Sareban, N; Amrein, S; Langmann, A FEMALE AUTHORS IN TOP-RANK JOURNALS OF DIFFERENT MEDICAL SPECIALTIES
Critical Care Supplement2011; -ISICEM; MAR 21-25, 2011; Brussels, Belgium. [Poster]

 

Amrein, K; Worm, H; Köhler, G; Mader, JK; Pieber, T; Fahrleitner-Pammer, A Moxibustion warning for diabetic patients
J Klin Endokrinol Stoffw2011; -ÖGES Jahrestagung; MAY 12-13, 2011; Vienna, AUSTRIA. [Poster]

 

Bock, G; Froehlich-Reiterer, E; Tauschmann, M; Prietl, B; Mader, J; Neuper, C; Borkenstein, M; Pieber, TR Characterization of beta cell function in patients with newly manifested Type 1 diabetes mellitus and Patients with positive autoantibodies at even low glucose abnormalities
WIEN KLIN WOCHENSCHR. 2011; 123: S15-S16.-ÖDG; NOV 17-19, 2011; Salzburg, Austria. [Poster]
Web of Science

 

Bock, G; Froehlich-Reiterer, E; Tauschmann, M; Prietl, B; Mader, JK; Neuper, C; Borkenstein, M; Pieber, TR. Charakterisierung der Betazellfunktion bei Patienten mit neumanifestiertem Diabetes mellitus Typ 1 und Patienten mit positiven Autoantikörpern bei noch gering abnormen Blutzuckerwerten
Wiener Klinische Wochenschrift. 2011; Suppl 2/11: 14--39. Jahrestagung der ÖDG; NOV 17-19,2011; Salzburg, AUSTRIA. [Poster]

 

Bock, G; Mader, JK; Prietl, B; Neuper, C; Pilz, S; Obermayer-Pitsch, B; Pieber, TR; Safety of high dose vitamin D supplementation: RCT in healthy humans
Abstraktband ÖGES. 2011; -ÖGES, 16. Jahrestagung; MAY 12-13; Vienna, AUSTRIA. [Oral Communication]

 

Bock, G; Olynec, J; Mader, JK; Semlitsch, P; Köhler, G; Horvath, K; Pieber, TR. PREGNANCY OUTCOME IN TYPE 1 DIABETIC WOMEN WITH INITIAL ELEVATED HbA1c.
Prceedings at the Conference. 2011; -The 6th International Symposium on Diabetes and Pregnancy; March 23-26, 2011; Salzburg, Austria. [Poster]

 

Bock, G; Prietl, B; Mader, JK; Kohler, G; Pilz, S; Obermayer-Pietsch, B; Pieber, TR No Sex-Specific Effect of Vitamin D Supplementation on Peripheral Regulatory T Cells and Other Immune Cells and Glucose Metabolism in Healthy Humans
J WOMENS HEALTH. 2011; 20(3):483-484.-Women's Health 2011, 19th Annual Congress; APR 1-3, 2011; Washington DC, USA. [Poster]
Web of Science

 

Deller, S; Neubauer, K; Korsatko, S; Wolf, M; Urschitz, M; Zahiragic, S; Mader, J; Adrian, C; Thomsen, H; Haahr, H; Pieber, T Ultra-Long-acting insulin Degludec: Two different concentrations (U100 and U200) showing bioequivalence and comparable pharmacodynamics
WIEN KLIN WOCHENSCHR. . 2011; 123: S10-S11.-39. Jahrestagung der Österreichischen Diabetes Gesellschaft; NOV 17-19, 2011; Salzburg, AUSTRIA. [Oral Communication]
Web of Science

 

Guerra, S; Facchinetti, A; Bruttomesso, D; Luijf, YM; Ellmerer, M; Mader, JK; Heinemann, L; Benesch, C; Cobelli, C Accuracy of Continuous Glucose Monitoring Enhanced Online via a Deconvolution-Based Algorithm.
Konferenzband. 2011; -11th Annual Diabetes Technology Meeting; OCT 27-29, 2011; San Francisco, USA. [Poster]

 

Heller, SR; Pieber, TR; Korsatko, S; Köhler, G; Deller, S; Bock, G; Zahiragic, S; Mader, JK; Roepstorff; C; Rasmussen, S; Haahr,H; A higher counter-regulatory hormone response is seen with insulin degludec than insulin glargine in response to induced hypoglycaemia in type 1 diabetes
Diabetologia. 2011; -47th Annual Meeting of EASD; SEP 12-16, 2011; Lisbon, PORTUGAL. [Poster]

 

Kohler, G; Korsatko, S; Deller, S; Neubauer, K; Bock, G; Mader, J; Roepstorff, C; Rasmussen, S; Haahr, H; Pieber, T; Heller, S Induced hypoglycemia in type 1 diabetes with insulin Degludev and Insulin Glargine
WIEN KLIN WOCHENSCHR. 2011; 123: S9-S9.-ÖDG; NOV 17-19, 2011; Salzburg, Austria. [Oral Communication]
Web of Science

 

Köhler, G; Korsatko, S; Deller, S; Neubauer, K; Bock, G; Mader, J; Roepstorff, C; Rasmussen, S; Haahr, H; Pieber, TR; Heller, S Induzierte Hypoglykämie bei Typ 1 Diabetikern mit Insulin Degludec und Insulin Glargin
Konferenzband. 2011; -39. Jahrestagung der ÖDG; NOV 17-19,2011; Salzburg, AUSTRIA. [Oral Communication]

 

Korsatko, S; Deller, S; Zahiragic, S; Mader, JK; Neubauer, K; Adrian, C; Thomsen, H; Haahr, H; Pieber, TR Ultra-long-acting Insulin degludec: two different formulations (U100 and U200) are bioequivalent and show similar pharmacodynamics
Diabetes Care. 2011; -71st Scientific Sessions ADA; 2011; Maryland, USA. [Poster]

 

Korsatko, S; Deller, S; Zahiragic, S; Mader, JK; Neubauer, K; Adrian, C; Thomsen, H; Haahr, H; Pieber TR Ultra-long-acting insulin degludec: bioequivalence and similar pharmacodynamics shown for two different formulations (U100 and U200)
Konferenzband. 2011; -World Diabetes Congress - International Diabetes Federation; 2011; Dubai. [Poster]

 

Korsatko, S; Deller, S; Zahiragic, S; Mader, JK; Neubauer, K; Adrian, C; Thomsen, H; Haahr, H; Pieber, TR Ultra-long-acting insulin degludec: bioequivalence and similar pharmacodynamics shown for two different formulations (U100 and U200)
Diabetologia. 2011; -47th EASD Annual meeting; 2001; Lissabon, PORTUGAL. [Poster]

 

LippRW, Grohs S, Mader J, Obermayer-Pitsch B, T Pieber, Piswanger-JC Routine calcitonin screening for medullary thyroid cancer detection in an Austrian population
Annual Congress of the EANM 2011. 2011; 38(Su2):S100-S100.-Annual Congress of the EANM 2011; Oct 15-19,2011; Birmingham, UK. [Oral Communication]

 

Luijf, YM, Avogaro, A; Benesch, C; Bruttomesso, D; Ellmerer, M; Heinemann, L; Mader, JK; DeVries, JH Continuous Glucose Monitoring Accuracy Assessed at Home Is Seemingly Better than When Assessed at the Clinical Research Center.
Konferenzband. 2011; -11th Annual Diabetes Technology Meeting; OCT 27-29, 2011; San Francisco, USA. [Poster]

 

Mader, J; Lucarelli, F; Scuffi, C; Friedrich, S; Korsatko, S; Urschitz, M; Wolf, M; Ellmerer, M; Valgimigli, F; Pieber, T Evaluate the safety and accuracy of GlucoMen (R) Day system for continuous subcutaneous glucose monitoring in patients with Type 1 diabetes
WIEN KLIN WOCHENSCHR. . 2011; 123: S5-S5.-39. Jahrestagung der Österreichischen Diabetes Gesellschaft; NOV 17-19, 2011; Salzburg, AUSTRIA. [Oral Communication]
Web of Science

 

Mader, JK; Lucarelli, F; Scuffi, C; Friedrich, S; Korsatko, S; Ellmerer, M; Valgimigli, F; Pieber, TR GlucoMen(R)Day continuous glucose monitor: assessment of safety and accuracy performance in type-1-diabetic patients.
Konferenzband. 2011; -11th Annual Diabetes Technology Meeting; OCT 27-29, 2011; San Francisco, USA. [Poster]

 

PIEBER, T; KORSATKO, S; KÖHLER, G; DELLER, S; BOCK, G; ZAHIRAGIC, S; MADER, J; ROEPSTORFF, C; RASMUSSEN, S; HAAHR, H; HELLER, S; Response to Induced Hypoglycemia in Type 1 Diabetes: Insulin Degludec Elicits an Enhanced Counter-Regulatory Hormone Response Compared to Insulin Glargine
Diabetes. 2011; -71st Scientific Sessions of ADA; JUN 24-28, 2011; San Diego, USA. [Poster]

 

Pieber, TR; Korsatko, S; Koehler, G; Deller, S; Bock, G; Zahiragic, S; Mader, JK; Roepstorff, C; Rasmussen, S; Haahr, H; Heller, S Induced hypoglycemia in type 1 diabetes: enhanced counter-regulatrory hormone response with insulin degludec versus insulin glargine
Konferenzband. 2011; -World Diabetes Congress- International Diabetes Federation; 2011; Dubai. [Poster]

 

Pieber, TR; Korsatko, S; Koehler, G; Deller, S; Bock, G; Zahiragic, S; Mader, JK; Roepstorff, C; Rasmussen, S; Haahr, H; Heller, S Response to induced hypoglycemia in type 1 diabetes: Insulin degludec elicits an enhanced counter-regulatrory hormone response compared to insulin glargine
Konferenzband. 2011; -14th Professional Congress and Annual Meeting - Canadian Diabetes Association; 2011; Toronot, KANADA. [Poster]

 

Prietl, B; Bock, G; Hoeller, E; Mader, J; Wolf, M; Graninger, W; Obermayer-Pietsch, BM; Pieber; TR; Decreased levels of memory T cells and increased levels of plasmacytoid dendritic cells in type 1 diabetes patients with short disease duration
Diabetologia. 2011; -47th Annual Meeting of EASD; SEP 12-16, 2011; Lisbon, PORTUGAL. [Poster]

 

Prietl, B; Bock, G; Mader, J; Holler, E; Wolf, M; Graninger, WB; Tauschmann, M; Obermayer-Pietsch, BM; Frohlich-Reiterer, E; Pieber, TR Differences in the frequency of memory T-cells and of plasmacytoid dendritic cells in the blood of patients with type 1 diabetes mellitus and healthy subjects
WIEN KLIN WOCHENSCHR. 2011; 123: S14-S14.-ÖDG; NOV 17-19, 2011; Salzburg, Austria. [Oral Communication]
Web of Science

 

Prietl, B; Bock, G; Mader, JK; Höller, E; Wolf, M; Graninger, WB; Tauschmann, M; Obermayer-Pietsch, B; Fröhlich-Reiterer, E; Pieber, TR. Unterschiede in der Frequenz der memory T Zellen und der plasmazytoiden dendritischen Zellen im Blut von Patienten mit Diabetes mellitus Typ 1 und gesunden Probanden.
Wiener Klinische Wochenschrift. 2011; Suppl 2: 13--39. Jahrestagung der ÖDG; NOV 17-19,2011; Salzburg, AUSTRIA. [Oral Communication]

 

Ribitsch, A; Haas, W; Koehler, G; Valentin, Th; Mader, J; Horvath, K; Pieber, TR; Bock, G; Keimspektrum in infizierten neuropathischen Wunden bei Vorstellung in der Diabetes Fußambulanz eines tertiären Zentrums
Konferenzband. 2011; -39.Jahrestagung der ÖDG; NOV 17-19,2011; Salzburg, AUSTRIA. [Poster]

 

Ribitsch, A; Haas, W; Kohler, G; Valentin, T; Mader, J; Horvath, K; Pieber, TR; Bock, G Spectrum of germs in infected wounds in neuropathic diabetic foot performance in the outpatient clinic of a tertiary center
WIEN KLIN WOCHENSCHR. 2011; 123: S13-S13.-ÖDG; NOV 17-19, 2011; Salzburg, Austria. [Poster]
Web of Science

 

Bock, G; Köhler, G; Haas, W; Mader, JM; Horvath, K; Pieber, TR An acute Charcot foot is still getting misdiagnosed and proper therapy delayed – A case report.
DFSG; 17.9-20.2010; Uppsala, SCHWEDEN. 2010. [Poster]

 

Bock, G; Mader, J; Prietl, B; Fruhmann, J; Urschitz, M; Hueter, N; Obermayer-Pietsch, B; Pieber, T Placebo-controlled trial to investigate dan effects of vitamin D substitution on the glucose metabolism in healthy subjects.
WIEN KLIN WOCHENSCHR. 2010; 122: S5-S5.-ÖDG; [Oral Communication]
Web of Science

 

Bock, G; Mader, JK; Kohler, G; Svehlikova, E; Horvath, K; Pieber, TR Pseudo-hypoglycemia - a diagnostosche challenge in the investigation.
WIEN KLIN WOCHENSCHR. 2010; 122: S5-S5. [Poster]
Web of Science

 

Bock, G; Mader, JK; Prietl, B; Pilz, S; Obermayer-Pietsch, B; Pieber, TR; Different pattern of glucose excursions following a standard mixed meal tolerance test in females than in males
Proceedings of 5th International Conference on Gender Medicine. 2010; -5th International Congress on Gender Medicine; IGM; Nov 30-Dez 3, 2010; Tel Aviv, Israel. [Poster]

 

Bock, G; Mader,JK; Prietl,B; Pilz,S; Obermayer-Pietsch, B; Pieber, TR; Different pattern of glucose excursions following a standard mixed meal tolerance test in females than in males
Gender Medicine. 2010; -5th International Congress on Gender Medicine 2010; 30 NOV- 3. Dec 2010; Tel Aviv, Israel. [Poster]

 

Bock, G; Prietl, B; Mader, JK; Fruhmann, J; Pilz, S; Hueter, N; Obermayer-Pietsch, BM; Pieber, TR The effect of vitamin D supplementation on beta cell function and insulin sensitivity during a mixed meal tolerance test in healthy humans
DIABETOLOGIA. 2010; 53: 889 [Poster]
Web of Science

 

Köhler, G; Bock, G; Fahrleitner-Pammer, A; Mader, J; Pieber, TH Der akute Charcot Fuß wird häufig verspätet diagnostiziert und damit eine adäquate Therapie zu spät eingeleitet ¿ ein Fallbericht
www.oegekm.at2010; -Wissenschaftliche Herbsttagung der Ögekm; 26. - 27. November 2010; Vienna. [Poster]

 

Mader, JK; Köhler, G; Bock, G; Plank, J; Pieber, TR; Ellmerer, M Body Mass Index as limiting factor for the performance of subcutaneous glucose monitoring systems in type 1 diabetic patients.
3rd International Conference on Advanced Technologies & Treatments for Diabetes; FEB 10-13, 2010; Basel, SWITZERLAND. 2010. [Poster]

 

Mader, JK; Bock, G; Wagner, M; Forrer, F; Lackner, C; Portugaller, RH; Fickert, P; Krejs, GJ; Pieber, TR Recurrent hypoglycemia in adults - a diagnostic challenge (case report).
WIEN KLIN WOCHENSCHR. 2010; 122(17-18):A7-A7.-ÖGIM; Sep 29-Oct. 1; Salzburg, Austria. [Poster]
Web of Science

 

Mader, JK; Koehler, G; Bock, G; Amrein, K; Plank, J; Ellmerer, M; Pieber, TR Der Einfluss des Body-Mass-Index auf die Signalqualität von kontinuierlichem subkutanen Glukosemonitoring bei Patienten mit Typ-1-Diabetes
J Klin Endokrinol Stoffw2010; 3 (Sonderheft 1): 2010; -Österreichische Gesellschaft für Endokrinologie; MAY 07-08, 2010; Vienna, AUSTRIA. [Poster]

 

Mader, JK; Korsatko, S; Bock, B; Koehler, G; Plank, J; Pieber TR; Ellmerer, M Performance of Continuous Subcutaneous Glucose Monitoring using Microdialysis in Different Groups of Critically Ill Patients.
keine2010; -10th Diabetes Technology Meeting ; NOV 11-13, 2010; Bethesda, MAryland, USA,. [Poster]

 

Mader, JK; Korsatko, S; Bock, G; Kohler, G; Plank, J; Pieber, TR; Ellmerer, M Comparison of continuous subcutaneous glucose monitoring in different populations of critically ill patients.
WIEN KLIN WOCHENSCHR. 2010; 122: S14-S14.-Jahrestagung der Österreichischen Diabetesgesellschaft; NOV, 2010; Salzburg, AUSTRIA. [Poster]
Web of Science

 

Mader, JK; Korsatko, S; Köhler, G; Bock, G; Plank, J; Pieber, TR; Ellmerer, M Evaluation of continuous subcutaneous glucose monitoring in different groups of critically ill patients.
Diabetes, Supplement 12010; 59: A131-A131.-70th Scientific Sessions of the American Diabetes Association (ADA); JUN 25-29, 2010; Orlando, USA. [Poster]

 

Mader, JM; Bock, G; Wagner, M; Forrer,F; Lackner, C; Portugaller, RH; Fickert, P; Krejs, GJ; Pieber, TR; Rezidivierende Hypoglykämie im Erwachsenenalter - eine diagnostische Herausforderung (Fallbericht).
Abstractband. 2010; -ÖGIM; 29.9-2.10.2010; Salzburg, Austria. [Poster]

 

Prietl, B; Bock, G; Mader, JK; Hoeller, E; Wolf, M; Pilz, S; Graninger, WB; Obermayer-Pietsch, BM; Pieber, TR The effect of vitamin D supplementation on peripheral regulatory T cells and other immune cells in healthy humans - A randomized controlled trial
The 11th International Congress of the Immunology of Diabetes Society2010; -The 11th IDS; OCT 31 - NOV 3, 2010; Incheon, KOREA. [Poster]

 

Prietl, B; Bock, G; Mader, JK; Holler, E; Wolf, M; Pilz, S; Graninger, WB; Obermayer-Pietsch, BM; Pieber, TR The effect of Vitamin D supplementation on peripheral regulatory T cells in healthy humans, a randomised controlled trial
DIABETOLOGIA. 2010; 53: 441 [Poster]
Web of Science

 

Prietl, B; Bock, G; Mader, JK; Wulz, C; Fruhmann, J; Pilz, S; Graninger, W; Obermayer-Pietsch, B; Pieber, TR Significant increase of peripheral regulatory T cells in healthy subjects after vitamin D intake - a randomized placebo-controlled study
WIEN KLIN WOCHENSCHR. 2010; 122: S15-S15. [Oral Communication]
Web of Science

 

Ribitsch,A; Kienreich,T; Mader,J; Höller,V; Köhler,G;Horvath,K; Pieber,T; Treiber,G Übergewicht und Adipositas bei Patienten mit Diabetes mellitus Typ 1 zeigt ein unterschiedliches Profil zwischen Frauen und Männern
Wiener Klinische Wochenschrift. 2010; -15. Jahrestagung der Österreichischen Adipositasgesellschaft; Okt 24-25, 2014; Vienna, AUSTRIA. [Poster]

 

Ellmerer, M; Mader, JK; Ikeoka, D; Korsatko, S; Plank, J; Pieber, TR; Comparison of a population-based versus a one-point calibration technique for subcutaneous glucose monitoring in type-1-diabetic patients
DIABETOLOGIA, 2009. 2009; 52: -45th Annual Meeting of the EASD (European Association for the Study of Diabetes); SEP 29 - OCT 2, 2009; Vienna, AUSTRIA. [Poster]

 

Ikeoka, D; Korsatko, S; Pachler, C; Mader, JK; Bodenlenz, M; Plank, J; Ellmerer, M; Pieber, TR Clinical impact of inflammatory cytokines produced in adipose tissue of septic patients
DIABETOLOGIA. 2009; 52: 643--45th Annual Meeting of the EASD (European Association for the Study of Diabetes); SEP 29 - OCT 2, 2009; Vienna, AUSTRIA. [Poster]
Web of Science

 

Ikeoka, D; Korsatko, S; Pachler, C; Mader, JK; Smolle, KH; Bodenlenz, M; Plank, J; Ellmerer, M; Pieber, TR INTERLEUKIN-6 PRODUCED IN ADIPOSE TISSUE IS STRONGLY LINKED TO DIASTOLIC BLOOD PRESSURE DURING SEVERE SEPSIS
INTENS CARE MED. 2009; 35: 0959--22nd Congress of the European Society of Intensive Care Medicine; OCT 11-14, 2009; Vienna, AUSTRIA. [Poster]
Web of Science

 

Korsatko, S; Gettler, K; Olsen, KJ; Wutte, A; Bock, G; Kohler, G; Mader, J; Semlitsch, B; Pieber, T Comparison of pharmacodynamic and pharmacokinetic properties of insulin detemir and neutral protamine lispro (NPL) insulin in patients with Type 1 Diabetes.
WIEN KLIN WOCHENSCHR. 2009; 121: S17-S17.-37. Jahrestagung der Österreichischen Diabetes Gesellschaft; NOV 19-21, 2009; Salzburg, Österreich. [Oral Communication]
Web of Science

 

Korsatko, S; Glettler, K; Olsen, KJ; Wutte, A; Bock, G; Koehler, G; Mader, JK; Semlitsch, B; Pieber, TR A direct comparison of pharmacodynamics and pharmacokinetics of insulin detemir and neutral protamine lispro (NPL) insulin in subjects with type 1 diabetes
DIABETOLOGIA. 2009; 52: 499--c; SEP 29 - OCT 2, 2009; Vienna, AUSTRIA. [Poster]
Web of Science

 

Lipp, RW; Schnedl, WJ; Bock, G; Kohler, G; Horvath, K; Mader, JK; Pieber, TR; Piswanger-Soelkner, J Gastric emptying as prognostic factor for life expectancy in patients with type 1 diabetes
DIABETOLOGIA. 2009; 52: 977--45th Annual Meeting of the EASD (European Association for the Study of Diabetes); SEP 29 - OCT 2, 2009; Vienna, AUSTRIA. [Poster]
Web of Science

 

Mader, J; Feichtner, F; Bock, G; Kohler, G; Schaller, R; Plank, J; Pieber, T; Ellmerer, M Evaluation of Microdialysis-based glucose monitoring in blood and subcutaneous adipose tissue in patients with Type 1 Diabetes.
WIEN KLIN WOCHENSCHR. 2009; 121: S20-S20. [Poster]
Web of Science

 

Mader, JK; Bock, G; Plank, J; Pieber, TR; Ellmerer, M Definition of hypoglycaemia for patients in the ICU.
9th Diabetes Technology Meeting; NOV 5-7, 2009; San Francisco, USA. 2009. [Poster]

 

Mader, JK; Dunzinger, A; Krejs, GJ; Pieber, TR; Lipp RW Erste Erfahrungen mit Y-90 und Lu-177 Radioliganden-Therapie bei Patienten mit metastasierenden neuroendokrinen Tumoren.
Nuklearmedizin2009; 47(6):A154-A154.-Jahrestagung der Österreichischen Gesellschaft für Nuklearmedizin; JAN 22-24, 2009; Salzburg, AUSTRIA. [Oral Communication]

 

Mader, JK; Feichtner, F; Bock, G; Köhler, G; Schaller, R; Plank, J; Pieber, TR; Ellmerer, M Evaluation of microdialysis-based glucose monitoring in blood and subcutaneous adipose tissue in type 1 diabetic patients.
9th Diabetes Technology Meeting; NOV 5-7, 2009; San Francisco, USA. 2009. [Poster]

 

Mader, JK; Feichtner, F; Ikeoka, D; Korsatko, G; Köhler, G; Schaller, R; Plank, J; Pieber, TR; Ellmerer, M Evaluation of Microdialysis-based Glucose monitoring in Blood and Subcutaneous adipose tissue in Patients with Type 1 Diabetes
WIEN KLIN WOCHENSCHR. 2009; 121(15-16):A19-A19.-40. Jahrestagung der Österreichischen Gesellschaft für Innere Medizin (ÖGIM); SEP 17-19, 2009; Vienna, AUSTRIA. [Poster]
Web of Science

 

Mader, JK; Feichtner, F; Korsatko, S; Köhler, G; Schaller, R; Plank, J; Pieber, TR; Ellmerer, M Evaluation of microdialysis-based glucose monitoring in blood and subcutaneous adipose tissue in type-1-diabetic patients.
Abstractbook of the 2nd International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)2009; -2nd International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) ; FEB 25-28, 2009; Athens, GREECE. [Oral Communication]

 

Mader, JK; Ikeoka, D; Korsatko, S; Plank, J; Pieber, TR; Ellmerer, M Population-based vs. one-point prospective calibration for subcutaneous glucose monitoring in type-1-diabetic patients.
Abstractbook of the 28th Workshop of the AIDPIT Study Group2009; -28th Workshop of the AIDPIT Study Group; JAN 25-27, 2009; Innsbruck-Igls, AUSTRIA. [Poster]

 

Mader, JK; Kohler, G; Plank, J; Suppan, M; Ikeoka, D; Kohler, H; Pieber, TR; Ellmerer, M Comparison of three different techniques for subcutaneous glucose monitoring in type 1 diabetic patients
DIABETOLOGIA. 2009; 52: 924--EASD - European Association for the Study of Diabetes; SEP 28-OCT 2, 2009; Vienna, AUSTRIA. [Poster]
Web of Science

 

Pichler, EM; Ikeoka, D; Pachler, C; Mader, JK; Bock, G; Krusinova, E; Feichtner, F; Koehler, G; Pieber, T; Ellmerer, M Serum and adipose tissue adipokine concentrations are affected by non-esterified fatty-acids in healthy individuals
DIABETOLOGIA. 2009; 52: 61--45th Meeting of the EASD (European Society for the Study of Diabetes); SEP 29 - OCT 2, 2009; Vienna, AUSTRIA. [Oral Communication]
Web of Science

 

Piswanger-Soelkner, J; Schnedl, WJ; Bock, G; Kohler, G; Horvath, K; Mader, JK; Pieber, TR; Lipp, RW The influence of gastric emptying patterns on blood glucose in type 1 diabetes
DIABETOLOGIA. 2009; 52: 978--45th Annual Meeting of the EASD (European Association for the Study of Diabetes); SEP 29 - OCT 2, 2009; Vienna, AUSTRIA. [Poster]
Web of Science

 

Feichtner, F; Mader, JK; Doll, W; Pieber, TR Data analysis tool for evaluation of glucose concentration profiles in type 1 diabetic subjects or intensive care patients.
Abstractbook of the 27th Workshop of the AIDPIT Study Group of the European Society for the Study of Diabetes (EASD)2008; -27th Workshop of the AIDPIT Study Group of the European Society for the Study of Diabetes (EASD); JAN 27-29, 2008; Innsbruck-Igls, AUSTRIA. [Poster]

 

Ikeoka, D; Pachler, C, Mader, JK; Bock, G; Wutte, A; Krusinova, E; Feichtner, F; Köhler, G; Pieber, TR; Ellmerer; M The effect of lipid-heparin infusion on systemic and locally stimulated inflammation in subcutaneous tissue of healthy volunteers.
Wiener Klinische Wochenschrift, Supplement2008; -36. Jahrestagung der Österreichischen Diabetesgesellschaft (ÖDG); NOV 20-22, 2008; Baden, AUSTRIA. [Poster]

 

Ikeoka, D; Pachler, C; Mader, JK; Suppan, M; Neves, AL; Feichtner, F; Bock, G; Pieber, TR; Ellmerer, M Non-esterified fatty acids induce a systemic inflammatory and prothrombotic state and depress anti-inflammatory response in adipose tissue of healthy volunteers.
Abstractbook2008; -European Society of Cardiology (ESC) Congress; AUG 30 - SEP 3, 2008; Munich, GERMANY. [Poster]

 

Koehler, H; Pasic, A; Bauer, G; Bodenlenz, M; Feichtner, F; Schaller, R; Mader, J; Klimat, I; Schaupp, L; Pieber, TR Fiberoptic hybrid sensor for continuous glucose monitoring.
Abstractbook of the 27th Workshop of the AIDPIT Study Group of the European Society for the Study of Diabetes (EASD)2008; -27th Workshop of the AIDPIT Study Group of the European Society for the Study of Diabetes (EASD); JAN 27-29, 2008; Innsbruck-Igls, AUSTRIA. [Poster]

 

Mader, JK; Feichtner, F; Korsatko, S; Kohler, G; Schaller, R; Plank, J; Pieber, TR; Ellmerer, M Evaluation of microdialysis-based glucose monitoring in blood and subcutaneous adipose tissue in type 1 diabetic patients
DIABETOLOGIA. 2008; 51: S435-S435.-EASD Annual Meeting; SEP 7-11, 2008; Rome, ITALY. [Poster]
Web of Science

 

Mader, JK; Feichtner, F; Korsatko, S; Köhler, G; Schaller, R; Plank, J; Pieber, TR; Ellmerer, M Evaluation of microdialysis-based glucose monitoring in blood and subcutaneous adipose tissue for icu application.
Abstractbook2008; -21st annual meeting of the ESICM (European Society of Intensive Care Medicine); SEP 21-24, 2008; Lisbon, PORTUGAL. [Poster]

 

Mader, JK; Pachler, C; Plank, J; Korsatko, S; Köhler, G; Feichtner, F; Hovorka, R; Pieber, TR; Ellmerer, M Comparison of 24h blood glucose variability between critically ill, type 1 diabetic and healthy individuals.
Abstractbook of 27th Workshop of the AIDPIT Study Group of the European Society for the Study of Diabetes (EASD)2008; -27th Workshop of the AIDPIT Study Group of the European Society for the Study of Diabetes (EASD); JAN 27-29, 2008; Innsbruck-Igls, AUSTRIA. [Poster]

 

Mader, JK; Weinhandl, H; Köhler, G; Plank, J; Ikeoka, D; Wutte, A; Köhler, H; Sinner, F; Pieber, TR; Ellmerer, M Evaluierung von Techniken zum subkutanen Glukosemonitoring bei Typ-1-Diabetikern.
Wiener Klinische Wochenschrift, Supplement2008; -36. Jahrestagung der Österreichischen Diabetesgesellschaft (ÖDG); NOV 20-22, 2008; Baden, AUSTRIA. [Poster]

 

Mader, JK; Weinhandl, H; Köhler, G; Plank, J; Suppan, M; Ikeoka, D; Wutte, A; Köhler, H; Sinner, F; Pieber, TR; Ellmerer, M Evaluation of Different Techniques for Subcutaneous Glucose Monitoring in Type 1 Diabetic Patients During “Real-Life” Glucose Excursions.
Scientific Sessions Abstract Book, the June supplement to the journal Diabetes 2008; -American Diabetes Association (ADA) 68th scientific sessions; JUN 6-10, 2008; San Francisco, USA.

 

Mader, JK; Weinhandl; H; Köhler, G; Plank, J; Suppan, M; Ikeoka, D; Wutte, A; Köhler, H; Sinner, F; Pieber, TR; Ellmerer, M Evaluation of Different Techniques for Subcutaneous Glucose Monitoring in Type 1 Diabetic Patients During “Real-Life” Glucose Excursions.
Abstractbook of the 27th Workshop of the AIDPIT Study Group of the European Society for the Study of Diabetes (EASD)2008; -27th Workshop of the AIDPIT Study Group of the European Society for the Study of Diabetes (EASD); JAN 27-29, 2008; Innsbruck-Igls, AUSTRIA. [Oral Communication]

 

Heise, HM; Damm, U; Kondepati, VR; Oszinda, T; Mader, JK; Ellmerer, M Continuous monitoring of subcutaneous interstitial glucose and metabolites in human subjects using micro-dialysis and IR-spectrometry
7th Australian Conference on Vibrational Spectroscopy (ACOVS-7) ; SEP 26 - 28, 2007; Wollongong, Australia. 2007. [Poster]

 

Heise, HM; Damm, U; Kondepati, VR; Oszinda, T; Mader, JK; Ellmerer M Clinical performance of microdialysis-infrared spectroscopy for continuous bedside monitoring of subcutaneous interstitial glucose
Proceedings of the 7th Annual Diabetes Technology Meeting2007; A65-A65.-7th Annual Diabetes Technology Meeting; OCT 25-27, 2007; San Francisco, USA. [Poster]

 

Ikeoka, D; Pachler, C; Korsatko, S; Bodenlenz, M; Mader, J; Weinhandl, H; Plasnik, A; Suppan, M; Smolle, KH; Plank, J; Pieber, T; Ellmerer, M Local stimulated secretion of inflammatory cytokines from adipose tissue is impaired in septic patients in comparison to healthy controls.
ZMF-Tag 2007; NOV 21, 2007; Graz, AUSTRIA. 2007. [Poster]

 

Ikeoka, D; Pachler, C; Korsatko, S; Bodenlenz, M; Mader, J; Weinhandl, H; Plasnik, A; Suppan, M; Smolle, KH; Plank, J; Pieber, T; Ellmerer; M Local Stimulated Secretion of Inflammatory Cytokines from Adipose Tissue is Reduced in Septic Patients in Comparison to Healthy Controls.
. 2007; 39(1): 17-17. Doi: 10.1016/j.cyto.2007.07.065 [Poster]
Web of Science FullText FullText_MUG

 

Ikeoka, D; Pachler, C; Korsatko, S; Bodenlenz, M; Mader JK; Weinhandl, H; Plasnik, A; Suppan, M; Smolle, KH; Plank, J; Pieber, TR; Ellmerer, M Reduced local inflammatory reactivity in septic patients compared to healthy controls.
Critical Care, Supplement 2;2007; 11: 21-21.-Symposium on Intensive Care and Emergency Medicine; Mar 27-30, 2007; Brussels, Belgium. [Poster]

 

Ikeoka, D; Pachler, C; Mader, JK; Wutte, A; Suppan, M; Neves, AL; Feichtner, F; Bodenlenz, M; Bock, G; Koehler, G; Plank, J; Pieber, TR; Ellmerer, M Non-esterified fatty acids induce insulin resistance and promote a systemic increase of macrophage chemoattractant protein-1 and plasminogen activator inhibitor-1 in humans.
ZMF Tag 2007; NOV 21, 2007; Graz, AUSTRIA. 2007. [Poster]

 

Ikeoka, D; Pachler, C; Mader, JK; Wutte, A; Suppan, M; Neves, AL; Feichtner, F; Bodenlenz, M; Bock, G; Koehler, G; Plank, J; Pieber TR; Ellmerer, M Non-Esterified Fatty Acids Induce Insulin Resistance and Promote a Systemic increase of Macrophage Chemoattractant Protein-1 and Plasminogen Activator Inhibitor-1 in Humans.
Cytokines2007; -15th Annual Meeting of the International Cytokine Society; OCT 26-30, 2007; San Francisco, USA. [Poster]

 

Mader, JK; Korsatko, S; Ikeoka, D; Plank, J; Bodenlenz, M ; Suppan, M; Sinner , F; Smolle, KH; Pieber, TR; Ellmerer, M Subcutaneous glucose monitoring in patients with severe sepsis
Critical Care Supplement 2; 11: 58-58.-27th Symposium on Intensive Care and Emergency Medicine; MAR 27-30, 2007; Brussels, BELGIUM. [Poster]
FullText

 

Mader, JK; Pachler, C; Plank, J; Korsatko, S; Köhler, G; Feichtner, F; Hovorka, R; Pieber, TR; Ellmerer, M Comparison of 24h blood glucose variability between critically ill, type 1 diabetic and healthy individuals
Proceedings of the 7th Annual Diabetes Technology Meeting2007; A103-A103.-7th Annual Diabetes Technology Meeting; OCT 25-27, 2007; San Francisco, USA. [Poster]

 

Mader, JK; Pachler, C; Plank, J; Korsatko, S; Köhler, G; Feichtner, F; Hovorka, R; Pieber, TR; Ellmerer, M Comparison of 24h blood glucose variability between critically ill, type 1 diabetic and healthy individuals
ZMF Tag 2007; NOV 21, 2007; Graz, AUSTRIA. 2007. [Poster]

 

Mader, JK; Pachler, C; Plank, J; Korsatko, S; Köhler, G; Feichtner, F; Pieber, TR; Ellmerer, M Vergleich der 24-Stunden Blutglukose-Variabilität zwischen kritisch Kranken, Typ-1-Diabetikern und gesunden Probanden
Wiener Klinische Wochenschrift - Supplementum 4 . 2007; 119: 14-15.-35. Jahrestagung der Österreichischen Diabetes Gesellschaft; NOV 29 - DEC 1, 2007; Innsbruck, AUSTRIA. [Poster]

 

Mader, JK; Weinhandl, H; Köhler, G; Plank, J; Suppan, M; Ikeoka, D; Wutte, A; Köhler, H; Sinner, F; Pieber, TR; Ellmerer, M Evaluation of different techniques for subcutaneous glucose monitoring in type 1 diabetic patients during „real-life“ glucose excursions
ZMF Tag 2007; NOV 21, 2007; Graz, AUSTRIA. 2007. [Poster]

 

Pachler, C; Ikeoka, D; Plank, J; Weinhandl, H; Suppan, M; Mader, JK; Bodenlenz, M; Regittnig, W; Mangge, H; Pieber, TR; Ellmerer, M Inflammatory cytokine response of subcutaneous adipose tissue after minimal trauma in humans
DIABETES. 2007; 56: A354-A355. [Poster]
Web of Science

 

Weinhandl, H; Pachler, C; Mader JK; Mautner, A; Falk, A; Suppan, M; Köhler, H; Pieber, TR; Ellmerer, M Physiological Hyperinsulinemia has No Detectable Effect on Tissue Perfusion in Humans
Scientific Sessions Abstract Book, the June supplement to the journal Diabetes;2007; -American Diabetes Association (ADA) 67th scientific sessions; Jun 22-26, 2007; Chicago, USA. [Poster]

 

Ellmerer, M; Korsatko, S; Mader, J; Ikeoka, D; Plank, J; Bodenlenz, M; Schaupp, L; Mautner, A; Smolle, KH; Pieber, TR Clinical evaluation of subcutaneous glucose monitoring in patients with severe sepsis
Proceedings of the 6th Annual Diabetes and Technology Meeting2006; -6th Annual Diabetes and Technology Meeting; Nov 2-4, 2006; Atlanta, USA. [Oral Communication]

 

Ikeoka, D; Pachler, C; Korsatko, S; Bodenlenz, M; Mader J; Weinhandl, H; Plasnik, A; Plank, J; Pieber, TR; Ellmerer, M Reduced local inflammatory reactivity in septic patients compared to healthy controls.
Wiener Klinische Wochenschrift. Supplement 4; 118(19):10-10.-34. Jahrestagung der Österreichischen Diabetes Gesellschaft; Nov 16-18, 2006; Innsbruck, Austria. [Poster]

 

Korsatko, S; Ellmerer, M; Mader, J; Ikeoka, D; Plank, J; Smolle, KH; Pieber ,TR Klinische Evaluierung eines „Point of care“ Glukosemesssystems bei Patienten mit schwerer Sepsis.
Wiener Klinische Wochenschrift. -34. Jahrestagung der Österreichischen Diabetes Gesellschaft 16. - 18. Nov. 2006, Innsbruck; NOV 16-18, 2006; Innsbruck, AUSTRIA. [Poster]

 

Korsatko, S; Mader, J; Ikeoka, D; Plank, J; Bodenlenz, M; Schaupp, L; Mautner, A; Smolle, K; Pieber, TR; Ellmerer, M EVALUATION OF SUBCUTANEOUS GLUCOSE MEASUREMENTS IN PATIENTS WITH SEVERE SEPSIS.
Intensive Care Medicine. -19th ESICM Annual Congress; SEP 24–27, 2006; Barcelona, SPAIN. [Oral Communication]

 

Mader, J; Ellmerer, M; Korsatko, S; Ikeoka, D; Plank, J; Bodenlenz, M; Suppan, M; Sinner, F; Smolle, KH; Pieber, TR SUBKUTANES GLUKOSEMONITORING BEI PATIENTEN MIT SCHWERER SEPSIS.
Wiener Klinische Wochenschrift. -34. Jahrestagung der Österreichischen Diabetes Gesellschaft; NOV 16-18, 2006; Innsbruck, AUSTRIA. [Oral Communication]

 

Pachler, C; Ikeoka, D; Plank, J; Weinhandl, H; Mader, JK; Suppan, M; Falk, A; Bodenlenz, M; Mangge, H; Pieber, TR; Ellmerer, M Direkte Messung des Effektes von Insulin auf die Sekretion von proinflammatorischen Zytokinen im subkutanen Fettgewebe beim Menschen.
ZMF Tag 2006; 24. Oktober 2006; Graz, AUSTRIA. 2006. [Oral Communication]

 

Pachler, C; Ikeoka, D; Plank, J; Weinhandl, H; Mader, JK; Suppan, M; Falk, A; Bodenlenz, M; Mangge, H; Pieber, TR; Ellmerer, M Direkte Messung des Effektes von Insulin auf die Sekretion von proinflammatorischen Zytokinen im subkutanen Fettgewebe beim Menschen.
Wiener Klinische Wochenschrift. Supplementum 4; 118(19):14-14.-Jahrestagung des OEDG; Nov 16, 2006; Insbruck, Austria. [Oral Communication]

 

Weinhandl, H; Köhler, H; Pachler, C; Mader, J; Mautner, A; Falk, A; Ikeoka, D; Bodenlenz, M; Pieber, TR; Ellmerer, M Untersuchung des Effektes physiologischer Hyperinsulinämie auf den Zugang von Makromolekülen zu Insulin-sensitiven Geweben.
Wiener Klinische Wochenschrift. Supplement 4; 118(19):21-21.-34. Jahrestagung der Österreichischen Diabetes Gesellschaft; Nov 16-18, 2006; Innsbruck, Austria. [Poster]

 

Ellmerer, M; Haluzik, M; Blaha, J; Kremen, M; Svacina, S; Toller, W; Mader, J; Schaupp, L; Plank, J; Pieber, T Interstitielle Glukosemessung als Ersatz für Blutglukosemessung in Patienten nach kardiothorakalen Operationen
Wien Klin Wochenschr.. 2005; 117(Supp.5):4-4.-33. Jahrestagung der Österreichischen Diabetes Gesellschaft (ÖDG); DEC 1-3, 2005; Baden, AUSTRIA. [Poster]

 

↑ Top of page / Navigation

© Med Uni Graz • Imprint